Processing 00000000.tx.1: Msx homeobox genes inhibit differentiation through upregulation of cyclin D1

Phrase: "Msx homeobox genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017347:Genes, Homeo Box [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]
   827   C0242303:Homeo Box [Gene or Genome]
   827   C0598306:Homeo Box [Spatial Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "differentiation through upregulation of cyclin D1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0007589:Differentiation [Cell Function]
   753   C1511938:Differentiation [Clinical Attribute]
   753   C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.1: Gezhi Hu1,2,  Hansol Lee1,2,  Sandy M. 

Phrase: "Gezhi Hu1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Hansol Lee1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Sandy M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Price1,3,  Michael M. 

Phrase: "Price1,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "Michael M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: Shen1,3 and  Cory Abate-Shen1,2,*

Phrase: "Shen1,"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "Cory"

Phrase: "Abate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: "Shen1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "*"
Processing 00000000.tx.1: 1 Center for Advanced Biotechnology and Medicine, UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA

Phrase: "1 Center for Advanced Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013227:Medicine, NOS [Pharmacologic Substance]
  1000   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "UMDNJ-Robert Wood Johnson Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   799   C0036375:School [Manufactured Object,Organization]

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ 08854,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.1: 2 Department of Neuroscience and Cell Biology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA

Phrase: "2 Department of Neuroscience"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Cell Biology,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "UMDNJ-Robert Wood Johnson Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   799   C0036375:School [Manufactured Object,Organization]

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ 08854,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.1: 3 Department of Pediatrics, UMDNJRobert Wood Johnson Medical School, Piscataway, NJ 08854, USA

Phrase: "3 Department of Pediatrics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587482:department pediatrics [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "UMDNJRobert Wood Johnson Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   804   C0036375:School [Manufactured Object,Organization]

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ 08854,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.1: *Author for correspondence (e-mail: abate{at}cabm.rutgers.edu)

Phrase: "*Author for correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0221193:Author [Professional or Occupational Group]

Phrase: "(e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "abate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: "{at}cabm.rutgers.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: ")"
Processing 00000000.tx.1: Accepted May  4, 2001

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "May  4,"

Phrase: "2001"
Processing 00000000.tx.1: &nbsp;&nbsp; 

Phrase: "&nbsp"

Phrase: ";&nbsp"

Phrase: ";"
Processing 00000000.tx.2: SUMMARY

Phrase: "SUMMARY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.1: TOP

Phrase: "TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.1: SUMMARY

Phrase: "SUMMARY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.1: INTRODUCTION

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]
Processing 00000000.tx.1: MATERIALS AND METHODS

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.1: RESULTS

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.1: DISCUSSION

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.1: REFERENCES

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: During development, patterning and morphogenesis of tissues are intimately coordinated through control of cellular proliferation and differentiation. 

Phrase: "During development,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "patterning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "morphogenesis of tissues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C1657442:tissue morphogenesis [Organ or Tissue Function]
   790   C0026559:Morphogenesis [Organism Function]

Phrase: "are"

Phrase: "intimately"

Phrase: "coordinated through control of cellular proliferation"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   790   C0020507:Cellular proliferation [Pathologic Function]
   790   C0596290:Cellular Proliferation [Cell Function]
   753   C0007634:Cellular [Cell]
   753   C0178539:Cellular [Functional Concept]
   753   C0243148:control [Qualitative Concept]
   753   C0334094:Proliferation [Pathologic Function]
   753   C0427184:Coordinated [Finding]
   753   C0700114:Coordinated [Functional Concept]
   753   C1514485:Proliferation [Functional Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C1707511:Coordinate [Spatial Concept]

Phrase: "and"

Phrase: "differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.2: We describe a mechanism by which vertebrate Msx homeobox genes inhibit cellular differentiation by regulation of the cell cycle. 

Phrase: "We"

Phrase: "describe"

Phrase: "a mechanism by which vertebrate Msx homeobox genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "cellular differentiation by regulation of the cell cycle."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   815   C1160033:regulation of cell differentiation [Cell Function]
   770   C1511938:Cellular Differentiation [Clinical Attribute]
           Differentiation
   767   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   744   C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.3: We show that misexpression of Msx1 via retroviral gene transfer inhibits differentiation of multiple mesenchymal and epithelial progenitor cell types in culture. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that misexpression of Msx1"

Phrase: "via retroviral gene transfer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1517499:Gene Transfer [Molecular Biology Research Technique]
   827   C0017337:Gene [Gene or Genome]
   827   C0040671:Transfer [Mental Process]
   827   C1705822:Transfer [Activity]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "differentiation of multiple mesenchymal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1334700:Mesenchymal Differentiation [Finding]
   770   C0007589:Differentiation [Cell Function]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "and"

Phrase: "epithelial progenitor cell types in culture."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0038250:Progenitor Cell [Cell]
   790   C0449475:Cell types [Intellectual Product]
   783   C0007585:Cell Culture [Laboratory Procedure]
   783   C0014597:Epithelial cell [Cell]
   756 E C0007634:Cell Type [Cell]
           Cell
   753   C0332307:Types [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.4: This activity of Msx1 is associated with its ability to upregulate cyclin D1 expression and Cdk4 activity, while Msx1 has minimal effects on cellular proliferation. 

Phrase: "This activity of Msx1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "associated with its ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0085732:Ability [Organism Attribute]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "upregulate"

Phrase: "cyclin D1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Cdk4 activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "while"

Phrase: "Msx1"

Phrase: "has"

Phrase: "minimal effects on cellular proliferation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.5: Transgenic mice that express Msx1 under the control of the mouse mammary tumor virus long terminal repeat (MMTV LTR) display impaired differentiation of the mammary epithelium during pregnancy, which is accompanied by elevated levels of cyclin D1 expression. 

Phrase: "Transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "express"

Phrase: "Msx1 under the control"

Phrase: "of the mouse mammary tumor virus long terminal repeat (MMTV LTR) display impaired differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   835   C2752630:terminal differentiation [Cell Function]
   790   C0007589:Differentiation [Cell Function]
   790   C1511938:Differentiation [Clinical Attribute]
   790   C2945687:Differentiation [Functional Concept]
   718 E C0205615:Differentiated [Qualitative Concept]

Phrase: "of the mammary epithelium"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0596882:Mammary Epithelium [Body Part, Organ, or Organ Component]
   861   C0014609:Epithelium [Tissue]
   789 E C0221908:Epithelial [Qualitative Concept]

Phrase: "during pregnancy,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "which"

Phrase: "is"

Phrase: "accompanied by elevated levels of cyclin D1 expression."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   770   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C3244092:expression level [Idea or Concept]
   744   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205250:Elevated [Qualitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C1150565:cyclin [Molecular Function]
   744   C1416886:D1 [Gene or Genome]
   744   C3163633:Elevated [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.6: We propose that Msx1 gene expression maintains cyclin D1 expression and prevents exit from the cell cycle, thereby inhibiting terminal differentiation of progenitor cells. 

Phrase: "We"

Phrase: "propose"

Phrase: "that Msx1 gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1417387:MSX1 gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "maintains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "cyclin D1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "exit from the cell cycle,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0337094:Exit [Spatial Concept]
   760   C1550550:exit [Temporal Concept]

Phrase: "thereby"

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "terminal differentiation of progenitor cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C2752630:terminal differentiation [Cell Function]
   797   C0007589:cells differentiation [Cell Function]
           Differentiation
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.7: Our model provides a framework for reconciling the mutant phenotypes of Msx and other homeobox genes with their functions as regulators of cellular proliferation and differentiation during embryogenesis.

Phrase: "Our model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a framework for reconciling"

Phrase: "the mutant phenotypes of Msx"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0031437:Phenotypes [Organism Attribute]
   726 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "and"

Phrase: "other homeobox genes with their functions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0017347:Genes, Homeo Box [Gene or Genome]
   767   C0314627:function genes [Genetic Function]
   753   C0017337:Genes [Gene or Genome]
   753   C0242303:Homeo Box [Gene or Genome]
   753   C0598306:Homeo Box [Spatial Concept]

Phrase: "as regulators"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0182953:regulators [Medical Device]
   966 E C1704734:Regulator [Medical Device]
   966 E C1704735:Regulator [Conceptual Entity]

Phrase: "of cellular proliferation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020507:Cellular proliferation [Pathologic Function]
  1000   C0596290:Cellular Proliferation [Cell Function]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "differentiation during embryogenesis."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0007589:Differentiation [Cell Function]
   790   C1511938:Differentiation [Clinical Attribute]
   790   C2945687:Differentiation [Functional Concept]
   718 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.1: Key words: Cell cycle, Differentiation, Proliferation, Homeobox genes, Transgenic mice, Mammary gland

Phrase: "Key words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "Cell cycle,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "Differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "Proliferation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "Homeobox genes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017347:Genes, Homeo Box [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]
   861   C0242303:Homeo Box [Gene or Genome]
   861   C0598306:Homeo Box [Spatial Concept]

Phrase: "Transgenic mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "Mammary gland"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0929301:Mammary gland [Body Part, Organ, or Organ Component]
           Mammary
  1000   C1521747:GLAND, MAMMARY [Tissue]
   861   C0006141:Mammary [Body Part, Organ, or Organ Component]
   861   C1285092:Gland [Body Part, Organ, or Organ Component]
Processing 00000000.tx.1: &nbsp;&nbsp; 

Phrase: "&nbsp"

Phrase: ";&nbsp"

Phrase: ";"
Processing 00000000.tx.2: INTRODUCTION

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]
Processing 00000000.tx.1: TOP

Phrase: "TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.1: SUMMARY

Phrase: "SUMMARY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.1: INTRODUCTION

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]
Processing 00000000.tx.1: MATERIALS AND METHODS

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.1: RESULTS

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.1: DISCUSSION

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.1: REFERENCES

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Homeobox genes are a large family of developmental regulatory genes that have diverse activities during embryogenesis. 

Phrase: "Homeobox genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017347:Genes, Homeo Box [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]
   861   C0242303:Homeo Box [Gene or Genome]
   861   C0598306:Homeo Box [Spatial Concept]

Phrase: "are"

Phrase: "a large family of developmental regulatory genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0424972:Large family [Family Group]
   757   C1517488:Gene Family [Gene or Genome]
   748   C0015576:Family [Family Group]
   748   C1704727:Family [Conceptual Entity]

Phrase: "that"

Phrase: "have"

Phrase: "diverse activities during embryogenesis."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441655:Activities [Activity]
   737 E C0205177:Activity [Functional Concept]
   737 E C0439167:% activity [Quantitative Concept]
   737 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.2: The biological functions of many homeobox genes have been elucidated through loss- and gain-of-function analyses, which have demonstrated their essential roles in controlling cellular proliferation and differentiation during development. 

Phrase: "The biological functions of many homeobox genes"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   757   C0314627:function genes [Genetic Function]
   748   C0005532:Biological [Biomedical Occupation or Discipline]
   748   C0205460:biological [Qualitative Concept]
   748   C0542341:Functions [Functional Concept]
   745   C0031845:Biological function, NOS [Physiologic Function]
   714 E C0031843:function [Physiologic Function]
   714 E C0700205:FUNCTION [Classification]
   714 E C1705273:Function [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "elucidated through loss-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "gain-of-function analyses,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   808   C0558024:Functional analysis [Health Care Activity]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "which"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "their essential roles in controlling cellular proliferation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0035820:Roles [Social Behavior]
   714 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "differentiation during development."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0007589:Differentiation [Cell Function]
   790   C1511938:Differentiation [Clinical Attribute]
   790   C2945687:Differentiation [Functional Concept]
   718 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.3: However, the molecular mechanisms by which homeoproteins mediate these activities have not been examined extensively.

Phrase: "However,"

Phrase: "the molecular mechanisms by which homeoproteins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "these activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "extensively."
Processing 00000000.tx.1: The vertebrate Msx homeobox gene family contains three members, two of which (Msx1 and Msx2) have been well studied with respect to their expression patterns and biochemical properties (reviewed by Bendall and Abate-Shen, 2000; Davidson, 1995). 

Phrase: "The vertebrate Msx homeobox gene family"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C1517488:Gene Family [Gene or Genome]
   804   C0015576:Family [Family Group]
   804   C1704727:Family [Conceptual Entity]
   733 E C0241888:Familial [Functional Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "three members,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680022:members [Population Group]
   827 E C2698041:Member [Professional or Occupational Group]

Phrase: "two of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205448:Two [Quantitative Concept]

Phrase: "(Msx1"

Phrase: "and"

Phrase: "Msx2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417388:MSX2 [Gene or Genome]

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "well studied with respect to their expression patterns"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205170:Well [Qualitative Concept]
   744   C3146287:Well [Manufactured Object]
   711   C0557651:Study [Manufactured Object]
   711   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "biochemical properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "("

Phrase: "reviewed by Bendall"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "Abate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: "Shen,"

Phrase: "2000"

Phrase: "; Davidson,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.2: These genes encode closely related homeoproteins that function as transcriptional repressors through interactions with components of the core transcription complex as well as other homeoproteins (Catron et al., 1996; Catron et al., 1995; Zhang et al., 1996; Zhang et al., 1997). 

Phrase: "These genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "closely related homeoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242617:Homeoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "function as transcriptional repressors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   816   C1336789:Transcriptional Repressor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Repressor
   770   C0031843:function [Physiologic Function]
   770   C0040649:Transcriptional [Genetic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "through interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "with components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "of the core transcription complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "as well as"

Phrase: "other homeoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242617:Homeoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Catron et al.,"

Phrase: "1996"

Phrase: "; Catron et al.,"

Phrase: "1995"

Phrase: "; Zhang et al.,"

Phrase: "1996"

Phrase: "; Zhang et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.3: Both Msx1 and Msx2 are expressed in overlapping spatial and temporal domains during development, in discrete regions of the facial primordia, limbs, neural tube and other embryonic regions (Bendall and Abate-Shen, 2000; Davidson, 1995).

Phrase: "Both Msx1"

Phrase: "and"

Phrase: "Msx2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417388:MSX2 [Gene or Genome]

Phrase: "are"

Phrase: "expressed in overlapping spatial"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0185027:Overlapping [Therapeutic or Preventive Procedure]
   770   C1428114:spatial [Gene or Genome]
   770   C1948020:Overlapping [Conceptual Entity]

Phrase: "and"

Phrase: "temporal domains during development,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1880389:Domain [Functional Concept]
   737   C1883221:Domain [Conceptual Entity]
   737   C3541951:Domain [Intellectual Product]

Phrase: "in discrete regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "of the facial primordia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678727:Primordium [Organ or Tissue Function]

Phrase: "limbs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015385:Limbs [Body Part, Organ, or Organ Component]
   966 E C1280090:Limb [Body Part, Organ, or Organ Component]

Phrase: "neural tube"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0231024:Neural tube [Embryonic Structure]
   861   C0175730:Tube [Medical Device]
   861   C0599851:Neural [Functional Concept]
   861   C1547937:Tube NOS [Intellectual Product]
   861   C1561954:tube [Conceptual Entity]
   861   C1704730:TUBE [Medical Device]
   805 E C0027740:Nerve [Tissue]
   805 E C0027757:NERVE [Tissue]
   805 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   768 E C0027769:nervy [Sign or Symptom]

Phrase: "and"

Phrase: "other embryonic regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "(Bendall"

Phrase: "and"

Phrase: "Abate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: "Shen,"

Phrase: "2000"

Phrase: "; Davidson,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.1: Although they are expressed in relatively diverse tissues, a common feature of Msx gene expression is its association with multipotent progenitor cells. 

Phrase: "Although"

Phrase: "they"

Phrase: "are"

Phrase: "expressed in relatively diverse tissues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040300:Tissues [Tissue]
   760   C1880371:Diverse [Qualitative Concept]
   726 E C1547928:Tissue [Intellectual Product]

Phrase: "a common feature of Msx gene expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1517022:Expression Feature [Conceptual Entity]
   774   C1517495:Gene Feature [Gene or Genome]
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]

Phrase: "is"

Phrase: "its association with multipotent progenitor cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]
Processing 00000000.tx.2: For example, expression of Msx1 is robust in the progress zone of the limb bud, which corresponds to a region of highly proliferative, multipotential cells that give rise to chondrogenic and osteogenic derivatives of the limb. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "expression of Msx1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "robust in the progress zone of the limb bud,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2986815:Robust [Qualitative Concept]

Phrase: "which"

Phrase: "corresponds to a region of highly proliferative, multipotential cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   745   C1268228:Cell region [Cell Component]
   742   C0007634:Cells [Cell]
   742   C0017446:Region [Geographic Area]
   742   C0205147:Region [Spatial Concept]
   742   C0205250:Highly [Qualitative Concept]
   742   C0334094:Proliferative [Pathologic Function]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to chondrogenic"

Phrase: "and"

Phrase: "osteogenic derivatives of the limb."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0243072:derivatives [Chemical Viewed Structurally]
   726 E C1527240:Derivative [Functional Concept]
Processing 00000000.tx.3: In contrast, Msx1 is not expressed in the more proximal regions of the limb, where cells have ceased to proliferate and have begun to undergo differentiation (Bendall and Abate-Shen, 2000; Davidson, 1995). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "Msx1"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "expressed in the more proximal regions of the limb,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   773   C0504081:Region of limb [Body Location or Region]
           Limb region
   742   C0015385:Limb [Body Part, Organ, or Organ Component]
   742   C0205107:Proximal [Spatial Concept]
   742   C1280090:Limb [Body Part, Organ, or Organ Component]
   708   C0017446:Region [Geographic Area]
   708   C0205147:Region [Spatial Concept]

Phrase: "where cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "ceased"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947925:Cease [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "proliferate"

Phrase: "and"

Phrase: "have"

Phrase: "begun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "undergo"

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(Bendall"

Phrase: "and"

Phrase: "Abate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: "Shen,"

Phrase: "2000"

Phrase: "; Davidson,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.4: These, and other observations, have led to the hypothesis that Msx genes promote cellular proliferation, and that their expression is inversely correlated with differentiation (Bendall et al., 1999; Dodig et al., 1999; Mina et al., 1996; Pavlova et al., 1994; Song et al., 1992; Woloshin et al., 1995).

Phrase: "These,"

Phrase: "and"

Phrase: "other observations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "have"

Phrase: "led to the hypothesis"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C1512571:Hypothesis [Idea or Concept]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that Msx genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cellular proliferation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020507:Cellular proliferation [Pathologic Function]
  1000   C0596290:Cellular Proliferation [Cell Function]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "that"

Phrase: "their expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "inversely"

Phrase: "correlated with differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0007589:Differentiation [Cell Function]
   790   C1511938:Differentiation [Clinical Attribute]
   790   C1707520:Correlated [Qualitative Concept]
   790   C2945687:Differentiation [Functional Concept]
   718 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(Bendall et al.,"

Phrase: "1999"

Phrase: "; Dodig et al.,"

Phrase: "1999"

Phrase: "; Mina et al.,"

Phrase: "1996"

Phrase: "; Pavlova et al.,"

Phrase: "1994"

Phrase: "; Song et al.,"

Phrase: "1992"

Phrase: "; Woloshin et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.1: This model has garnered support from cell culture data, which have shown that forced expression of Msx1 in myogenic precursors blocks their differentiation and represses expression of lineage specific genes, such as MyoD (Myod1  Mouse Genome Informatics) (Song et al., 1992; Woloshin et al., 1995). 

Phrase: "This model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "has"

Phrase: "garnered"

Phrase: "support from cell culture data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0183683:Support [Medical Device]
   760   C1521721:Support [Conceptual Entity]

Phrase: "which"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that forced expression of Msx1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in myogenic precursors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709634:Precursor [Idea or Concept]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "their differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "represses"

Phrase: "expression of lineage specific genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "such as MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "(Myod1  Mouse Genome Informatics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1709079:Mouse Genome Informatics [Intellectual Product]
   812   C0599807:Informatics [Occupation or Discipline]
   812   C1552237:Informatics [Professional or Occupational Group]

Phrase: ")"

Phrase: "(Song et al.,"

Phrase: "1992"

Phrase: "; Woloshin et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.2: Moreover, ectopic expression of Msx1 during chicken embryogenesis inhibits development of the limb musculature and represses MyoD expression in vivo (Bendall et al., 1999). 

Phrase: "Moreover,"

Phrase: "ectopic expression of Msx1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1512167:Ectopic Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "during chicken embryogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013936:Embryogenesis [Organ or Tissue Function]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "development of the limb musculature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1517884:Limb Development [Organ or Tissue Function]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "represses"

Phrase: "MyoD expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(Bendall et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.3: Msx genes have also been implicated as inhibitors of chondrogenic and osteogenic differentiation in culture (Dodig et al., 1999; Mina et al., 1996), suggesting that these activities may not be limited to the myogenic lineage. 

Phrase: "Msx genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "implicated as inhibitors of chondrogenic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "osteogenic differentiation in culture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007589:Differentiation [Cell Function]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "(Dodig et al.,"

Phrase: "1999"

Phrase: "; Mina et al.,"

Phrase: "1996"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "limited to the myogenic lineage."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0439801:Limited [Functional Concept]
   760   C1881379:Lineage [Conceptual Entity]
   760   C3542948:Limited [Intellectual Product]
   726 E C1549649:Limit [Idea or Concept]
   726 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.4: Furthermore, the phenotypes of Msx loss- or gain-of-function mutations are also consistent with roles for Msx genes in regulating cellular proliferation and differentiation in vivo (Jabs et al., 1993; Liu et al., 1995; Satokata et al., 2000; Satokata and Maas, 1994; Wilkie et al., 2000; Winograd et al., 1997).

Phrase: "Furthermore,"

Phrase: "the phenotypes of Msx loss-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0031437:Phenotypes [Organism Attribute]
   726 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "or"

Phrase: "gain-of-function mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "also consistent with roles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "for Msx genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "in"

Phrase: "regulating"

Phrase: "cellular proliferation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020507:Cellular proliferation [Pathologic Function]
  1000   C0596290:Cellular Proliferation [Cell Function]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "("

Phrase: "Jabs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1426208:JAB [Gene or Genome]
  1000   C3273630:JAB [Gene or Genome]
  1000   C3275256:JAB [Amino Acid, Peptide, or Protein]

Phrase: "et al.,"

Phrase: "1993"

Phrase: "; Liu et al.,"

Phrase: "1995"

Phrase: "; Satokata et al.,"

Phrase: "2000"

Phrase: "; Satokata"

Phrase: "and"

Phrase: "Maas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1416953:MAA [Gene or Genome]
   966   C1979919:MAA [Indicator, Reagent, or Diagnostic Aid]

Phrase: "1994"

Phrase: "; Wilkie et al.,"

Phrase: "2000"

Phrase: "; Winograd et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.1: We have explored the mechanism(s) by which Msx genes, particularly Msx1, function as negative regulators of differentiation. 

Phrase: "We"

Phrase: "have"

Phrase: "explored"

Phrase: "the mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "("

Phrase: "s) by which Msx genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017337:Genes [Gene or Genome]
   760   C2603362:S' [Clinical Attribute]

Phrase: "particularly Msx1,"

Phrase: "function as negative regulators of differentiation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
   748   C2752631:functional differentiation [Cell Function]
Processing 00000000.tx.2: Using both cell culture and in vivo model systems, we demonstrate that Msx1 inhibits the differentiation of multiple mesenchymal and epithelial cell types. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "in vivo model systems,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   844   C0026339:Model System [Intellectual Product,Research Device]
   844   C3161035:Model System [Intellectual Product]
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   756   C1515657:In Vivo Model [Research Activity]
   729 E C0205373:Systemic [Functional Concept]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that Msx1"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the differentiation of multiple mesenchymal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1334700:Mesenchymal Differentiation [Finding]
   760   C0007589:Differentiation [Cell Function]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "and"

Phrase: "epithelial cell types."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0449475:Cell types [Intellectual Product]
   867 E C0007634:Cell Type [Cell]
   827   C0332307:Types [Qualitative Concept]
   793 E C1547052:*Type [Quantitative Concept]
   734   C0014597:Epithelial cell [Cell]
Processing 00000000.tx.3: This inhibition is associated with upregulation of cyclin D1 (Ccnd1  Mouse genome Informatics) expression as well as Cdk4 activity, while Msx1 has minimal effects on cellular proliferation. 

Phrase: "This inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "is"

Phrase: "associated with upregulation of cyclin D1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0162493:Up-Regulation [Genetic Function]
   753   C1150565:cyclin [Molecular Function]
   753   C1416886:D1 [Gene or Genome]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Ccnd1  Mouse genome Informatics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1709079:Mouse Genome Informatics [Intellectual Product]
   812   C0599807:Informatics [Occupation or Discipline]
   812   C1552237:Informatics [Professional or Occupational Group]

Phrase: ")"

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "as well as"

Phrase: "Cdk4 activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "while"

Phrase: "Msx1"

Phrase: "has"

Phrase: "minimal effects on cellular proliferation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.4: Transgenic mice that overexpress Msx1 in the mammary gland display significant defects in epithelial differentiation during pregnancy, which are correlated with increased cyclin D1 expression. 

Phrase: "Transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "Msx1 in the mammary gland"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "significant defects in epithelial differentiation"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0243067:defects [Functional Concept]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "during pregnancy,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "which"

Phrase: "are"

Phrase: "correlated with increased cyclin D1 expression."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1150565:cyclin [Molecular Function]
   753   C1416886:D1 [Gene or Genome]
   753   C1707520:Correlated [Qualitative Concept]
Processing 00000000.tx.5: We propose a model in which Msx1 prevents exit from the cell cycle by maintaining high levels of cyclin D1 expression, thereby blocking terminal differentiation of progenitor cell populations.

Phrase: "We"

Phrase: "propose"

Phrase: "a model in which Msx1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "exit from the cell cycle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0337094:Exit [Spatial Concept]
   760   C1550550:exit [Temporal Concept]

Phrase: "by maintaining high levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "of cyclin D1 expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "thereby"

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "terminal differentiation of progenitor cell populations."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C2752630:terminal differentiation [Cell Function]
   783   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   753   C1511938:Differentiation [Clinical Attribute]
   753   C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.1: &nbsp;&nbsp; 

Phrase: "&nbsp"

Phrase: ";&nbsp"

Phrase: ";"
Processing 00000000.tx.2: MATERIALS AND METHODS

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.1: TOP

Phrase: "TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.1: SUMMARY

Phrase: "SUMMARY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.1: INTRODUCTION

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]
Processing 00000000.tx.1: MATERIALS AND METHODS

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.1: RESULTS

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.1: DISCUSSION

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.1: REFERENCES

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Retroviral and transgenic expression plasmids

Phrase: "Retroviral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035366:Retroviral [Virus]

Phrase: "and"

Phrase: "transgenic expression plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.1: Mammalian retroviruses were made in a derivative of LZRSpBMN-Z (Kinsella and Nolan, 1996) in which the lacZ gene was excised to make pLZRS. 

Phrase: "Mammalian retroviruses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035366:Retroviruses [Virus]

Phrase: "were"

Phrase: "made in a derivative of LZRSpBMN-Z (Kinsella"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1527240:Derivative [Functional Concept]
   711   C1881534:Make [Functional Concept]

Phrase: "and"

Phrase: "Nolan,"

Phrase: "1996"

Phrase: ")"

Phrase: "in which"

Phrase: "the lacZ gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022959:LacZ Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "excised"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "pLZRS."
Processing 00000000.tx.2: Sequences corresponding to the coding region of Msx1, Msx2, a mutated Msx1 derivative (Msx1A; Zhang et al., 1996), Hoxa7, Hoxc8, Dlx2 and Dlx5 were subcloned as BamHI-HindIII fragments into pLZRS. 

Phrase: "Sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "corresponding to the coding region of Msx1,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0079941:Coding Region [Gene or Genome]
   748   C0009219:Coding [Occupational Activity]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   714 E C0805701:Code [Intellectual Product]

Phrase: "Msx2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417388:MSX2 [Gene or Genome]

Phrase: "a mutated Msx1 derivative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1527240:Derivative [Functional Concept]

Phrase: "(Msx1A"

Phrase: "; Zhang et al.,"

Phrase: "1996"

Phrase: ")"

Phrase: ","

Phrase: "Hoxa7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415661:HOXA7 [Gene or Genome]

Phrase: "Hoxc8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415680:HOXC8 [Gene or Genome]

Phrase: "Dlx2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414076:DLX2 [Gene or Genome]

Phrase: "and"

Phrase: "Dlx5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414079:DLX5 [Gene or Genome]

Phrase: "were"

Phrase: "subcloned as BamHI-HindIII"

Phrase: "fragments into pLZRS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332255:fragment [Functional Concept]
   790   C0486805:Fragments [Body Substance]
   790   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.3: Each contains an N-terminal Myc epitope, which allows for detection with an anti-Myc monoclonal antibody. 

Phrase: "Each"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an N-terminal Myc epitope,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003316:Epitope [Immunologic Factor]

Phrase: "which"

Phrase: "allows for detection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0683607:allow [Social Behavior]
   790   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "with an anti-Myc monoclonal antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]
Processing 00000000.tx.4: Truncated Msx1 genes, designated Msx11, Msx12 and Msx13, correspond to amino acid sequences 2-270, 158-270 and 158-293, respectively. 

Phrase: "Truncated Msx1 genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1417387:MSX1 gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "designated Msx11,"

Phrase: "Msx12"

Phrase: "and"

Phrase: "Msx13,"

Phrase: "correspond to amino acid sequences 2-270,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   814   C0002518:Sequences, Amino Acid [Amino Acid Sequence]
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0162326:Sequences [Nucleotide Sequence]
   748   C0202406:Acid [Laboratory Procedure]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "158-270"

Phrase: "and"

Phrase: "158-293,"

Phrase: "respectively."
Processing 00000000.tx.5: These were generated by PCR amplification and subcloned as BamHI-HindIII fragments into pLZRS. 

Phrase: "These"

Phrase: "were"

Phrase: "generated by PCR amplification"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C1517480:Amplification [Molecular Biology Research Technique]
   770   C1521871:Amplification [Phenomenon or Process]
   770   C1705759:Amplification [Cell or Molecular Dysfunction]
   770   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "subcloned as BamHI-HindIII"

Phrase: "fragments into pLZRS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332255:fragment [Functional Concept]
   790   C0486805:Fragments [Body Substance]
   790   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.6: The Msx1-estrogen receptor fusion gene (Msx11-ER) was generated using PCR amplification to join sequences corresponding to Msx11(2-270) with the amino acids 281-599 of the estrogen receptor tamoxifen mutant (MOR G525R) (Littlewood et al., 1995) and cloned into the BamHI-HindIII sites of pLZRS. 

Phrase: "The Msx1-estrogen receptor fusion gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C1417387:MSX1 gene [Gene or Genome]
   853   C1335671:Receptor Gene [Gene or Genome]
   840   C1533585:Fusion Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]

Phrase: "(Msx11-ER)"

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PCR amplification to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1517480:Amplification [Molecular Biology Research Technique]
   790   C1521871:Amplification [Phenomenon or Process]
   790   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "join"

Phrase: "sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "corresponding to Msx11"

Phrase: "(2-270"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "with the amino acids 281-599"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "of the estrogen receptor tamoxifen mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(MOR G525R"

Phrase: ")"

Phrase: "(Littlewood et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: "and"

Phrase: "cloned into the BamHI-HindIII sites of pLZRS."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   754   C2945843:Site of [Qualitative Concept]
   744   C0009013:cloned [Cell]
   744   C0205145:Sites [Spatial Concept]
   711 E C1515974:Site [Body Location or Region]
   711 E C1522642:Clone [Tissue]
   711 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.7: The cyclin D1 retrovirus was made by subcloning pFLEX-Flag-D1 (Diehl and Sherr, 1997) into pLZRS. 

Phrase: "The cyclin D1 retrovirus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035366:Retrovirus [Virus]
   734   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "made by subcloning pFLEX-Flag-D1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1416886:D1 [Gene or Genome]
   753   C1708067:Flag [Functional Concept]
   719   C1881534:Make [Functional Concept]

Phrase: "(Diehl"

Phrase: "and"

Phrase: "Sherr,"

Phrase: "1997"

Phrase: ")"

Phrase: "into pLZRS."
Processing 00000000.tx.8: Avian retroviruses, RCASBP(A)-Msx1 and RCASBP(A)-Msx1A, were described (Bendall et al., 1999; Hu et al., 1998). 

Phrase: "Avian retroviruses,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1622661:Avian retroviruses [Virus]
   983 E C0004423:Avian Retrovirus [Virus]
   983 E C1223849:Avian retrovirus [Virus]
   861   C0035366:Retroviruses [Virus]

Phrase: "RCASBP"

Phrase: "(A)-Msx1"

Phrase: "and"

Phrase: "RCASBP"

Phrase: "(A)-Msx1A,"

Phrase: "were"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Bendall et al.,"

Phrase: "1999"

Phrase: "; Hu et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.9: The transgenic plasmid, MMTV-Msx1, was made by cloning the full-length coding region of Msx1 with Kozak sequences preserved into the HindIII site of the MMTV-SV40-BSSK (Stewart et al., 1984). 

Phrase: "The transgenic plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "MMTV-Msx1,"

Phrase: "was"

Phrase: "made by cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0009015:Cloning [Research Activity]
   756   C1881534:Make [Functional Concept]

Phrase: "the full-length coding region of Msx1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0079941:Coding Region [Gene or Genome]
   748   C0009219:Coding [Occupational Activity]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   714 E C0805701:Code [Intellectual Product]

Phrase: "with Kozak sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "preserved into the HindIII site of the MMTV-SV40-BSSK"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C2945843:Site of [Qualitative Concept]
   739   C0024662:MMTV [Virus]
   739   C0033085:Preserved [Laboratory Procedure]
   739   C0038975:SV 40 [Virus]
   739   C0205145:Site [Spatial Concept]
   739   C1515974:Site [Body Location or Region]
   739   C2825164:Site [Spatial Concept]

Phrase: "(Stewart et al.,"

Phrase: "1984"

Phrase: ")."
Processing 00000000.tx.10: The complete sequences of all PCR-amplified constructs were confirmed. 

Phrase: "The complete sequences of all PCR-amplified constructs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0162326:Sequences [Nucleotide Sequence]
   711 E C0004793:Sequence [Nucleotide Sequence]
   711 E C0162327:Sequence [Nucleotide Sequence]
   711 E C1519249:Sequence [Functional Concept]

Phrase: "were"

Phrase: "confirmed."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.11: Expression of retrovirally expressed proteins was verified by western blot analysis using lysates from infected C2C12 cells (for mammalian retroviruses, Fig. 3B and data not shown) or chicken embryonic fibroblasts (for avian retroviruses, data not shown).

Phrase: "Expression of retrovirally expressed proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "verified by western blot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   760   C1711411:Verified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "lysates from infected C2C12 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "("

Phrase: "for mammalian retroviruses,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035366:Retroviruses [Virus]

Phrase: "Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "chicken embryonic fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016030:Fibroblasts [Cell]

Phrase: "("

Phrase: "for avian retroviruses,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1622661:Avian retroviruses [Virus]
   983 E C0004423:Avian Retrovirus [Virus]
   983 E C1223849:Avian retrovirus [Virus]
   861   C0035366:Retroviruses [Virus]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.1: View larger version (82K):

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(82K"

Phrase: ")"

Phrase: ":"
Processing 00000000.tx.1: [in this window]

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"
Processing 00000000.tx.1: [in a new window] &nbsp;

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "] &nbsp"

Phrase: ";"
Processing 00000000.tx.1: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.2: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.3: Msx1 upregulates cyclin D1 expression and Cdk4 activity. 

Phrase: "Msx1"

Phrase: "upregulates"

Phrase: "cyclin D1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Cdk4 activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.4: (A) C2C12 cells were infected with a control retrovirus (Vector) or retroviruses expressing Msx1 or cyclin D1 and grown under normal culture conditions (a, undifferentiated) or conditions that promote differentiation (b-d, differentiated). 

Phrase: "(A) C2C12 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "infected with a control retrovirus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0035366:Retrovirus [Virus]
   760   C0243148:control [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "retroviruses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035366:Retroviruses [Virus]

Phrase: "expressing"

Phrase: "Msx1"

Phrase: "or"

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "and"

Phrase: "grown under normal culture conditions"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   781   C0231162:Normal condition [Finding]
   760   C0010453:Culture [Idea or Concept]
   760   C0205307:Normal [Qualitative Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439166:% normal [Quantitative Concept]
   760   C2242979:Culture [Laboratory Procedure]
   760   C2347086:% Normal [Quantitative Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "("

Phrase: "a,"

Phrase: "undifferentiated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205618:Undifferentiated [Qualitative Concept]
  1000   C1524083:Undifferentiated [Organism Attribute]
  1000   C1704620:Undifferentiated [Organism Attribute]

Phrase: ")"

Phrase: "or"

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "that"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(b-d,"

Phrase: "differentiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007589:Differentiated [Cell Function]
  1000   C0205615:Differentiated [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.5: Scale bar: 0.1 mm. 

Phrase: "Scale bar"

Phrase: ":"

Phrase: "0.1 mm."
Processing 00000000.tx.6: (B,C) Western blot analysis was performed using extracts prepared from C2C12 cells infected with a control retrovirus (Vector) or with retroviruses expressing Msx1 or Msx1A, followed by cell growth under normal culture conditions (undifferentiated) or conditions that promote differentiation (differentiated). 

Phrase: "(B,C) Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   840   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   804   C1705493:Western [Spatial Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "prepared from C2C12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1521827:Prepare [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "infected with a control retrovirus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0035366:Retrovirus [Virus]
   760   C0243148:control [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or with retroviruses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035366:Retroviruses [Virus]

Phrase: "expressing"

Phrase: "Msx1"

Phrase: "or"

Phrase: "Msx1A,"

Phrase: "followed by cell growth"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0007595:Cell Growth [Cell Function]
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0007634:Cell [Cell]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1269647:Cell [Cell]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C2911660:Growth [Activity]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "under normal culture conditions"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   896   C0231162:Normal condition [Finding]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(undifferentiated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205618:Undifferentiated [Qualitative Concept]
  1000   C1524083:Undifferentiated [Organism Attribute]
  1000   C1704620:Undifferentiated [Organism Attribute]

Phrase: ")"

Phrase: "or"

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "that"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(differentiated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0007589:Differentiated [Cell Function]
  1000   C0205615:Differentiated [Qualitative Concept]
   928 E C1511938:Differentiation [Clinical Attribute]
   928 E C2945687:Differentiation [Functional Concept]

Phrase: ")."
Processing 00000000.tx.7: The panels show whole-cell extracts probed with the indicated antibodies, except for panels labeled -Cdk4 nuclear or -Cdk2 nuclear, in which nuclear extracts were used. 

Phrase: "The panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "whole-cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0007592:Cell Extracts [Cell Component]
   793   C2828366:Extract [Substance]

Phrase: "probed with the indicated antibodies,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C1444656:Indicated [Finding]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "except for panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "labeled -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "Cdk4 nuclear or -Cdk2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0108855:CDK2 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1332733:CDK2 [Gene or Genome]

Phrase: "nuclear,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "in which nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.8: RNA polymerase II (-RNA PolII) is a control for protein loading. 

Phrase: "RNA polymerase II (-RNA PolII)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0035679:RNA Polymerase II [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0140652:RNA II [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0035681:RNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C2984241:RNA polymerase [Functional Concept]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a control for protein loading."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.9: (D) Cdk4 and Cdk2 kinase assays were performed using cell lysates from undifferentiated C2C12 cells or 293T cells infected with a control retrovirus (Vector) or those expressing Msx1 or Msx1A. 

Phrase: "("

Phrase: "D)"

Phrase: "Cdk4"

Phrase: "and"

Phrase: "Cdk2 kinase assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cell lysates from undifferentiated C2C12 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "or"

Phrase: "293T cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "infected with a control retrovirus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0035366:Retrovirus [Virus]
   760   C0243148:control [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "those expressing Msx1"

Phrase: "or"

Phrase: "Msx1A."
Processing 00000000.tx.10: The indicated kinases were immunoprecipitated using the corresponding antisera and kinase assays were performed using GST-Rb (amino acids 379-792) as substrate. 

Phrase: "The indicated kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the corresponding antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "kinase assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GST-Rb (amino acids 379-792"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C0001128:Acids [Chemical]
   793 E C2917660:Amino Acid [Pharmacologic Substance]
   766 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "as"

Phrase: "substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.11: Similar results were obtained using lysates prepared from differentiated C2C12 cells (data not shown).

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "prepared from differentiated C2C12 cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   762   C0007589:cells differentiation [Cell Function]
           Differentiated
   760   C0007634:Cells [Cell]
   760   C0205615:Differentiated [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1521827:Prepare [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Retroviral gene transfer and differentiation assays

Phrase: "Retroviral gene transfer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1517499:Gene Transfer [Molecular Biology Research Technique]
   827   C0017337:Gene [Gene or Genome]
   827   C0040671:Transfer [Mental Process]
   827   C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "differentiation assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.1: Production of replication-competent avian retroviruses was described previously (Bendall et al., 1999; Hu et al., 1998). 

Phrase: "Production of replication-competent avian retroviruses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Bendall et al.,"

Phrase: "1999"

Phrase: "; Hu et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.2: Replication-defective mammalian retroviruses were made in Phoenix ecotropic retroviral packaging cells (ATCC) by transfection of the relevant pLZRS plasmids using Lipofectamine Reagent (GIBCO-BRL). 

Phrase: "Replication-defective mammalian retroviruses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035366:Retroviruses [Virus]

Phrase: "were"

Phrase: "made in Phoenix ecotropic retroviral packaging cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   748   C0007634:Cells [Cell]
   748   C0013194:Packaging [Medical Device]
   748   C0030176:Packaging [Human-caused Phenomenon or Process]
   748   C0035366:Retroviral [Virus]
   748   C0331993:Phoenix [Health Care Related Organization]
   748   C1080696:Phoenix [Plant]
   748   C2828395:Packaging [Activity]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714   C1881534:Make [Functional Concept]
   714 E C1948049:Cell [Spatial Concept]
   714 E C2700580:Package [Manufactured Object]

Phrase: "(ATCC) by transfection of the relevant pLZRS plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0598079:ATCC [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Lipofectamine Reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(GIBCO-BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.3: Viral supernatants were collected 24 hours after transfected cells reached confluence; 

Phrase: "Viral supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "24 hours after transfected cells"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0439584:24 hours [Temporal Concept]
   806   C0456696:/24 hours [Temporal Concept]
   806   C1442770:24 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "confluence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205200:Confluent [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.4: 4 g/ml polybrene was added to enhance infectivity. 

Phrase: "4 g/ml polybrene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0282194:Polybrene [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "infectivity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0030657:infectivity [Qualitative Concept]
   888 E C0009450:Infection, NOS [Disease or Syndrome]
   877 E C0439663:Infected [Functional Concept]
Processing 00000000.tx.5: Target cells were seeded 1 day before infection at low density (1 x 104/cm2) and infected with viral supernatants on two consecutive days at a multiplicity of infection of 20-50.

Phrase: "Target cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0221284:Target cells [Cell]
  1000   C3272919:Target Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0036563:Seed [Plant]
   966   C1705192:Seed [Laboratory Procedure]
   966   C1882540:{Seed} [Quantitative Concept]
   966   C2346495:Seed [Conceptual Entity]

Phrase: "1 day before infection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1442449:1 Day [Temporal Concept]
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]

Phrase: "at low density"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0178587:density [Quantitative Concept]
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "(1 x 104/cm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439479:cm2 [Quantitative Concept]
   812   C0555206:CM2 [Congenital Abnormality]

Phrase: ")"

Phrase: "and"

Phrase: "infected with viral supernatants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439663:Infected [Functional Concept]
   770   C0521026:Viral [Functional Concept]
   737   C1550101:Supernatant [Body Substance]

Phrase: "on two consecutive days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "at a multiplicity of infection"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0009450:Infection, NOS [Disease or Syndrome]
   827   C0449822:Multiplicity [Quantitative Concept]
   755 E C0439064:Multiple [Quantitative Concept]
   755 E C0439663:Infected [Functional Concept]
   716 E C0030657:infectivity [Qualitative Concept]

Phrase: "of 20-50."
Processing 00000000.tx.1: C2C12 cells were grown in Dubleccos Modified Eagle Medium (DMEM) supplemented with 20% fetal bovine serum (FBS). 

Phrase: "C2C12 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in Dubleccos Modified Eagle Medium (DMEM)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 20% fetal bovine serum (FBS)."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.2: Myogenic differentiation was initiated by incubating confluent cells for 3 days in DMEM containing 2% horse serum and verified by visual detection of myotubes and by western blot analysis using an MHC antibody (see below). 

Phrase: "Myogenic differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "was"

Phrase: "initiated by incubating confluent cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0205200:Confluent [Qualitative Concept]
   760   C1439852:incubating [Laboratory Procedure]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1548602:Initiate [Idea or Concept]
   726 E C1704653:Cell [Medical Device]
   726   C1704686:Initiate [Functional Concept]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "for 3 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "in DMEM"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0009458:Medium [Intellectual Product]
   804   C0150312:In [Quantitative Concept]
   804   C0325564:Eagle [Bird]
   804   C0332285:In [Spatial Concept]
   804   C0392747:Modified [Functional Concept]
   804   C0439536:Medium [Quantitative Concept]
   804   C1551720:Eagle [Population Group]
   804   C1705217:Medium [Substance]
   804   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2% horse serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1518416:Serum, Horse [Immunologic Factor]
   827   C0019944:Horse [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C0242616:Horse [Mammal]
   827   C1265527:Horse [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "verified by visual detection of myotubes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0234621:Visual [Functional Concept]
   753   C0242697:myotubes [Cell]
   753   C1511790:Detection [Therapeutic or Preventive Procedure]
   753   C1704336:Myotubes [Cell]
   753   C1711411:Verified [Functional Concept]

Phrase: "and by western blot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1515981:And [Idea or Concept]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an MHC antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.3: 10T1/2 cells (ATCC) were grown in Basal Medium Eagle (BME) supplemented with 15% FBS. 

Phrase: "10T1/2 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(ATCC)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598079:ATCC [Intellectual Product]

Phrase: "were"

Phrase: "grown in Basal Medium Eagle (BME)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0009458:Medium [Intellectual Product]
   760   C0205112:Basal [Spatial Concept]
   760   C0325564:Eagle [Bird]
   760   C0439536:Medium [Quantitative Concept]
   760   C1551720:Eagle [Population Group]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 15% FBS."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.4: Adipocyte differentiation was initiated by treatment with 3 M 5-azacytidine for 24 hours. 

Phrase: "Adipocyte differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1159884:adipocyte differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "was"

Phrase: "initiated by treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756   C1548602:Initiate [Idea or Concept]
   756   C1704686:Initiate [Functional Concept]

Phrase: "with 3 M 5-azacytidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0004475:Azacitidine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   708   C0442758:3 5 [Quantitative Concept]

Phrase: "for 24 hours."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.5: After retroviral infection, confluent cells were treated with 1 M dexamethasone for 7 days.

Phrase: "After retroviral infection,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0035369:retroviral infection [Disease or Syndrome]
   861   C0009450:Infection, NOS [Disease or Syndrome]
   789 E C0439663:Infected [Functional Concept]
   750 E C0030657:infectivity [Qualitative Concept]

Phrase: "confluent cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 1 M dexamethasone"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]
   704 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   704 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   704 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "for 7 days."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1547085:7 days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.1: Micromass assays were performed essentially as described (Ahrens et al., 1977). 

Phrase: "Micromass assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "essentially"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Ahrens et al.,"

Phrase: "1977"

Phrase: ")."
Processing 00000000.tx.2: White Leghorn chicken eggs (SPAFAS) were incubated to stage 21-22 (Hamburger and Hamilton, 1951). 

Phrase: "White Leghorn chicken eggs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0013710:Eggs [Food]
   779 E C0029974:Egg [Cell]
   779 E C1508746:Egg [Organic Chemical,Pharmacologic Substance]

Phrase: "(SPAFAS"

Phrase: ")"

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "21-22"

Phrase: "(Hamburger"

Phrase: "and"

Phrase: "Hamilton,"

Phrase: "1951"

Phrase: ")."
Processing 00000000.tx.3: Forelimb buds were collected and digested with 0.1% trypsin-0.1% collagenase. 

Phrase: "Forelimb buds"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2945744:buds [Anatomical Structure]
   827 E C2700462:Bud [Plant]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "digested with 0.1% trypsin-0.1% collagenase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0962754:collagenase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C1418965:TRYPSIN 1 [Gene or Genome]
   744   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0868946:digested [Physiologic Function]
Processing 00000000.tx.4: 10 l of digested cells (2x107 cells/ml) were infected with 1 l of concentrated avian retroviruses (109 cfu/ml) in growth media (F12/DMEM supplemented with 10% FBS) containing 8 g/ml polybrene. 

Phrase: "10 l of digested cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   797   C0347983:cells/L [Quantitative Concept]
   781 E C0022827:cell l [Cell]

Phrase: "(2x107 cells/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2699156:Cells/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "infected with 1 l of concentrated avian retroviruses"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C1622661:Avian retroviruses [Virus]
   754 E C0004423:Avian Retrovirus [Virus]
   754 E C1223849:Avian retrovirus [Virus]
   744   C0005595:Avian [Bird]
   744   C0035366:Retroviruses [Virus]
   744   C0439663:Infected [Functional Concept]
   744   C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(109 cfu/ml) in growth media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
   799   C0009458:Media [Intellectual Product]
   799   C0162867:Media [Tissue]
   799   C1254021:Media [Tissue]
   766 E C0439536:Medium [Quantitative Concept]
   766 E C1705217:Medium [Substance]
   766 E C3244283:medium [Intellectual Product]

Phrase: "(F12/DMEM"

Phrase: "supplemented with 10% FBS)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "8 g/ml polybrene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0282194:Polybrene [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.5: Infected cells were incubated for 4 days and differentiation was verified by staining with 0.5% Alcian Blue 8GX (pH 1). 

Phrase: "Infected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 4 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0439228:days [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "was"

Phrase: "verified by staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]
   790   C1711411:Verified [Functional Concept]

Phrase: "with 0.5% Alcian Blue 8GX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   884   C0001933:Alcian Blue 8GX [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(pH 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1412290:PH1 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.6: TMC23 cells (Xu et al., 1998) were grown in DMEM supplemented with 10% FBS. 

Phrase: "TMC23 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Xu et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: "were"

Phrase: "grown in DMEM"

Phrase: "supplemented with 10% FBS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.7: Differentiation was initiated by treating confluent cells were with 50 g/ml ascorbic acid and 4 mM -glycerol phosphate for 16 days.

Phrase: "Differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "was"

Phrase: "initiated by treating confluent cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   760   C0007634:Cells [Cell]
   760   C0205200:Confluent [Qualitative Concept]
   760   C0332293:treating [Therapeutic or Preventive Procedure]
   760   C1522326:Treating [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1292734:TREAT [Functional Concept]
   726   C1548602:Initiate [Idea or Concept]
   726 E C1704653:Cell [Medical Device]
   726   C1704686:Initiate [Functional Concept]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were with 50 g/ml ascorbic acid"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   778   C0003968:Ascorbic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   778   C1300565:g/mL [Quantitative Concept]
   774 E C1637390:mL/g [Quantitative Concept]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0439267:g% [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
   723 E C0699147:Cecon [Carbohydrate,Pharmacologic Substance,Vitamin]
   723 E C0699151:Cenolate [Carbohydrate,Pharmacologic Substance,Vitamin]
   723 E C0699153:Cevalin [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "4 mM -glycerol phosphate for 16 days."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.1: Chicken calvarial osteoblasts were prepared essentially as described (Gerstenfeld et al., 1987). 

Phrase: "Chicken calvarial osteoblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0029418:Osteoblasts [Cell]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "essentially"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Gerstenfeld et al.,"

Phrase: "1987"

Phrase: ")."
Processing 00000000.tx.2: Eggs were incubated to stage 42 (Hamburger and Hamilton, 1951) after which the calvaria (skull bone) were digested with 0.25% trypsin-0.2% collagenase. 

Phrase: "Eggs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0013710:Eggs [Food]
   966 E C0029974:Egg [Cell]
   966 E C1508746:Egg [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "42"

Phrase: "(Hamburger"

Phrase: "and"

Phrase: "Hamilton,"

Phrase: "1951"

Phrase: ")"

Phrase: "after which"

Phrase: "the calvaria"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205950:Calvaria [Body Part, Organ, or Organ Component]
   928 E C2825501:Calvarial [Qualitative Concept]

Phrase: "(skull bone"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0037303:Skull bone [Body Part, Organ, or Organ Component]
   861   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   861   C0391978:Bone [Tissue]
   861   C1266908:Bone [Body Part, Organ, or Organ Component]
   861   C1266909:Bone [Body System]
   789 E C0443157:Bony [Functional Concept]

Phrase: ")"

Phrase: "were"

Phrase: "digested with 0.25% trypsin-0.2% collagenase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0172956:Collagenase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C1418970:TRYPSIN 2 [Gene or Genome]
   744   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0868946:digested [Physiologic Function]
Processing 00000000.tx.3: Digested cells were plated at 5000 cells/cm2 in -Minimum Eagle media (-MEM) supplemented with 10% FBS. 

Phrase: "Digested cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated at 5000 cells/cm2 in -Minimum Eagle media (-MEM)"
Meta Candidates (Total=22; Excluded=6; Pruned=0; Remaining=16)
   745   C1166718:cells plate [Cell Component]
   742   C0007634:Cells [Cell]
   742   C0009458:Media [Intellectual Product]
   742   C0162867:Media [Tissue]
   742   C0325564:Eagle [Bird]
   742   C0439479:cm2 [Quantitative Concept]
   742   C0555206:CM2 [Congenital Abnormality]
   742   C1254021:Media [Tissue]
   742   C1524031:Minimum [Qualitative Concept]
   742   C1551720:Eagle [Population Group]
   742   C1552614:minimum [Idea or Concept]
   742   C2826545:MINIMUM [Quantitative Concept]
   742   C3282337:Cells [Cell]
   708   C0005971:Plate [Medical Device]
   708 E C0439536:Medium [Quantitative Concept]
   708   C1139930:plate [Medical Device]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1705217:Medium [Substance]
   708 E C1948049:Cell [Spatial Concept]
   708 E C3244283:medium [Intellectual Product]
   708   C3537155:Plate [Manufactured Object]

Phrase: "supplemented with 10% FBS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.4: Differentiation was initiated by addition of 100 g/ml ascorbic acid and 5 mM -glycerol phosphate for 16 days and verified by staining with Von Kossas stain (silver staining). 

Phrase: "Differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "was"

Phrase: "initiated by addition of 100 g/ml ascorbic acid"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   764   C0003968:Ascorbic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   764   C1300565:g/mL [Quantitative Concept]
   762 E C1637390:mL/g [Quantitative Concept]
   742   C0001128:Acid [Chemical]
   742   C0202406:Acid [Laboratory Procedure]
   742   C0439267:g% [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C1883712:Addition [Functional Concept]
   709 E C0699147:Cecon [Carbohydrate,Pharmacologic Substance,Vitamin]
   709 E C0699151:Cenolate [Carbohydrate,Pharmacologic Substance,Vitamin]
   709 E C0699153:Cevalin [Carbohydrate,Pharmacologic Substance,Vitamin]
   708   C1548602:Initiate [Idea or Concept]
   708   C1704686:Initiate [Functional Concept]

Phrase: "and"

Phrase: "5 mM -glycerol phosphate for 16 days"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "verified by staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]
   790   C1711411:Verified [Functional Concept]

Phrase: "with Von Kossas stain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1293943:von Kossa stain [Laboratory Procedure]
   827   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(silver staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1293950:Silver Staining [Laboratory Procedure]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: ")."
Processing 00000000.tx.5: BMP2T3 calvarial cells (Ghosh-Choudhury et al., 1996) were grown in MEM supplemented with 7% FBS. 

Phrase: "BMP2T3 calvarial cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Ghosh-Choudhury et al.,"

Phrase: "1996"

Phrase: ")"

Phrase: "were"

Phrase: "grown in MEM"

Phrase: "supplemented with 7% FBS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.6: Differentiation was initiated by treating confluent cells with 100 g/ml ascorbic acid and 5 mM -glycerol phosphate for 16 days.

Phrase: "Differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "was"

Phrase: "initiated by treating confluent cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   760   C0007634:Cells [Cell]
   760   C0205200:Confluent [Qualitative Concept]
   760   C0332293:treating [Therapeutic or Preventive Procedure]
   760   C1522326:Treating [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1292734:TREAT [Functional Concept]
   726   C1548602:Initiate [Idea or Concept]
   726 E C1704653:Cell [Medical Device]
   726   C1704686:Initiate [Functional Concept]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "with 100 g/ml ascorbic acid"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   840   C0003968:Ascorbic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]
   784 E C0699147:Cecon [Carbohydrate,Pharmacologic Substance,Vitamin]
   784 E C0699151:Cenolate [Carbohydrate,Pharmacologic Substance,Vitamin]
   784 E C0699153:Cevalin [Carbohydrate,Pharmacologic Substance,Vitamin]
   756 E C2349136:Vitamin C [Organic Chemical,Vitamin]

Phrase: "and"

Phrase: "5 mM -glycerol phosphate for 16 days."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.1: HC11 mammary epithelial cells (Hynes et al., 1990) were grown in RPMI 1640 media supplemented with 10% FBS, 5 g/ml insulin and 10 ng/ml epidermal growth factor (EGF). 

Phrase: "HC11 mammary epithelial cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0014597:Epithelial Cells [Cell]
   861   C1273342:Epithelial Cells [Laboratory Procedure]
   812   C0006141:Mammary [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0221908:Epithelial [Qualitative Concept]
   812   C0929301:Mammary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(Hynes et al.,"

Phrase: "1990"

Phrase: ")"

Phrase: "were"

Phrase: "grown in RPMI 1640 media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "supplemented with 10% FBS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "5 g/ml insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "10 ng/ml epidermal growth factor (EGF)."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   861   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1323367:epidermal growth factor [Molecular Function]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0014520:Epidermal [Tissue]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C0221920:Epidermal [Spatial Concept]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
Processing 00000000.tx.2: Differentiation was initiated by removal of EGF for 3 days, followed by treatment with 10 M dexamethasone, 5 g/ml prolactin and 5 g/ml insulin.

Phrase: "Differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "was"

Phrase: "initiated by removal of EGF"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   814   C1323367:epidermal growth factor [Molecular Function]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0014520:Epidermal [Tissue]
   748   C0015252:Removal [Therapeutic or Preventive Procedure]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0221920:Epidermal [Spatial Concept]
   748   C0728940:Removal [Therapeutic or Preventive Procedure]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   714   C1548602:Initiate [Idea or Concept]
   714   C1704686:Initiate [Functional Concept]

Phrase: "for 3 days,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with 10 M dexamethasone,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   771 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   771 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   771 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "5 g/ml prolactin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033371:Prolactin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1744644:prolactin [Molecular Function]

Phrase: "and"

Phrase: "5 g/ml insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.1: Expression analysis and probes

Phrase: "Expression analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "probes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.1: Northern blot analysis was performed using mRNA (2.5 g per lane) prepared by the Poly(A)Pure mRNA purification kit (Ambion). 

Phrase: "Northern blot analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1621557:Northern Blot [Research Device]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mRNA (2.5 g per lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "prepared by the Poly(A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   760   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0747726:POLY [Conceptual Entity]
   726   C1521827:Prepare [Functional Concept]

Phrase: ")"

Phrase: "Pure mRNA purification kit (Ambion"

Phrase: ")."
Processing 00000000.tx.2: Probes used for northern Blot analysis were labeled by StripEZ DNA labeling kit (Ambion) and are described in the text. 

Phrase: "Probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "used for northern Blot analysis"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   806   C1621557:Northern Blot [Research Device]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1273517:used [Finding]
   760   C1524024:analysis [Functional Concept]
   760   C1709269:Northern [Spatial Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "labeled by StripEZ DNA labeling kit (Ambion"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0812225:KIT [Medical Device]
   748   C1150635:KIT [Molecular Function]
   748   C1167624:Labeling [Mental Process]
   748   C1705212:Kit [Medical Device]
   748   C1705213:KIT [Medical Device]
   748   C1708632:Labeled [Qualitative Concept]
   748   C1947902:Labeling [Manufactured Object]
   748   C2827499:Labeling [Governmental or Regulatory Activity]
       E   Label
   748   C3273202:Kit [Manufactured Object]
   714 E C0181496:Label [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "are"

Phrase: "described in the text."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1527021:Text [Intellectual Product]
   770   C1552738:described [Idea or Concept]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]
Processing 00000000.tx.3: Ribonuclease protection assays were performed as described (Shen and Leder, 1992) using total RNA prepared with Trizol RNA Isolation Reagent (GIBCO-BRL). 

Phrase: "Ribonuclease protection assays"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1545588:Protection [Finding]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed as described"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Shen"

Phrase: "and"

Phrase: "Leder,"

Phrase: "1992"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "prepared with Trizol RNA Isolation Reagent"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0204727:Isolation [Therapeutic or Preventive Procedure]
   753   C0205409:Isolation [Functional Concept]
   753   C0220862:isolation [Laboratory Procedure]
   753   C0916178:trizol [Organic Chemical]
   719   C1521827:Prepare [Functional Concept]

Phrase: "(GIBCO-BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.4: The Msx1 riboprobe corresponds to sequences encoding amino acids 1-57. 

Phrase: "The Msx1 riboprobe"

Phrase: "corresponds to sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   790   C0162326:Sequences [Nucleotide Sequence]
   756 E C0004793:Sequence [Nucleotide Sequence]
   756 E C0162327:Sequence [Nucleotide Sequence]
   756 E C1519249:Sequence [Functional Concept]
   706 E C1548958:Sequential [Idea or Concept]
   706 E C1705294:Sequential [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "amino acids 1-57."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.5: The riboprobe for -casein corresponds to sequences encoding amino acids 126 to 134. 

Phrase: "The riboprobe for -casein"

Phrase: "corresponds to sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   790   C0162326:Sequences [Nucleotide Sequence]
   756 E C0004793:Sequence [Nucleotide Sequence]
   756 E C0162327:Sequence [Nucleotide Sequence]
   756 E C1519249:Sequence [Functional Concept]
   706 E C1548958:Sequential [Idea or Concept]
   706 E C1705294:Sequential [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "amino acids 126 to 134."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   773 E C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acids [Chemical]
   726 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.6: The rpL32 riboprobe has been described (Shen and Leder, 1992). 

Phrase: "The rpL32 riboprobe"

Phrase: "has"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Shen"

Phrase: "and"

Phrase: "Leder,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.7: Northern blot and ribonuclease protection assays were quantitated using a phosphorimager (Molecular Dynamics).

Phrase: "Northern blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005861:Northern Blot [Molecular Biology Research Technique]
  1000   C1621557:Northern Blot [Research Device]
   861   C1709269:Northern [Spatial Concept]

Phrase: "and"

Phrase: "ribonuclease protection assays"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1545588:Protection [Finding]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "quantitated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a phosphorimager"

Phrase: "(Molecular Dynamics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: ")."
Processing 00000000.tx.1: Western blot analysis, antibodies and kinase assays

Phrase: "Western blot analysis,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "kinase assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.1: Western blot analysis was performed with an ECL-Plus chemiluminescence kit (Amersham Pharmacia Biotech) using the following antibodies: monoclonal antibody against myosin heavy chain (MF20) from Developmental Studies Hybridoma Bank; 

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "was"

Phrase: "performed with an ECL-Plus chemiluminescence kit (Amersham Pharmacia Biotech"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   739   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   739   C0331955:Pharmacia [Health Care Related Organization]
   739   C0332287:Plus [Qualitative Concept]
   739   C0812225:KIT [Medical Device]
   739   C0884358:Performed [Functional Concept]
   739   C1150635:KIT [Molecular Function]
   739   C1332684:ECL [Gene or Genome]
   739   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   739   C1705212:Kit [Medical Device]
   739   C1705213:KIT [Medical Device]
   739   C3273202:Kit [Manufactured Object]
   706 E C2947996:Perform [Pharmacologic Substance]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "monoclonal antibody against myosin heavy chain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C3533097:Myosin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]

Phrase: "(MF20"

Phrase: ")"

Phrase: "from Developmental Studies Hybridoma Bank"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0442598:Bank [Manufactured Object]
   812   C0872261:Bank [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.2: monoclonal antibody against murine cyclin D1 from Oncogene Sciences; 

Phrase: "monoclonal antibody against murine cyclin D1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]

Phrase: "from Oncogene Sciences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Sciences [Occupation or Discipline]

Phrase: ";"
Processing 00000000.tx.3: polyclonal antisera against Cdk4 and Cdk2 from Santa Cruz; 

Phrase: "polyclonal antisera against Cdk4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "Cdk2 from Santa Cruz"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0108855:CDK2 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1332733:CDK2 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.4: and polyclonal antisera against RNA polymerase II small subunit band 7, a gift from Danny Reinberg. 

Phrase: "and"

Phrase: "polyclonal antisera against RNA polymerase II small subunit band 7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "a gift from Danny Reinberg."
Processing 00000000.tx.5: The monoclonal antibody directed against murine Msx1 was generated using the bacterially expressed full-length Msx1 protein as antigen. 

Phrase: "The monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "directed against murine Msx1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0026809:Murine [Mammal]
   770   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   737   C0439851:Direct [Qualitative Concept]
   737   C1947931:Direct [Qualitative Concept]

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the bacterially"

Phrase: "expressed"

Phrase: "full-length Msx1 protein as antigen."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1291777:Protein antigen [Immunologic Factor]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.6: This antibody specifically recognizes an N-terminal epitope of the mouse Msx1 protein and does not crossreact with Msx2 (G. H. and C. A.-S., unpublished). 

Phrase: "This antibody specifically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognizes"

Phrase: "an N-terminal epitope of the mouse Msx1 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0003316:Epitope [Immunologic Factor]

Phrase: "and"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "crossreact with Msx2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1417388:MSX2 [Gene or Genome]

Phrase: "(G. H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0560020:g h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "C. A.-S.,"

Phrase: "unpublished"

Phrase: ")."
Processing 00000000.tx.7: Cdk4 and Cdk2 kinase assays were performed as described (Parry et al., 1999). 

Phrase: "Cdk4"

Phrase: "and"

Phrase: "Cdk2 kinase assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed as described"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Parry et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.8: Cell lysates (500 g) were immunoprecipitated with 10 l of anti-Cdk4 or anti-Cdk2 antibody plus 10 l of protein-A/G agarose beads (Santa Cruz). 

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(500 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "immunoprecipitated with 10 l of anti-Cdk4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "or"

Phrase: "anti-Cdk2 antibody plus 10 l"

Phrase: "of protein-A/G agarose beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0991566:Beads [Biomedical or Dental Material]
   771 E C2346972:Bead [Spatial Concept]

Phrase: "(Santa Cruz"

Phrase: ")."
Processing 00000000.tx.9: Kinase assays were performed using GST-RB (amino acids 379-792, 0.5 g) as substrate.

Phrase: "Kinase assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GST-RB (amino acids 379-792,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C0001128:Acids [Chemical]
   793 E C2917660:Amino Acid [Pharmacologic Substance]
   766 E C0202406:Acid [Laboratory Procedure]

Phrase: "0.5 g)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439267:g% [Quantitative Concept]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "as"

Phrase: "substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.1: Generation and analysis of MMTV-Msx1 transgenes

Phrase: "Generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "and"

Phrase: "analysis of MMTV-Msx1 transgenes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.1: Transgenic mice were generated as described (Stewart et al., 1984) in FVB/N (Taconic Biotechnology) mice. 

Phrase: "Transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "generated as described"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552738:described [Idea or Concept]
   790   C3146294:Generated [Activity]

Phrase: "(Stewart et al.,"

Phrase: "1984"

Phrase: ")"

Phrase: "in FVB/N (Taconic Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: "mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.2: Founders were identified by Southern blot analysis, using genomic DNA digested with BamHI and an Msx1 cDNA probe; 

Phrase: "Founders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0263541:founders [Disease or Syndrome]

Phrase: "were"

Phrase: "identified by Southern blot analysis,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0005862:Southern blot analysis [Molecular Biology Research Technique]
           Southern Blot
   862   C1148472:southern blot analysis [Laboratory or Test Result]
           Blot, Southern
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0205396:Identified [Qualitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1710133:Southern [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "digested with BamHI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "an Msx1 cDNA probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0182400:Probe [Medical Device]
   827   C1704681:Probe [Gene or Genome]
   827   C2347609:Probe [Chemical Viewed Functionally]
   827   C3536729:Probe [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.3: progeny were genotyped by PCR. 

Phrase: "progeny"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680063:Progeny [Family Group]

Phrase: "were"

Phrase: "genotyped by PCR."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   756   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.4: Three independent transgenic lines were established; 

Phrase: "Three independent transgenic lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0003069:Transgenic [Animal]
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.5: two lines expressed the Msx1 transgene specifically in the mammary gland. 

Phrase: "two lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "expressed"

Phrase: "the Msx1 transgene specifically in the mammary gland."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0282641:Transgene [Gene or Genome]
Processing 00000000.tx.6: Results shown are from one of these lines; 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are from one of these lines"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0205132:lines [Spatial Concept]
   753   C0205447:One [Quantitative Concept]
   753   C1551058:Are [Quantitative Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.7: the other line had a similar phenotype. 

Phrase: "the"

Phrase: "other line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205132:Line [Spatial Concept]
  1000   C1550648:Line [Substance]
  1000   C1552960:Line [Quantitative Concept]

Phrase: "had"

Phrase: "a similar phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.8: No additional mammary epithelial abnormalities have been detected during 1 year of observation (data not shown).

Phrase: "No additional mammary epithelial abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   812   C0000768:Abnormalities [Congenital Abnormality]
   812   C0000769:abnormalities [Functional Concept]
   779 E C1704258:Abnormality [Finding]
   729 E C0205161:Abnormal [Qualitative Concept]
   729 E C2347472:% Abnormal [Quantitative Concept]
   729 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "detected during 1 year of observation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0302523:Observation [Research Activity]
   753   C0439234:year [Temporal Concept]
   753   C0439508:/year [Temporal Concept]
   753   C0442726:Detected [Finding]
   753   C0700325:observation [Health Care Activity]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1964257:Observation [Diagnostic Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.1: For whole-mount and immunohistochemical analyses, mammary fat pads from virgin or pregnant transgenic female mice or littermate controls were dissected, spread onto glass slides, and fixed in 10% formalin; 

Phrase: "For whole-mount"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0181909:Mount [Medical Device]
   861   C0444667:Whole [Quantitative Concept]
   861   C0449878:mount [Finding]

Phrase: "and"

Phrase: "immunohistochemical analyses,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1441616:Immunohistochemical [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "mammary fat pads from virgin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   845   C1512979:Mammary Fat Pad [Tissue]
   806   C0154270:fat pads [Finding]
   806   C0935625:Fat pads [Tissue]
   760   C0182158:Pads [Medical Device]
   760   C0332568:Pad [Neoplastic Process]
   760   C0424612:FAT [Organism Attribute]
   760   C1706529:Pads [Biomedical or Dental Material]
   760   C3540603:PAD [Gene or Genome]

Phrase: "or"

Phrase: "pregnant transgenic female mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0025936:Mice, Transgenic [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   708   C0033011:pregnant female [Population Group]

Phrase: "or"

Phrase: "littermate controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "dissected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissected [Functional Concept]

Phrase: ","

Phrase: "spread onto glass slides,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0017596:Glass [Manufactured Object]
   770   C0332261:Spread [Qualitative Concept]
   770   C0444330:slides [Research Device]
   770   C1947932:Spread [Activity]
   770   C1947936:Glass [Medical Device]
   737 E C1705201:Slide [Manufactured Object]

Phrase: "and"

Phrase: "fixed in 10% formalin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1550067:10% Formalin [Biomedical or Dental Material,Organic Chemical]
   833   C1561470:10% Formalin [Intellectual Product]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   770   C2827483:Fixed [Body Substance]

Phrase: ";"
Processing 00000000.tx.2: in each case the posterior fat pad (#4) was examined. 

Phrase: "in each case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "the posterior fat pad"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0154270:fat pad [Finding]
   901   C0935625:Fat pad [Tissue]
   827   C0182158:pad [Medical Device]
   827   C0332568:Pad [Neoplastic Process]
   827   C0424612:FAT [Organism Attribute]
   827   C3540603:PAD [Gene or Genome]

Phrase: "(#4"

Phrase: ")"

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.3: For whole mounts, the mammary pads were stained with Hematoxylin. 

Phrase: "For whole mounts,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0181909:Mounts [Medical Device]
   861   C0444667:Whole [Quantitative Concept]
   827 E C0449878:mount [Finding]

Phrase: "the mammary pads"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0182158:Pads [Medical Device]
   861   C0332568:Pad [Neoplastic Process]
   861   C1706529:Pads [Biomedical or Dental Material]
   861   C3540603:PAD [Gene or Genome]

Phrase: "were"

Phrase: "stained with Hematoxylin."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   841   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.4: For immunohistochemistry, the formalin-fixed mammary pads were embedded in paraffin and adjacent sections were stained with either anti-Msx1 or anti-cyclin D1 antibodies (as above). 

Phrase: "For immunohistochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "the formalin-fixed mammary pads"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0182158:Pads [Medical Device]
   812   C0332568:Pad [Neoplastic Process]
   812   C1706529:Pads [Biomedical or Dental Material]
   812   C3540603:PAD [Gene or Genome]

Phrase: "were"

Phrase: "embedded in paraffin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0085185:embedded paraffin [Laboratory Procedure]
   790   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   790   C1707903:Embedded [Laboratory Procedure]

Phrase: "and"

Phrase: "adjacent sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained with either anti-Msx1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "anti-cyclin D1 antibodies"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1150565:cyclin [Molecular Function]
   812   C1416886:D1 [Gene or Genome]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "as above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.5: Staining was performed using Vector M.O.M. 

Phrase: "Staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Vector M.O.M."
Processing 00000000.tx.6: Immunodection kit and Vector NovaRED substrate kit (Vector Laboratories). 

Phrase: "Immunodection kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0812225:KIT [Medical Device]
   861   C1150635:KIT [Molecular Function]
   861   C1705212:Kit [Medical Device]
   861   C1705213:KIT [Medical Device]
   861   C3273202:Kit [Manufactured Object]

Phrase: "and"

Phrase: "Vector NovaRED substrate kit (Vector Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0022877:Laboratories [Manufactured Object,Organization]
   799   C1619828:Laboratories [Intellectual Product]
   766 E C3244292:laboratory [Functional Concept]

Phrase: ")."
Processing 00000000.tx.7: For ribonuclease protection analysis, total RNA was prepared (as above) from the anterior fat pad (#3).

Phrase: "For ribonuclease protection analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "("

Phrase: "as above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")"

Phrase: "from the anterior fat pad"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0154270:fat pad [Finding]
   901   C0935625:Fat pad [Tissue]
   827   C0182158:pad [Medical Device]
   827   C0332568:Pad [Neoplastic Process]
   827   C0424612:FAT [Organism Attribute]
   827   C3540603:PAD [Gene or Genome]

Phrase: "(#3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.1: &nbsp;&nbsp; 

Phrase: "&nbsp"

Phrase: ";&nbsp"

Phrase: ";"
Processing 00000000.tx.2: RESULTS

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.1: TOP

Phrase: "TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.1: SUMMARY

Phrase: "SUMMARY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.1: INTRODUCTION

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]
Processing 00000000.tx.1: MATERIALS AND METHODS

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.1: RESULTS

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.1: DISCUSSION

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.1: REFERENCES

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Msx1 inhibits differentiation of multiple mesenchymal progenitor cell types

Phrase: "Msx1"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "differentiation of multiple mesenchymal progenitor cell types"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C1820192:mesenchymal cell differentiation [Cell Function]
   774   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   774   C1334700:Mesenchymal Differentiation [Finding]
   748   C1511938:Differentiation [Clinical Attribute]
   748   C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.1: To investigate the regulatory function of Msx1 in cellular differentiation, we examined the consequences of its misexpression in progenitor cells that give rise to distinct mesenchymal lineages: muscle, fat, cartilage and bone (Fig. 1). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the regulatory function of Msx1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "in cellular differentiation,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1511938:Cellular Differentiation [Clinical Attribute]
           Differentiation
   861   C0007589:Differentiation [Cell Function]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the consequences of its misexpression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "in progenitor cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0038250:Progenitor Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to distinct mesenchymal lineages"

Phrase: ":"

Phrase: "muscle,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "fat,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0424612:FAT [Organism Attribute]

Phrase: "cartilage"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0007301:Cartilage [Tissue]
   944 E C0442012:Chondral [Spatial Concept]

Phrase: "and"

Phrase: "bone"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
  1000   C0391978:Bone [Tissue]
  1000   C1266908:Bone [Body Part, Organ, or Organ Component]
  1000   C1266909:Bone [Body System]
   928 E C0443157:Bony [Functional Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.2: Our strategy was to introduce exogenous Msx1 using retroviral gene transfer and then to assess differentiation, comparing the Msx1-infected cells with those infected with control retroviruses. 

Phrase: "Our strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679199:strategy [Mental Process]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "introduce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292748:introduce [Functional Concept]

Phrase: "exogenous Msx1"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "retroviral gene transfer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1517499:Gene Transfer [Molecular Biology Research Technique]
   827   C0017337:Gene [Gene or Genome]
   827   C0040671:Transfer [Mental Process]
   827   C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "then to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "the Msx1-infected cells with those"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0007634:THE CELL [Cell]
           Cells
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "infected with control retroviruses."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0035366:Retroviruses [Virus]
   770   C0243148:control [Qualitative Concept]
   770   C0439663:Infected [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.3: To achieve high-level infectivity of mammalian cells, we used a derivative of the replication-defective pLZRS retrovirus (Kinsella and Nolan, 1996), while for avian cells we used a replication-competent RCAS retrovirus (Hughes et al., 1987). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "achieve"

Phrase: "high-level infectivity of mammalian cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030657:infectivity [Qualitative Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a derivative of the replication-defective pLZRS retrovirus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1527240:Derivative [Functional Concept]

Phrase: "(Kinsella"

Phrase: "and"

Phrase: "Nolan,"

Phrase: "1996"

Phrase: ")"

Phrase: ","

Phrase: "while for avian cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0005595:Avian [Bird]
   770   C0007634:Cells [Cell]
   770   C0750519:while [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a replication-competent RCAS retrovirus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035366:Retrovirus [Virus]

Phrase: "(Hughes et al.,"

Phrase: "1987"

Phrase: ")."
Processing 00000000.tx.4: The percentage of Msx1-infected cells was monitored by immunofluorescence using an anti-Msx1 antibody (see Materials and Methods), and in each case was greater than 80% (data not shown). 

Phrase: "The percentage of Msx1-infected cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "monitored by immunofluorescence"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0016318:Immunofluorescence [Laboratory Procedure]
   790   C0079603:Immunofluorescence [Laboratory Procedure]
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]
   734 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   718 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an anti-Msx1 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and in each case"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0868928:Case [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C1706255:CASE [Medical Device]
   770   C1706256:Case [Conceptual Entity]

Phrase: "was"

Phrase: "greater than 80%"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.5: As a control, we compared the activity of Msx1 with a mutated derivative, Msx1A, which contains three amino acid substitutions in the N-terminal arm of the homeodomain (Zhang et al., 1996). 

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the activity of Msx1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "with a mutated derivative,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527240:Derivative [Functional Concept]

Phrase: "Msx1A,"

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "three amino acid substitutions in the N-terminal arm of the homeodomain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   703   C1555721:Substitution [Idea or Concept]
   703   C1706204:Substitution [Activity]

Phrase: "(Zhang et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.6: The resulting Msx1A protein is stable and localizes to the nucleus (as does Msx1), but it is biochemically and biologically inert (Bendall et al., 1999; Hu et al., 1998; Zhang et al., 1996; Zhang et al., 1997).

Phrase: "The resulting Msx1A protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "stable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205360:Stable [Qualitative Concept]
  1000   C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "localizes to the nucleus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007610:Nucleus [Cell Component]
   770   C0392752:localize [Spatial Concept]

Phrase: "("

Phrase: "as"

Phrase: "does"

Phrase: "Msx1"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "it"

Phrase: "is"

Phrase: "biochemically"

Phrase: "and"

Phrase: "biologically inert"

Phrase: "(Bendall et al.,"

Phrase: "1999"

Phrase: "; Hu et al.,"

Phrase: "1998"

Phrase: "; Zhang et al.,"

Phrase: "1996"

Phrase: "; Zhang et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.1: View larger version (111K):

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(111K"

Phrase: ")"

Phrase: ":"
Processing 00000000.tx.1: [in this window]

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"
Processing 00000000.tx.1: [in a new window] &nbsp;

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "] &nbsp"

Phrase: ";"
Processing 00000000.tx.1: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.2: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.3: Msx1 inhibits differentiation of multiple mesenchymal progenitor cell types. 

Phrase: "Msx1"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "differentiation of multiple mesenchymal progenitor cell types."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C1820192:mesenchymal cell differentiation [Cell Function]
   774   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   774   C1334700:Mesenchymal Differentiation [Finding]
   748   C1511938:Differentiation [Clinical Attribute]
   748   C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.4: (A) C2C12 cells (a-d) or 10T1/2 cells (e-h) were infected with a control mammalian retrovirus (Vector) or retroviruses expressing Msx1 or Msx1A. 

Phrase: "(A) C2C12 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(a-d)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "or"

Phrase: "10T1/2 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(e-"

Phrase: "h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "infected with a control mammalian retrovirus"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0024660:Mammalian [Mammal]
   753   C0035366:Retrovirus [Virus]
   753   C0243148:control [Qualitative Concept]
   753   C0439663:Infected [Functional Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "retroviruses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035366:Retroviruses [Virus]

Phrase: "expressing"

Phrase: "Msx1"

Phrase: "or"

Phrase: "Msx1A."
Processing 00000000.tx.5: Infected cells were grown under normal culture conditions (undifferentiated; a,e) or conditions that promote differentiation (differentiated; b-d,f-h) to myoctyes (b-d) or adipocytes (f-h). 

Phrase: "Infected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown under normal culture conditions"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   781   C0231162:Normal condition [Finding]
   760   C0010453:Culture [Idea or Concept]
   760   C0205307:Normal [Qualitative Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439166:% normal [Quantitative Concept]
   760   C2242979:Culture [Laboratory Procedure]
   760   C2347086:% Normal [Quantitative Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "(undifferentiated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205618:Undifferentiated [Qualitative Concept]
  1000   C1524083:Undifferentiated [Organism Attribute]
  1000   C1704620:Undifferentiated [Organism Attribute]

Phrase: "; a,e)"

Phrase: "or"

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "that"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "("

Phrase: "differentiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007589:Differentiated [Cell Function]
  1000   C0205615:Differentiated [Qualitative Concept]

Phrase: "; b-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "d,"

Phrase: "f-h) to myoctyes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0439133:(f) [Intellectual Product]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1553038:[f] [Quantitative Concept]

Phrase: "(b-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "d)"

Phrase: "or"

Phrase: "adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "(f-h)."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439133:(f) [Intellectual Product]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.6: (B) Primary cultures of chicken limb chondrogenic cells (a-c) or calvarial osteogenic cells (e-g) were infected with a control avian retrovirus (Vector) or those expressing Msx1 or Msx1A. 

Phrase: "(B) Primary cultures of chicken limb chondrogenic cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   778   C1449562:Primary Cell Cultures [Laboratory Procedure]
   767   C0007585:cells cultures [Laboratory Procedure]
   744   C0010453:Cultures [Idea or Concept]
   744   C0205225:Primary [Qualitative Concept]
   744   C0439631:Primary [Therapeutic or Preventive Procedure]
   711 E C0220814:culture [Functional Concept]
   711 E C0430400:Culture [Laboratory Procedure]
   711 E C2242979:Culture [Laboratory Procedure]

Phrase: "(a-c)"

Phrase: "or"

Phrase: "calvarial osteogenic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "e-g)"

Phrase: "were"

Phrase: "infected with a control avian retrovirus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0004423:Avian Retrovirus [Virus]
   790   C1223849:Avian retrovirus [Virus]
   753   C0005595:Avian [Bird]
   753   C0035366:Retrovirus [Virus]
   753   C0243148:control [Qualitative Concept]
   753   C0439663:Infected [Functional Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "those expressing Msx1"

Phrase: "or"

Phrase: "Msx1A."
Processing 00000000.tx.7: Differentiation is visualized by Alcian Blue staining (a-c) or silver staining (e-g). 

Phrase: "Differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "is"

Phrase: "visualized by Alcian Blue staining"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   845   C0001933:Alcian blue stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Alcian Blue
   760   C0234621:Visualized [Functional Concept]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1260957:Blue [Qualitative Concept]
   760   C1704680:Staining [Finding]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(a-c)"

Phrase: "or"

Phrase: "silver staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1293950:Silver Staining [Laboratory Procedure]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "("

Phrase: "e-g)."
Processing 00000000.tx.8: TMC23 chondrocytes (d) or BMP2T3 osteoblasts (h) were infected with a control mammalian retrovirus (Vector) or those expressing Msx1 or Msx1A followed by growth in conditions that promote differentiation. 

Phrase: "TMC23 chondrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0225369:Chondrocytes [Cell]

Phrase: "("

Phrase: "d)"

Phrase: "or"

Phrase: "BMP2T3 osteoblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029418:Osteoblasts [Cell]

Phrase: "(h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "infected with a control mammalian retrovirus"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0024660:Mammalian [Mammal]
   753   C0035366:Retrovirus [Virus]
   753   C0243148:control [Qualitative Concept]
   753   C0439663:Infected [Functional Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "those expressing Msx1"

Phrase: "or"

Phrase: "Msx1A"

Phrase: "followed by growth"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0018270:'growth' NOS [Organism Function]
   790   C0220844:growth [Physiologic Function]
   790   C1621966:Growth [Organ or Tissue Function]
   790   C2911660:Growth [Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "in conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "that"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.9: Alkaline phosphatase activity was measured from cell lysates; 

Phrase: "Alkaline phosphatase activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1149888:alkaline phosphatase activity [Molecular Function]
   901   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1149880:phosphatase activity [Molecular Function]
           phosphatase
   901   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   827   C1979842:Alkaline [Qualitative Concept]

Phrase: "was"

Phrase: "measured from cell lysates"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   833   C0449770:Measured from [Quantitative Concept]
   816   C1881488:Cell Lysate [Physical Object]
           Lysate
   770   C0007634:Cell [Cell]
   770   C0444706:Measured [Qualitative Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: ";"
Processing 00000000.tx.10: error bars show standard deviations of assays carried out in triplicate. 

Phrase: "error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "standard deviations of assays"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0871420:Standard deviation [Quantitative Concept]
   770   C1442989:Standard [Qualitative Concept]
   770   C2828392:Standard [Intellectual Product]
   737   C0012727:Deviation [Spatial Concept]
   737   C0205419:Deviation [Qualitative Concept]
   737   C1705236:Deviation [Finding]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in triplicate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.11: (A,B) Representative data from experiments repeated a minimum of three times. 

Phrase: "(A,B) Representative data from experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "a minimum of three times."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1524031:Minimum [Qualitative Concept]
   760   C1552614:minimum [Idea or Concept]
   760   C2826545:MINIMUM [Quantitative Concept]
Processing 00000000.tx.12: Scale bars: 0.1 mm in A; 

Phrase: "Scale bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ":"

Phrase: "0.1 mm in A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C1418486:MM-1 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.13: 1 mm in B.

Phrase: "1 mm in B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   819   C1418486:MM-1 [Gene or Genome]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: As a model for muscle differentiation, we used a murine myoblast cell line, C2C12 (Yaffe and Saxel, 1977). 

Phrase: "As a model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "for muscle differentiation,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0007589:Differentiation [Cell Function]
   861   C0026845:Muscle [Tissue]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a murine myoblast cell line,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0007600:Cell Line [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "C2C12"

Phrase: "(Yaffe"

Phrase: "and"

Phrase: "Saxel,"

Phrase: "1977"

Phrase: ")."
Processing 00000000.tx.2: These cells appear fibroblast-like under normal culture conditions, whereas in reduced serum they undergo terminal differentiation to elongated multinuclear myotubes (Fig. 1A, compare a with b). 

Phrase: "These cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "fibroblast-like under normal culture conditions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0016030:Fibroblast [Cell]

Phrase: "whereas in reduced serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0229671:Serum [Body Substance]
   770   C0392756:Reduced [Qualitative Concept]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]

Phrase: "they"

Phrase: "undergo"

Phrase: "terminal differentiation to elongated multinuclear myotubes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C2752630:terminal differentiation [Cell Function]
   767   C2265915:myotube differentiation [Cell Function]
   753   C0007589:Differentiation [Cell Function]
   753   C1511938:Differentiation [Clinical Attribute]
   753   C2945687:Differentiation [Functional Concept]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "a with b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   858   C1440044:A,B [Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.3: Misexpression of Msx1 by retroviral gene transfer blocked myogenic differentiation of the C2C12 cells whereas misexpression of Msx1A had no such effect (Fig. 1A, compare c with d). 

Phrase: "Misexpression of Msx1"

Phrase: "by retroviral gene transfer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1517499:Gene Transfer [Molecular Biology Research Technique]
   827   C0017337:Gene [Gene or Genome]
   827   C0040671:Transfer [Mental Process]
   827   C1705822:Transfer [Activity]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "myogenic differentiation of the C2C12 cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0007589:cells differentiation [Cell Function]
           Differentiation
   753   C1511938:Differentiation [Clinical Attribute]
   753   C2945687:Differentiation [Functional Concept]

Phrase: "whereas"

Phrase: "misexpression of Msx1A"

Phrase: "had"

Phrase: "no such effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "c with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1553033:[c] [Quantitative Concept]

Phrase: "d)."
Processing 00000000.tx.4: Inhibition of myogenic differentiation by Msx1 was also evident from the absence of myosin heavy chain (MHC) expression, a marker of terminal differentiation, in Western blots of cell lysates (see Fig. 3B, top panel).

Phrase: "Inhibition of myogenic differentiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by Msx1"

Phrase: "was"

Phrase: "also evident from the absence of myosin heavy chain (MHC) expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   722   C0332120:Evidence of [Functional Concept]

Phrase: "a marker of terminal differentiation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0005516:Marker [Clinical Attribute]

Phrase: "in Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "of cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.1: We observed a similar ability of Msx1 to inhibit differentiation of adipocytes, chondrocytes and osteoblasts. 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a similar ability of Msx1 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "differentiation of adipocytes,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   841   C1159884:adipocyte differentiation [Cell Function]
   790   C0007589:Differentiation [Cell Function]
   790   C1511938:Differentiation [Clinical Attribute]
   790   C2945687:Differentiation [Functional Concept]
   718 E C0205615:Differentiated [Qualitative Concept]

Phrase: "chondrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225369:Chondrocytes [Cell]

Phrase: "and"

Phrase: "osteoblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029418:Osteoblasts [Cell]
Processing 00000000.tx.2: In particular, misexpression of Msx1 in 10T1/2 fibroblasts, which have the potential to undergo differentiation into multiple cell types, including adipocytes (Reznikoff et al., 1973), resulted in a failure of the 10T1/2 cells to undergo adipogenesis, whereas overexpression of Msx1A had no significant effect (Fig. 1A, e-h). 

Phrase: "In particular, misexpression"

Phrase: "of Msx1"

Phrase: "in 10T1/2 fibroblasts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016030:Fibroblasts [Cell]

Phrase: "which"

Phrase: "have"

Phrase: "the potential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "undergo"

Phrase: "differentiation into multiple cell types,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "(Reznikoff et al.,"

Phrase: "1973"

Phrase: ")"

Phrase: ","

Phrase: "resulted in a failure of the 10T1/2 cells to"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   739   C0007634:Cells [Cell]
   739   C0231174:Failure [Functional Concept]
   739   C0680095:failure [Individual Behavior]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]
   706   C2825142:Result [Finding]

Phrase: "undergo"

Phrase: "adipogenesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596843:Adipogenesis [Molecular Function]

Phrase: "whereas"

Phrase: "overexpression of Msx1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "had"

Phrase: "no significant effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "e-h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.3: In micromass explant assays, in which mesenchymal cells from chicken forelimb buds form chondrogenic nodules in culture (Ahrens et al., 1977), misexpression of Msx1, but not of Msx1A, significantly inhibited chondrogenesis as evident by reduced Alcian Blue staining (Fig. 1B, a-c). 

Phrase: "In micromass explant assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "in which mesenchymal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1257975:Mesenchymal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "from chicken forelimb buds"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C2945744:buds [Anatomical Structure]
   793 E C2700462:Bud [Plant]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "chondrogenic nodules in culture"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0028259:Nodules [Acquired Abnormality]
   770   C0228505:nodules [Body Part, Organ, or Organ Component]
   737 E C2700389:Nodule [Plant]

Phrase: "(Ahrens et al.,"

Phrase: "1977"

Phrase: ")"

Phrase: ","

Phrase: "misexpression of Msx1,"

Phrase: "but"

Phrase: "not of Msx1A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1518422:Not [Functional Concept]

Phrase: "significantly"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "chondrogenesis as evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0598067:Chondrogenesis [Organ or Tissue Function]

Phrase: "by reduced Alcian Blue staining"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   906   C0001933:Alcian blue stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Alcian Blue
   812   C0487602:Staining [Laboratory Procedure]
   812   C1260957:Blue [Qualitative Concept]
   812   C1704680:Staining [Finding]
   779 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "a-c)."
Processing 00000000.tx.4: Similarly, misexpression of Msx1, but not of Msx1A, resulted in a sevenfold inhibition of chondrocyte differentiation in a murine chondrocyte cell line, TMC23 (Xu et al., 1998) (Fig. 1B, d). 

Phrase: "Similarly,"

Phrase: "misexpression of Msx1,"

Phrase: "but"

Phrase: "not of Msx1A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1518422:Not [Functional Concept]

Phrase: "resulted in a sevenfold inhibition of chondrocyte differentiation"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C2245572:inhibition of chondrocyte differentiation [Cell Function]
   770   C1817330:chondrocyte differentiation [Cell Function]
   744   C0007589:Differentiation [Cell Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0225369:Chondrocyte [Cell]
   744   C1511938:Differentiation [Clinical Attribute]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C2945687:Differentiation [Functional Concept]
   744   C3463820:Inhibition [Activity]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "in a murine chondrocyte cell line,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0007600:Cell Line [Cell]
   861   C0225369:Chondrocyte cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "TMC23"

Phrase: "(Xu et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "d)."
Processing 00000000.tx.5: Finally, Msx1, but not Msx1A, inhibited osteogenesis in chicken calvarial osteoblasts (Fig. 1B, e-g) as well as in a murine calvarial cell line, BMP2T3 (Ghosh-Choudhury et al., 1996) (Fig. 1B, h). 

Phrase: "Finally,"

Phrase: "Msx1,"

Phrase: "but"

Phrase: "not Msx1A,"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "osteogenesis in chicken calvarial osteoblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0029433:Osteogenesis [Organ or Tissue Function]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "e-g)"

Phrase: "as well as in a murine calvarial cell line,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0007600:Cell Line [Cell]
   742   C0007634:Cell [Cell]
   742   C0026809:Murine [Mammal]
   742   C0205132:Line [Spatial Concept]
   742   C0205170:Well [Qualitative Concept]
   742   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   742   C1269647:Cell [Cell]
   742   C1550648:Line [Substance]
   742   C1552960:Line [Quantitative Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C2825501:Calvarial [Qualitative Concept]
   742   C3146287:Well [Manufactured Object]

Phrase: "BMP2T3"

Phrase: "(Ghosh-Choudhury et al.,"

Phrase: "1996"

Phrase: ")"

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.6: In summary, we have found that Msx1 expression is incompatible with differentiation of multiple mesenchymal lineages, including muscle, fat, cartilage and bone, which confirms and extend previous findings (Bendall et al., 1999; Dodig et al., 1999; Mina et al., 1996; Song et al., 1992; Woloshin et al., 1995).

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that Msx1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "incompatible with differentiation of multiple mesenchymal lineages,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "muscle,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "fat,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0424612:FAT [Organism Attribute]

Phrase: "cartilage"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0007301:Cartilage [Tissue]
   944 E C0442012:Chondral [Spatial Concept]

Phrase: "and"

Phrase: "bone,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
  1000   C0391978:Bone [Tissue]
  1000   C1266908:Bone [Body Part, Organ, or Organ Component]
  1000   C1266909:Bone [Body System]
   928 E C0443157:Bony [Functional Concept]

Phrase: "which"

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "previous findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "(Bendall et al.,"

Phrase: "1999"

Phrase: "; Dodig et al.,"

Phrase: "1999"

Phrase: "; Mina et al.,"

Phrase: "1996"

Phrase: "; Song et al.,"

Phrase: "1992"

Phrase: "; Woloshin et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.1: In contrast to its potent effect on differentiation, misexpression of Msx1 had a minimal effect (10-20% activation) on cellular proliferation of embryonic fibroblasts or various other cell types (Fig. 2A; data not shown). 

Phrase: "In contrast to its potent effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "on differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "misexpression of Msx1"

Phrase: "had"

Phrase: "a minimal effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(10-20% activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: ")"

Phrase: "on cellular proliferation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020507:Cellular proliferation [Pathologic Function]
  1000   C0596290:Cellular Proliferation [Cell Function]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "of embryonic fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "or"

Phrase: "various"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]

Phrase: "other cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "(Fig. 2A"

Phrase: "; data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.2: This observation was unexpected as Msx genes have been thought to promote cellular proliferation, based on their expression in proliferating cells in vivo (reviewed in Bendall et al., 1999). 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "was"

Phrase: "unexpected as Msx genes"

Phrase: "have"

Phrase: "been"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cellular proliferation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020507:Cellular proliferation [Pathologic Function]
  1000   C0596290:Cellular Proliferation [Cell Function]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "based on their expression"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "in proliferating cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "("

Phrase: "reviewed in Bendall et al.,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0282443:reviewed [Intellectual Product]
   760   C1709940:Reviewed [Qualitative Concept]
   726 E C1552617:Review [Idea or Concept]

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.3: Taken together, we conclude that Msx1 is a potent inhibitor of cellular differentiation for multiple mesenchymal lineages, but does not significantly promote cellular proliferation.

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "we"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that Msx1"

Phrase: "is"

Phrase: "a potent inhibitor of cellular differentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1511940:Differentiation Inhibitor [Pharmacologic Substance]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "for multiple mesenchymal lineages,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1881379:Lineage [Conceptual Entity]

Phrase: "but"

Phrase: "does"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cellular proliferation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020507:Cellular proliferation [Pathologic Function]
  1000   C0596290:Cellular Proliferation [Cell Function]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.1: View larger version (44K):

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(44K"

Phrase: ")"

Phrase: ":"
Processing 00000000.tx.1: [in this window]

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"
Processing 00000000.tx.1: [in a new window] &nbsp;

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "] &nbsp"

Phrase: ";"
Processing 00000000.tx.1: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.2: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.3: Msx1 does not promote cellular proliferation, but alters the expression of cell cycle regulators. 

Phrase: "Msx1"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cellular proliferation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020507:Cellular proliferation [Pathologic Function]
  1000   C0596290:Cellular Proliferation [Cell Function]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "but"

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the expression of cell cycle regulators."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.4: (A) Proliferation assays were performed using chicken embryonic fibroblasts infected with a control retrovirus (Vector) or one expressing Msx1. 

Phrase: "(A) Proliferation assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "chicken embryonic fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016030:Fibroblasts [Cell]

Phrase: "infected with a control retrovirus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0035366:Retrovirus [Virus]
   760   C0243148:control [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "one expressing Msx1."
Processing 00000000.tx.5: Cells were plated at low density in media containing the indicated percentage of fetal bovine serum. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated at low density"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0178587:density [Quantitative Concept]
   770   C0205251:low [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "in media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the indicated percentage of fetal bovine serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
Processing 00000000.tx.6: Cell number was estimated by measuring the optical density of Napthal blue-black stained cells and is expressed as percent of the control; 

Phrase: "Cell number"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007584:Cell Number [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "estimated by measuring"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   790   C0750572:Estimated [Quantitative Concept]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the optical density of Napthal blue-black stained cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0439164:Optical density [Quantitative Concept]
   764   C1268822:Optical density [Clinical Attribute]
   745   C0162339:Cell Density [Quantitative Concept]
   742   C0178587:density [Quantitative Concept]
   734   C0854725:blue vision [Disease or Syndrome]

Phrase: "and"

Phrase: "is"

Phrase: "expressed as percent of the control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0243148:control [Qualitative Concept]
   753   C0439165:Percent [Quantitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.7: error bars indicate standard deviation of assays performed in triplicate. 

Phrase: "error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "indicate"

Phrase: "standard deviation of assays"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0871420:Standard deviation [Quantitative Concept]
   770   C0012727:Deviation [Spatial Concept]
   770   C0205419:Deviation [Qualitative Concept]
   770   C1442989:Standard [Qualitative Concept]
   770   C1705236:Deviation [Finding]
   770   C2828392:Standard [Intellectual Product]

Phrase: "performed in triplicate."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.8: Shown are representative data from assays repeated a minimum of five times. 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative data from assays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "a minimum of five times."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1524031:Minimum [Qualitative Concept]
   760   C1552614:minimum [Idea or Concept]
   760   C2826545:MINIMUM [Quantitative Concept]
Processing 00000000.tx.9: (B) Northern blot analyses were performed using mRNA prepared from undifferentiated C2C12 cells that had been infected with a control retrovirus (Vector) or retroviruses expressing Msx1 or Msx1A. 

Phrase: "(B) Northern blot analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   906   C0005861:Northern blot analysis [Molecular Biology Research Technique]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "prepared from undifferentiated C2C12 cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0205618:Undifferentiated [Qualitative Concept]
   760   C1524083:Undifferentiated [Organism Attribute]
   760   C1704620:Undifferentiated [Organism Attribute]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1521827:Prepare [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "infected with a control retrovirus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0035366:Retrovirus [Virus]
   760   C0243148:control [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "retroviruses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035366:Retroviruses [Virus]

Phrase: "expressing"

Phrase: "Msx1"

Phrase: "or"

Phrase: "Msx1A."
Processing 00000000.tx.10: Northern blots contained 2.5 g of mRNA per lane, and were probed with the indicated cDNAs and visualized by autoradiography. 

Phrase: "Northern blots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005861:northern blots [Molecular Biology Research Technique]
  1000   C1621557:Northern Blots [Research Device]
   861   C1709269:Northern [Spatial Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "2.5 g of mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "per lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "were"

Phrase: "probed with the indicated cDNAs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C1444656:Indicated [Finding]
   726   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "visualized by autoradiography."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004400:Autoradiography [Laboratory Procedure]
   790   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.11: Northern blots were performed a minimum of two times using mRNA prepared from independent experiments; 

Phrase: "Northern blots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005861:northern blots [Molecular Biology Research Technique]
  1000   C1621557:Northern Blots [Research Device]
   861   C1709269:Northern [Spatial Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a minimum of"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C1524031:Minimum [Qualitative Concept]
   790   C1552614:minimum [Idea or Concept]
   790   C2826545:MINIMUM [Quantitative Concept]
   718 E C0547040:Minimal [Qualitative Concept]
   718 E C2945599:Minimal [Qualitative Concept]

Phrase: "two times"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1948050:Two Times [Quantitative Concept]
   861   C0040223:times [Temporal Concept]
   861   C0205448:Two [Quantitative Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "prepared from independent experiments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0085862:Independent [Idea or Concept]
   770   C0681814:Experiments [Research Activity]
   770   C1299583:Independent [Finding]
   737   C1521827:Prepare [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.12: representative data are shown. 

Phrase: "representative data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.13: RPL32 is a control for RNA loading.

Phrase: "RPL32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419659:RPL32 [Gene or Genome]

Phrase: "is"

Phrase: "a control for RNA loading."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Msx1 upregulates cyclin D1 expression and Cdk4 activity

Phrase: "Msx1"

Phrase: "upregulates"

Phrase: "cyclin D1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Cdk4 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.1: Given its activity as a general inhibitor of mesenchymal cell differentiation, we anticipated that downstream effectors for Msx1 are likely to include widely expressed regulatory genes in addition to lineage-restricted genes such as MyoD (Bendall et al., 1999; Song et al., 1992; Woloshin et al., 1995). 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "its activity as a general inhibitor of mesenchymal cell differentiation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0441655:General activity [Activity]
           Activity
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "we"

Phrase: "anticipated"

Phrase: "that downstream effectors for Msx1"

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "widely"

Phrase: "expressed"

Phrase: "regulatory genes in addition to lineage-restricted genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017362:Regulatory Genes [Gene or Genome]
   744   C0017337:Genes [Gene or Genome]
   744   C0220905:regulatory [Regulation or Law]
   744   C1704735:Regulatory [Conceptual Entity]

Phrase: "such as MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "(Bendall et al.,"

Phrase: "1999"

Phrase: "; Song et al.,"

Phrase: "1992"

Phrase: "; Woloshin et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.2: We further reasoned that these Msx1 effectors would probably include cell cycle regulatory genes, particularly those that control exit from the cell cycle (the G1-G0 transition), which generally precedes terminal differentiation (Sherr and Roberts, 1999; Walsh and Perlman, 1997). 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "reasoned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392360:Reason [Idea or Concept]

Phrase: "that"

Phrase: "these Msx1 effectors"

Phrase: "would"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "cell cycle regulatory genes,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0243037:Cell Cycle Genes [Gene or Genome]
   886   C1861886:CELL Gene [Gene or Genome]
   861   C0017362:Regulatory Genes [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]
   812   C0220905:regulatory [Regulation or Law]
   812   C1704735:Regulatory [Conceptual Entity]

Phrase: "particularly"

Phrase: "those"

Phrase: "that control exit from the cell cycle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0337094:Exit [Spatial Concept]
   748   C1550550:exit [Temporal Concept]

Phrase: "("

Phrase: "the G1-G0 transition"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C2611014:G1/G0 transition [Cell Function]
   827   C0599156:Transition [Cell or Molecular Dysfunction]
   827   C2700061:Transition [Activity]
   755 E C1182674:Transitional [Spatial Concept]
   755 E C1548597:Transitional [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "which generally"

Phrase: "precedes"

Phrase: "terminal differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C2752630:terminal differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(Sherr"

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "1999"

Phrase: "; Walsh"

Phrase: "and"

Phrase: "Perlman,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.3: Therefore, we asked whether misexpressing Msx1 effected the steady-state expression levels of key cell cycle regulators, including G1 cyclins (cyclin D1, cyclin D2, cyclin D3 and cyclin E), G2 cyclins (cyclin A2 and cyclin B1), the retinoblastoma gene (Rb1), and the cyclin-dependent kinase inhibitors p21WAF1/CIP (Cdkn1a  Mouse Genome Informatics), p27kip1 (Cdkn1b  Mouse Genome Informatics), p57kip2 (Cdkn1c  Mouse Genome Informatics) and p16INK4a (Cdkn2a  Mouse Genome Informatics; Fig. 2B). 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "asked"

Phrase: "whether"

Phrase: "misexpressing Msx1"

Phrase: "effected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1280500:Effect [Qualitative Concept]
   966   C2348382:Effect [Qualitative Concept]

Phrase: "the steady-state expression levels of key cell cycle regulators,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   741   C0683927:state level [Spatial Concept]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0441889:Levels [Qualitative Concept]
   726   C3244092:expression level [Idea or Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "G1 cyclins"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0079183:Cyclins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827 E C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827 E C1150565:cyclin [Molecular Function]

Phrase: "(cyclin D1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "cyclin D2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0214570:Cyclin-D2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413173:CYCLIN D2 [Gene or Genome]
  1000   C2718191:Cyclin D2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "cyclin D3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0173532:cyclin D3 [Amino Acid, Peptide, or Protein]
  1000   C1413175:CYCLIN D3 [Gene or Genome]

Phrase: "and"

Phrase: "cyclin E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0111429:Cyclin E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1259807:Cyclin E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332697:CYCLIN E [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "G2 cyclins"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0079183:Cyclins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827 E C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827 E C1150565:cyclin [Molecular Function]

Phrase: "(cyclin A2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0297674:cyclin A2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332694:CYCLIN A2 [Gene or Genome]

Phrase: "and"

Phrase: "cyclin B1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0385333:Cyclin B1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332695:CYCLIN B1 [Gene or Genome]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]

Phrase: ")"

Phrase: ","

Phrase: "the retinoblastoma gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079424:Retinoblastoma Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "(Rb1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0080113:RB1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0694889:RB1 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the cyclin-dependent kinase inhibitors p21WAF1/CIP (Cdkn1a  Mouse Genome Informatics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   821   C1709079:Mouse Genome Informatics [Intellectual Product]
   790   C0599807:Informatics [Occupation or Discipline]
   790   C1552237:Informatics [Professional or Occupational Group]

Phrase: ")"

Phrase: ","

Phrase: "p27kip1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0169665:p27Kip1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332737:P27KIP1 [Gene or Genome]
  1000   C1705523:P27KIP1 [Gene or Genome]

Phrase: "(Cdkn1b  Mouse Genome Informatics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1709079:Mouse Genome Informatics [Intellectual Product]
   812   C0599807:Informatics [Occupation or Discipline]
   812   C1552237:Informatics [Professional or Occupational Group]

Phrase: ")"

Phrase: ","

Phrase: "p57kip2"

Phrase: "(Cdkn1c  Mouse Genome Informatics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1709079:Mouse Genome Informatics [Intellectual Product]
   812   C0599807:Informatics [Occupation or Discipline]
   812   C1552237:Informatics [Professional or Occupational Group]

Phrase: ")"

Phrase: "and"

Phrase: "p16INK4a"

Phrase: "(Cdkn2a  Mouse Genome Informatics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1709079:Mouse Genome Informatics [Intellectual Product]
   812   C0599807:Informatics [Occupation or Discipline]
   812   C1552237:Informatics [Professional or Occupational Group]

Phrase: "; Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.4: We examined the expression of these genes in C2C12 cells infected with a control retrovirus (Vector) or in cells infected with the Msx1- or Msx1A-expressing retroviruses.

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the expression of these genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in C2C12 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "infected with a control retrovirus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0035366:Retrovirus [Virus]
   760   C0243148:control [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the Msx1-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439663:Infected [Functional Concept]

Phrase: "or"

Phrase: "Msx1A-expressing retroviruses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035366:Retroviruses [Virus]
Processing 00000000.tx.1: Of the cell cycle regulatory genes examined, we found that the most prominent effect of Msx1 misexpression was a robust increase in cyclin D1 expression (20- to 30-fold), whereas misexpression of the Msx1A mutant had no significant effect (Fig. 2B). 

Phrase: "Of the cell cycle regulatory genes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0243037:Cell Cycle Genes [Gene or Genome]
   886   C1861886:CELL Gene [Gene or Genome]
   861   C0017362:Regulatory Genes [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]
   812   C0220905:regulatory [Regulation or Law]
   812   C1704735:Regulatory [Conceptual Entity]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ","

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the most prominent effect of Msx1 misexpression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "a robust increase in cyclin D1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "(20-"

Phrase: "to 30-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "misexpression of the Msx1A mutant"

Phrase: "had"

Phrase: "no significant effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.2: In contrast, misexpression of Msx1 modestly repressed cyclin D3, cyclin E, cyclin B1, Rb1 and p21WAF1/CIP, while it had little or no effect on cyclin D2, cyclin A2, p27KIP1, p57KIP2 and p16INK4a. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "misexpression of Msx1 modestly repressed cyclin D3,"

Phrase: "cyclin E,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0111429:Cyclin E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1259807:Cyclin E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332697:CYCLIN E [Gene or Genome]

Phrase: "cyclin B1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0385333:Cyclin B1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332695:CYCLIN B1 [Gene or Genome]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]

Phrase: "Rb1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0080113:RB1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0694889:RB1 [Gene or Genome]

Phrase: "and"

Phrase: "p21WAF1/CIP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707248:CIP [Research Activity]

Phrase: "while"

Phrase: "it"

Phrase: "had"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no effect on cyclin D2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "cyclin A2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0297674:cyclin A2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332694:CYCLIN A2 [Gene or Genome]

Phrase: "p27KIP1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0169665:p27Kip1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332737:P27KIP1 [Gene or Genome]
  1000   C1705523:P27KIP1 [Gene or Genome]

Phrase: "p57KIP2"

Phrase: "and"

Phrase: "p16INK4a."
Processing 00000000.tx.3: The finding that Msx1 upregulates cyclin D1 but not cyclin E or the G2 cyclins (cyclin A2 and cyclin B1), is consistent with our observation that Msx1 inhibits differentiation without promoting proliferation. 

Phrase: "The finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that Msx1"

Phrase: "upregulates"

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "but"

Phrase: "not cyclin E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0111429:Cyclin E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1259807:Cyclin E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1332697:CYCLIN E [Gene or Genome]

Phrase: "or"

Phrase: "the G2 cyclins"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0079183:Cyclins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827 E C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827 E C1150565:cyclin [Molecular Function]

Phrase: "(cyclin A2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0297674:cyclin A2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332694:CYCLIN A2 [Gene or Genome]

Phrase: "and"

Phrase: "cyclin B1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0385333:Cyclin B1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332695:CYCLIN B1 [Gene or Genome]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "consistent with our observation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that Msx1"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "differentiation without promoting proliferation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007589:Differentiation [Cell Function]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.4: Moreover, we have observed that a greater percentage of Msx1-expressing cells are found in the G1 phase by flow cytometry (G. H. and C. A.-S., unpublished). 

Phrase: "Moreover,"

Phrase: "we"

Phrase: "have"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "a greater percentage of Msx1-expressing cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: "are"

Phrase: "found in the G1 phase"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0079395:G1 Phase [Temporal Concept]
   760   C0150312:Found [Quantitative Concept]
   760   C0205390:Phase [Temporal Concept]
   726 E C0243095:Find [Finding]

Phrase: "by flow cytometry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016263:Flow Cytometry [Laboratory Procedure]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0814048:Cytometry [Laboratory Procedure]

Phrase: "(G. H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0560020:g h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "C. A.-S.,"

Phrase: "unpublished"

Phrase: ")."
Processing 00000000.tx.5: A similar upregulation of cyclin D1 after misexpression of Msx1 was observed in the adipocyte, chondrocyte and osteoblast lineages (data not shown).

Phrase: "A similar upregulation of cyclin D1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "after misexpression"

Phrase: "of Msx1"

Phrase: "was"

Phrase: "observed in the adipocyte,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0206131:Adipocyte [Cell]
   770   C1441672:Observed [Functional Concept]

Phrase: "chondrocyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225369:Chondrocyte [Cell]

Phrase: "and"

Phrase: "osteoblast lineages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881379:Lineage [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.1: cyclin D1 misexpression has been shown to inhibit differentiation of myogenic cells in culture (Skapek et al., 1995) and is therefore an excellent candidate for a primary downstream mediator of Msx1 activity. 

Phrase: "cyclin D1 misexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "differentiation of myogenic cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0007589:cells differentiation [Cell Function]
           Differentiation
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "in culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "(Skapek et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "therefore"

Phrase: "an excellent candidate for a primary downstream mediator of Msx1 activity."
Processing 00000000.tx.2: To assess whether the effect of misexpressing cyclin D1 is analogous to that of Msx1, we examined myogenic differentiation following misexpression of either gene in C2C12 cells (Fig. 3A). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "whether"

Phrase: "the effect of misexpressing cyclin D1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "analogous to that of Msx1,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "myogenic differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "misexpression of either gene"

Phrase: "in C2C12 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.3: Similar to Msx1, misexpression of cyclin D1 resulted in marked inhibition of myogenic differentiation, apparent from the absence of myotube formation. 

Phrase: "Similar to Msx1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "misexpression of cyclin D1"

Phrase: "resulted in marked inhibition of myogenic differentiation,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   748   C0007589:Differentiation [Cell Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0522501:Marked [Qualitative Concept]
   748   C1511938:Differentiation [Clinical Attribute]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C1706089:Marked [Qualitative Concept]
   748   C2945687:Differentiation [Functional Concept]
   748   C3463820:Inhibition [Activity]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "apparent from the absence of myotube formation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0750489:apparent [Idea or Concept]
Processing 00000000.tx.4: Moreover, in addition to upregulating cyclin D1 mRNA, Msx1 upregulated cyclin D1 protein, which was inversely correlated with inhibition of MHC expression (Fig. 3B). 

Phrase: "Moreover,"

Phrase: "in addition to upregulating cyclin D1 mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Msx1"

Phrase: "upregulated"

Phrase: "cyclin D1 protein,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1150565:cyclin [Molecular Function]
   827   C1416886:D1 [Gene or Genome]

Phrase: "which"

Phrase: "was"

Phrase: "inversely"

Phrase: "correlated with inhibition of MHC expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C1707520:Correlated [Qualitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.5: This result underscores the relationship between inhibition of differentiation by Msx1 and upregulation of cyclin D1.

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "underscores"

Phrase: "the relationship between inhibition of differentiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "by Msx1"

Phrase: "and"

Phrase: "upregulation of cyclin D1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041904:Up-Regulation [Cell Function,Molecular Function]
   770   C0162493:Up-Regulation [Genetic Function]
Processing 00000000.tx.1: The cell cycle regulatory activities of cyclin D1 are mediated through its interaction with catalytic partners, particularly Cdk4 (Sherr and Roberts, 1999). 

Phrase: "The cell cycle regulatory activities of cyclin D1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C0001289:Cycle, Activity [Temporal Concept]
   744   C0441655:Activities [Activity]
   711 E C0205177:Activity [Functional Concept]
   711 E C0439167:% activity [Quantitative Concept]
   711 E C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "mediated through its interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C1704675:Interaction [Functional Concept]

Phrase: "with catalytic partners,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0682323:partners [Family Group]

Phrase: "particularly Cdk4"

Phrase: "(Sherr"

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.2: Therefore, we asked whether Msx1 misexpression altered the protein level or activity of Cdk4. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "asked"

Phrase: "whether"

Phrase: "Msx1 misexpression"

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "the protein level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "activity of Cdk4."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.3: While Msx1 misexpression did not alter the overall levels of total cellular Cdk4, the accumulation of Cdk4 in the nucleus was significantly increased relative to controls (Fig. 3C). 

Phrase: "While"

Phrase: "Msx1 misexpression"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the overall levels of total cellular Cdk4,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "the accumulation of Cdk4"

Phrase: "in the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "was"

Phrase: "significantly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "relative to controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.4: Co-immunoprecipitation analysis with anti-cyclin D1 antibody confirmed an increased association of Cdk4 with cyclin D1 in Msx1-expressing cells (data not shown). 

Phrase: "Co-immunoprecipitation analysis with anti-cyclin D1 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "an increased association of Cdk4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "in Msx1-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.5: Moreover, Cdk4 kinase activity was also substantially elevated in Msx1-expressing cells, including C2C12 cells and a human kidney cell line, 293T (Fig. 3D). 

Phrase: "Moreover,"

Phrase: "Cdk4 kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "also substantially"

Phrase: "elevated in Msx1-expressing cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0205250:Elevated [Qualitative Concept]
   760   C3163633:Elevated [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "C2C12 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "a human kidney cell line,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0682523:Human Cell Line [Cell]
   875   C0427861:human cell [Laboratory or Test Result]
   861   C0007600:Cell Line [Cell]
   861   C0553257:kidney cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "293T"

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.6: In contrast, misexpression of Msx1 had no significant effect on the nuclear accumulation (Fig. 3C) or kinase activity (Fig. 3D) of Cdk2, the major partner of cyclin E. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "misexpression of Msx1"

Phrase: "had"

Phrase: "no significant effect on the nuclear accumulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150423:kinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")"

Phrase: "of Cdk2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0108855:CDK2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332733:CDK2 [Gene or Genome]

Phrase: "the major partner of cyclin E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0682323:Partner [Family Group]
Processing 00000000.tx.7: These findings are consistent with the observation that Msx1 inhibits differentiation but does not promote cellular proliferation. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with the observation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that Msx1"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cellular proliferation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020507:Cellular proliferation [Pathologic Function]
  1000   C0596290:Cellular Proliferation [Cell Function]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.8: Taken together, these data suggest that Msx1 inhibits cellular differentiation through upregulation of cyclin D1 and activation of Cdk4 activity.

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Msx1"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "cellular differentiation through upregulation of cyclin D1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1511938:Cellular Differentiation [Clinical Attribute]
           Differentiation
   748   C0007589:Differentiation [Cell Function]
   748   C2945687:Differentiation [Functional Concept]

Phrase: "and"

Phrase: "activation of Cdk4 activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]
Processing 00000000.tx.1: Upregulation of cyclin D1 is a conserved activity specific for the Msx family

Phrase: "Upregulation of cyclin D1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041904:Up-Regulation [Cell Function,Molecular Function]
   770   C0162493:Up-Regulation [Genetic Function]

Phrase: "is"

Phrase: "a conserved activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "specific for the Msx family"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]
Processing 00000000.tx.1: The Msx2 homeobox gene has many similarities to Msx1 with respect to its structure, expression pattern, biochemical properties, and biological functions (Bendall and Abate-Shen, 2000; Catron et al., 1996; Davidson, 1995; Satokata et al., 2000). 

Phrase: "The Msx2 homeobox gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1417388:MSX2 gene [Gene or Genome]
   901   C0017347:Homeo Box Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0242303:Homeo Box [Gene or Genome]
   827   C0598306:Homeo Box [Spatial Concept]

Phrase: "has"

Phrase: "many similarities to Msx1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2348205:Similarity [Qualitative Concept]

Phrase: "with respect to its structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "expression pattern,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "biochemical properties,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "and"

Phrase: "biological functions"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   966   C0031845:Biological function, NOS [Physiologic Function]
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205460:biological [Qualitative Concept]
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "(Bendall"

Phrase: "and"

Phrase: "Abate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: "Shen,"

Phrase: "2000"

Phrase: "; Catron et al.,"

Phrase: "1996"

Phrase: "; Davidson,"

Phrase: "1995"

Phrase: "; Satokata et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.2: We have found that Msx2 also inhibits differentiation of multiple mesenchymal lineages (Fig. 4A and data not shown), and therefore we examined whether its misexpression also affected cyclin D1 expression. 

Phrase: "We"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that Msx2 also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417388:MSX2 [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "differentiation of multiple mesenchymal lineages"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1334700:Mesenchymal Differentiation [Finding]
   760   C0007589:Differentiation [Cell Function]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "therefore"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "its misexpression also affected cyclin D1 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.3: Indeed, we found that misexpression of Msx2 upregulated cyclin D1 to a similar extent as Msx1, and was inversely correlated with inhibition of MHC expression and myotube formation (Figs 4A,B, 5B). 

Phrase: "Indeed,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that misexpression of Msx2"

Phrase: "upregulated"

Phrase: "cyclin D1 to a similar extent"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0079184:Cyclin A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1150565:cyclin [Molecular Function]
   753   C1416886:D1 [Gene or Genome]

Phrase: "as Msx1,"

Phrase: "and"

Phrase: "was"

Phrase: "inversely"

Phrase: "correlated with inhibition of MHC expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C1707520:Correlated [Qualitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "myotube formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(Figs 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "5B"

Phrase: ")."
Processing 00000000.tx.4: In contrast, two members of the Dlx homeobox gene family (Dlx2 and Dlx5), which are closely related to the Msx family (Bendall and Abate-Shen, 2000), inhibited differentiation but did not upregulate cyclin D1 (Fig. 4A,B). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "two members of the Dlx homeobox gene family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C0086282:Family Members [Family Group]
   750 E C1611821:Family Member [Intellectual Product]
   744   C0680022:members [Population Group]
   711 E C2698041:Member [Professional or Occupational Group]

Phrase: "(Dlx2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414076:DLX2 [Gene or Genome]

Phrase: "and"

Phrase: "Dlx5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414079:DLX5 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "closely"

Phrase: "related to the Msx family"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0015576:Family [Family Group]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1704727:Family [Conceptual Entity]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "(Bendall"

Phrase: "and"

Phrase: "Abate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: "Shen,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "upregulate"

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.5: Furthermore, two members of the Hox gene family (Hoxa7 and Hoxc8), which are less closely related to the Msx family did not inhibit differentiation or upregulate cyclin D1 (Fig. 4A,B). 

Phrase: "Furthermore,"

Phrase: "two members of the Hox gene family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   774   C0086282:Family Members [Family Group]
   757 E C1611821:Family Member [Intellectual Product]
   748   C0680022:members [Population Group]
   714 E C2698041:Member [Professional or Occupational Group]

Phrase: "(Hoxa7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415661:HOXA7 [Gene or Genome]

Phrase: "and"

Phrase: "Hoxc8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415680:HOXC8 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "less closely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439092:less [Intellectual Product]
   861   C0547044:Less [Qualitative Concept]

Phrase: "related to the Msx family"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0015576:Family [Family Group]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1704727:Family [Conceptual Entity]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "or"

Phrase: "upregulate"

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.6: Therefore, we conclude that inhibition of differentiation through upregulation of cyclin D1 is a conserved activity that is specific for the Msx family.

Phrase: "Therefore,"

Phrase: "we"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that inhibition of differentiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "through upregulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041904:Up-Regulation [Cell Function,Molecular Function]
  1000   C0162493:Up-Regulation [Genetic Function]

Phrase: "of cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "is"

Phrase: "a conserved activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "is"

Phrase: "specific for the Msx family."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]
Processing 00000000.tx.1: View larger version (84K):

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(84K"

Phrase: ")"

Phrase: ":"
Processing 00000000.tx.1: [in this window]

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"
Processing 00000000.tx.1: [in a new window] &nbsp;

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "] &nbsp"

Phrase: ";"
Processing 00000000.tx.1: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.2: 4. 

Phrase: "4."
Processing 00000000.tx.3: Upregulation of cyclin D1 is a conserved activity of the Msx family. 

Phrase: "Upregulation of cyclin D1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041904:Up-Regulation [Cell Function,Molecular Function]
   770   C0162493:Up-Regulation [Genetic Function]

Phrase: "is"

Phrase: "a conserved activity of the Msx family."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.4: (A) C2C12 cells were infected with a control retrovirus (Vector) or retroviruses expressing the indicated homeoproteins and grown under conditions that promote differentiation. 

Phrase: "(A) C2C12 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "infected with a control retrovirus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0035366:Retrovirus [Virus]
   760   C0243148:control [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "retroviruses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035366:Retroviruses [Virus]

Phrase: "expressing"

Phrase: "the indicated homeoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242617:Homeoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "grown under conditions"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   756   C0012634:condition [Disease or Syndrome]
   756   C0348080:Condition [Qualitative Concept]
   756   C1705253:Condition [Conceptual Entity]
   706 E C0009647:Conditioned [Mental Process]
   706 E C1701901:Conditional [Qualitative Concept]
   706 E C1963686:Conditional [Functional Concept]

Phrase: "that"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.5: Scale bar: 0.1 mm. 

Phrase: "Scale bar"

Phrase: ":"

Phrase: "0.1 mm."
Processing 00000000.tx.6: (B) Western blot analysis was performed using extracts prepared from C2C12 cells infected with a control retrovirus (Vector) or with retroviruses expressing the indicated homeoproteins, as in A. 

Phrase: "(B) Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   861   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
   812   C1705493:Western [Spatial Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "prepared from C2C12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1521827:Prepare [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "infected with a control retrovirus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0035366:Retrovirus [Virus]
   760   C0243148:control [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or with retroviruses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035366:Retroviruses [Virus]

Phrase: "expressing"

Phrase: "the indicated homeoproteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242617:Homeoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as in A."
Processing 00000000.tx.7: The panels show whole cell extracts probed with the indicated antibodies. 

Phrase: "The panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "whole cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0007592:Cell Extracts [Cell Component]
   793   C2828366:Extract [Substance]

Phrase: "probed with the indicated antibodies."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C1444656:Indicated [Finding]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.8: Equivalent expression of the various homeoproteins is shown by -Myc, which detects the Myc epitope present at the N-terminal region of each homeoprotein. 

Phrase: "Equivalent expression of the various homeoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "shown by -Myc,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "which"

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the Myc epitope present at the N-terminal region of each homeoprotein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0150312:Present [Quantitative Concept]
   736   C0449450:Present [Idea or Concept]
Processing 00000000.tx.9: RNA polymerase II (-RNA PolII) is a control for protein loading.

Phrase: "RNA polymerase II (-RNA PolII)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0035679:RNA Polymerase II [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0140652:RNA II [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0035681:RNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C2984241:RNA polymerase [Functional Concept]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a control for protein loading."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: View larger version (66K):

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(66K"

Phrase: ")"

Phrase: ":"
Processing 00000000.tx.1: [in this window]

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"
Processing 00000000.tx.1: [in a new window] &nbsp;

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "] &nbsp"

Phrase: ";"
Processing 00000000.tx.1: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.2: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.3: Regions of Msx1 required for upregulation of cyclin D1 include its transcriptional domains. 

Phrase: "Regions of Msx1"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   756   C0017446:Region [Geographic Area]
   756   C0205147:Region [Spatial Concept]
   706 E C0205276:Regional [Spatial Concept]
   706 E C1947913:Regional [Spatial Concept]

Phrase: "required for upregulation of cyclin D1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0162493:Up-Regulation [Genetic Function]
   753   C1150565:cyclin [Molecular Function]
   753   C1416886:D1 [Gene or Genome]
   753   C1514873:Required [Functional Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "its transcriptional domains."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.4: (A) Schematic diagrams showing the primary structures of Msx1 and Msx2; 

Phrase: "(A) Schematic diagrams"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0681494:diagrams [Intellectual Product]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the primary structures of Msx1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C0678594:structures [Spatial Concept]

Phrase: "and"

Phrase: "Msx2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417388:MSX2 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.5: the percent identity in the N-terminal region, homeodomain and C-terminal regions are indicated. 

Phrase: "the percent identity in the N-terminal region,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0424215:Identity [Mental Process]
   744   C2003939:Identity [Finding]

Phrase: "homeodomain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598306:Homeo Domain [Spatial Concept]

Phrase: "and"

Phrase: "C-terminal regions"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "are"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.6: Also shown are the protein regions contained in the truncated Msx1 derivatives, Msx11, Msx12 and Msx13. 

Phrase: "Also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "the protein regions"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C1514562:Protein Region [Amino Acid Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "contained in the truncated Msx1 derivatives,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0243072:derivatives [Chemical Viewed Structurally]
   753   C0332256:contained [Functional Concept]
   753   C2700400:Contained [Activity]
   719 E C1527240:Derivative [Functional Concept]

Phrase: "Msx11,"

Phrase: "Msx12"

Phrase: "and"

Phrase: "Msx13."
Processing 00000000.tx.7: (B) Western blot analyses were performed using extracts prepared from differentiated C2C12 cells following infection with a control retrovirus (Vector) or with retroviruses expressing the indicated Msx protein. 

Phrase: "(B) Western blot analyses"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   890   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   861   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   812   C1705493:Western [Spatial Concept]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "prepared from differentiated C2C12 cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   762   C0007589:cells differentiation [Cell Function]
           Differentiated
   760   C0007634:Cells [Cell]
   760   C0205615:Differentiated [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1521827:Prepare [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "infection with a control retrovirus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0035369:Retrovirus infection [Disease or Syndrome]
   797   C0085557:Infection Control [Health Care Activity]
   797   C1555984:Infection Control [Professional or Occupational Group]
   760   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or with retroviruses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035366:Retroviruses [Virus]

Phrase: "expressing"

Phrase: "the indicated Msx protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.8: Western blots were probed with -cyclin D1 or -MHC antibodies; 

Phrase: "Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "were"

Phrase: "probed with -cyclin D1 or -MHC antibodies"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1150565:cyclin [Molecular Function]
   748   C1416886:D1 [Gene or Genome]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714   C0182400:Probe [Medical Device]
   714   C1704681:Probe [Gene or Genome]
   714   C2347609:Probe [Chemical Viewed Functionally]
   714   C3536729:Probe [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.9: -RNA PolII is a control for protein loading. 

Phrase: "-RNA PolII"

Phrase: "is"

Phrase: "a control for protein loading."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.10: (C) C2C12 cells were infected with a control retrovirus (Vector) or a retrovirus expressing an Msx1-estrogen receptor fusion protein (Msx11-ER). 

Phrase: "(C) C2C12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0229579:C-Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "infected with a control retrovirus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0035366:Retrovirus [Virus]
   760   C0243148:control [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "a retrovirus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035366:Retrovirus [Virus]

Phrase: "expressing"

Phrase: "an Msx1-estrogen receptor fusion protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   888   C0059672:estrogen receptor protein [Amino Acid, Peptide, or Protein,Receptor]
   853   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   840   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "(Msx11-ER)."
Processing 00000000.tx.11: Infected cells were incubated in the presence (+) or absence (-) of tamoxifen (100 nM) and grown under conditions that promote differentiation. 

Phrase: "Infected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "(+"

Phrase: ")"

Phrase: "or"

Phrase: "absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(-"

Phrase: ")"

Phrase: "of tamoxifen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039286:Tamoxifen [Organic Chemical,Pharmacologic Substance]
   944 E C0919390:Nolvadex [Organic Chemical,Pharmacologic Substance]

Phrase: "(100 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "grown under conditions"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   756   C0012634:condition [Disease or Syndrome]
   756   C0348080:Condition [Qualitative Concept]
   756   C1705253:Condition [Conceptual Entity]
   706 E C0009647:Conditioned [Mental Process]
   706 E C1701901:Conditional [Qualitative Concept]
   706 E C1963686:Conditional [Functional Concept]

Phrase: "that"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.12: Scale bar: 0.1 mm. 

Phrase: "Scale bar"

Phrase: ":"

Phrase: "0.1 mm."
Processing 00000000.tx.13: (D) Ribonuclease protection analyses were performed using total RNA prepared from C2C12 cells that had been infected with a control retrovirus (Vector) or with a retrovirus expressing Msx11-ER. 

Phrase: "("

Phrase: "D)"

Phrase: "Ribonuclease protection analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "prepared from C2C12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1521827:Prepare [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "infected with a control retrovirus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0035366:Retrovirus [Virus]
   760   C0243148:control [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or with a retrovirus expressing Msx11-ER."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0035366:Retrovirus [Virus]
Processing 00000000.tx.14: Infected cells were treated with tamoxifen (100 nM) for the indicated times and ribonuclease protection assays were performed using a cyclin D1 riboprobe or an RPL32 riboprobe as a control for RNA loading.

Phrase: "Infected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with tamoxifen"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0039286:Tamoxifen [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0919390:Nolvadex [Organic Chemical,Pharmacologic Substance]

Phrase: "(100 nM) for the indicated times"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "ribonuclease protection assays"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1545588:Protection [Finding]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cyclin D1 riboprobe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "an RPL32 riboprobe as a control"

Phrase: "for RNA loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: The transcriptional domains of Msx1 are required for upregulation of cyclin D1

Phrase: "The transcriptional domains of Msx1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1880389:Domain [Functional Concept]
   726   C1883221:Domain [Conceptual Entity]
   726   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "required for upregulation of cyclin D1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0162493:Up-Regulation [Genetic Function]
   753   C1150565:cyclin [Molecular Function]
   753   C1416886:D1 [Gene or Genome]
   753   C1514873:Required [Functional Concept]
Processing 00000000.tx.1: To gain further insights into the mechanism(s) by which Msx1 inhibits differentiation and upregulates cyclin D1, we used an inducible expression system that is regulated by the hormone binding domain of the estrogen receptor. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "further insights into the mechanism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0233820:insights [Mental Process]

Phrase: "("

Phrase: "s) by which Msx1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2603362:S' [Clinical Attribute]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "upregulates"

Phrase: "cyclin D1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an inducible expression system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "that"

Phrase: "is"

Phrase: "regulated by the hormone binding domain of the estrogen receptor."
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   777   C1149369:estrogen receptor binding [Molecular Function]
   777   C1516971:Estrogen Binding Domain [Amino Acid Sequence]
   775   C1660250:hormone receptor binding [Molecular Function]
   760   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1148622:hormone binding [Molecular Function]
   760   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   760   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   757   C0019929:Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   757   C0597358:Receptor Binding [Molecular Function]
   757   C1367453:HORMONE RECEPTOR [Gene or Genome]
   739   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   739   C0019932:Hormone [Hormone]
   739   C0243122:binding [Functional Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0851285:Regulated [Governmental or Regulatory Activity]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C2936882:Estrogen [Pharmacologic Substance]
   739   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.2: First, we mapped the region(s) of Msx1 required for inhibition of differentiation and upregulation of cyclin D1 by generating a series of truncated derivatives that each contain the homeodomain, but lack varying portions of the N or C terminus (Msx11, Msx12 or Msx13) (Fig. 5A). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "we"

Phrase: "mapped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0024779:Map [Manufactured Object]
   966   C1706473:Map [Conceptual Entity]

Phrase: "the region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "("

Phrase: "s) of Msx1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2603362:S' [Clinical Attribute]

Phrase: "required for inhibition of differentiation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0007589:Differentiation [Cell Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C1514873:Required [Functional Concept]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C2945687:Differentiation [Functional Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "upregulation of cyclin D1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041904:Up-Regulation [Cell Function,Molecular Function]
   770   C0162493:Up-Regulation [Genetic Function]

Phrase: "by generating"

Phrase: "a series of truncated derivatives"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205549:Series [Quantitative Concept]
   760   C2348044:Series [Intellectual Product]

Phrase: "that"

Phrase: "each"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the homeodomain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598306:Homeo Domain [Spatial Concept]

Phrase: "but"

Phrase: "lack varying portions of the N"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0449719:Portion [Spatial Concept]

Phrase: "or"

Phrase: "C terminus"

Phrase: "(Msx11,"

Phrase: "Msx12"

Phrase: "or"

Phrase: "Msx13"

Phrase: ")"

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.3: We introduced these derivatives into C2C12 cells by retroviral gene transfer and examined their effects on myogenic differentiation. 

Phrase: "We"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "these derivatives into C2C12 cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0243072:derivatives [Chemical Viewed Structurally]
   726 E C1527240:Derivative [Functional Concept]

Phrase: "by retroviral gene transfer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1517499:Gene Transfer [Molecular Biology Research Technique]
   827   C0017337:Gene [Gene or Genome]
   827   C0040671:Transfer [Mental Process]
   827   C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "their effects on myogenic differentiation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.4: This analysis revealed that a truncated Msx1 protein containing the N-terminal domain plus the homeodomain (Msx11) upregulated cyclin D1, while it inhibited MHC expression and myotube formation (Fig. 5B, data not shown). 

Phrase: "This analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "a truncated Msx1 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the N-terminal domain plus the homeodomain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205088:Terminal [Temporal Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "(Msx11"

Phrase: ")"

Phrase: "upregulated cyclin D1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1150565:cyclin [Molecular Function]
   827   C1416886:D1 [Gene or Genome]

Phrase: "while"

Phrase: "it"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "MHC expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "myotube formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(Fig. 5B,"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.5: In contrast, a truncated Msx1 protein containing the homeodomain but lacking N-terminal or C-terminal sequences (Msx12) or a protein containing the homeodomain plus C-terminal sequences (Msx13) had no such effect (Fig. 5B).

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "a truncated Msx1 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the homeodomain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598306:Homeo Domain [Spatial Concept]

Phrase: "but"

Phrase: "lacking N-terminal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]

Phrase: "or"

Phrase: "C-terminal sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
   734   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "(Msx12"

Phrase: ")"

Phrase: "or"

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the homeodomain plus C-terminal sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "(Msx13"

Phrase: ")"

Phrase: "had"

Phrase: "no such effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.1: Next, we generated a chimeric fusion protein in which the essential regions of Msx1, namely the N-terminal region and the homeodomain, were fused with the hormone-binding domain of a tamoxifen-responsive mutant of the estrogen receptor (Littlewood et al., 1995). 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "a chimeric fusion protein in which"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
           Chimeric Protein
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332466:Fusion [Functional Concept]
   753   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "the essential regions of Msx1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "namely"

Phrase: "the N-terminal region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0017446:Region [Geographic Area]
   827   C0205088:Terminal [Temporal Concept]
   827   C0205147:Region [Spatial Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "the homeodomain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598306:Homeo Domain [Spatial Concept]

Phrase: "were"

Phrase: "fused with the hormone-binding domain of a tamoxifen-responsive mutant"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   756   C1148622:hormone binding [Molecular Function]
   754   C1512498:Hormone Responsive [Functional Concept]
   738   C0019932:Hormone [Hormone]
   738   C0039286:Tamoxifen [Organic Chemical,Pharmacologic Substance]
   738   C0205342:Responsive [Functional Concept]
   738   C0243122:binding [Functional Concept]
   738   C0596988:Mutant [Cell or Molecular Dysfunction]
   738   C0699952:Fused [Functional Concept]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1880389:Domain [Functional Concept]
   738   C1883221:Domain [Conceptual Entity]
   738   C3541951:Domain [Intellectual Product]
   704 E C1414861:FUSE [Gene or Genome]
   704 E C1708111:Fuse [Manufactured Object]

Phrase: "of the estrogen receptor"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(Littlewood et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.2: Infection of C2C12 cells with a retrovirus expressing this Msx11-ER chimeric gene resulted in tamoxifen-dependent inhibition of differentiation (Fig. 5C) that was comparable with that of native Msx1 (see Fig. 1A). 

Phrase: "Infection of C2C12 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: "with a retrovirus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035366:Retrovirus [Virus]

Phrase: "expressing"

Phrase: "this Msx11-ER chimeric gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0598467:chimeric gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "resulted in tamoxifen-dependent inhibition of differentiation"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   748   C0007589:Differentiation [Cell Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0039286:Tamoxifen [Organic Chemical,Pharmacologic Substance]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1511938:Differentiation [Clinical Attribute]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C2945687:Differentiation [Functional Concept]
   748   C3244310:dependent [Functional Concept]
   748   C3463820:Inhibition [Activity]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "(Fig. 5C"

Phrase: ")"

Phrase: "that"

Phrase: "was"

Phrase: "comparable with that of native Msx1"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.3: We used this estrogen receptor-regulated expression system to evaluate the time course for activation of cyclin D1 by Msx1. 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this estrogen receptor-regulated expression system to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the time course for activation of cyclin D1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0449247:Time course [Temporal Concept]
   744   C0040223:Time [Temporal Concept]
   744   C0750729:Course [Temporal Concept]
   744   C3541383:Time [Temporal Concept]

Phrase: "by Msx1."
Processing 00000000.tx.4: In Msx11-ER-infected cells, cyclin D1 expression increased as early as 2 hours after addition of tamoxifen and peaked by 24 hours (Fig. 5D), suggesting that cyclin D1 represents an early response gene for Msx1. 

Phrase: "In Msx11-ER-infected cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "cyclin D1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increased as early"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1279919:Early [Temporal Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "as 2 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292425:2 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "after addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of tamoxifen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039286:Tamoxifen [Organic Chemical,Pharmacologic Substance]
   944 E C0919390:Nolvadex [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "peaked by 24 hours"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0439584:24 hours [Temporal Concept]
   833   C0456696:/24 hours [Temporal Concept]
   833   C1442770:24 Hours [Temporal Concept]
   770   C0439227:hours [Temporal Concept]
   770   C0444505:peaked [Quantitative Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "(Fig. 5D"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an early response gene for Msx1."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0599295:early response gene [Gene or Genome]
   833   C1705964:Early Response Gene [Gene or Genome]
   783   C1417387:MSX1 gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0871261:Response [Organism Attribute]
   753   C1279919:Early [Temporal Concept]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.5: However, we were unable to address whether cyclin D1 is a direct target of Msx1 using cycloheximide treatment, as addition of cycloheximide by itself increased cyclin D1 mRNA levels (data not shown).

Phrase: "However,"

Phrase: "we"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "whether"

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "is"

Phrase: "a direct target of Msx1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1550500:direct target [Idea or Concept]
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cycloheximide treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "as"

Phrase: "addition of cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: "by itself"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "cyclin D1 mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.1: The ability for Msx1 to inhibit differentiation and upregulate cyclin D1 primarily requires the N-terminal domain (Fig. 5A,B); 

Phrase: "The ability for Msx1 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "upregulate"

Phrase: "cyclin D1 primarily"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1150565:cyclin [Molecular Function]
   827   C1416886:D1 [Gene or Genome]

Phrase: "requires"

Phrase: "the N-terminal domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.2: notably, this region contains the major regulatory domains defined in transcription assays (Catron et al., 1996; Catron et al., 1995). 

Phrase: "notably,"

Phrase: "this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the major regulatory domains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "defined in transcription assays"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0040649:Transcription [Genetic Function]
   770   C1704788:Defined [Conceptual Entity]
   770   C3539106:Defined [Intellectual Product]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "(Catron et al.,"

Phrase: "1996"

Phrase: "; Catron et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.3: However, as Msx proteins are potent transcriptional repressors and have no reported activator potential (Catron et al., 1995), it is likely that Msx1 upregulates cyclin D1 indirectly rather than by direct activation through cyclin D1 promoter elements. 

Phrase: "However,"

Phrase: "as"

Phrase: "Msx proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "potent transcriptional repressors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1336789:Transcriptional Repressor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Repressor

Phrase: "and"

Phrase: "have"

Phrase: "no reported activator potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3245505:Potential [Qualitative Concept]

Phrase: "(Catron et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that Msx1"

Phrase: "upregulates"

Phrase: "cyclin D1 indirectly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1150565:cyclin [Molecular Function]
   827   C1416886:D1 [Gene or Genome]

Phrase: "rather than by direct activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439851:Direct [Qualitative Concept]
   760   C1879547:Activation [Activity]
   760   C1947931:Direct [Qualitative Concept]

Phrase: "through cyclin D1 promoter elements."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0013879:Elements [Element, Ion, or Isotope]
   779 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.4: Indeed, we have found that Msx1 does not activate the cyclin D1 promoter in transient transfection assays, irrespective of the cell type or the human or rat cyclin D1 promoter/enhancer regions examined (G. H. and C. A.-S., unpublished).

Phrase: "Indeed,"

Phrase: "we"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that Msx1"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the cyclin D1 promoter in transient transfection assays,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "irrespective of the cell type"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007634:Cell Type [Cell]
           Cell
  1000   C0449475:cell type [Intellectual Product]
   861   C0332307:Type [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1547052:*Type [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "the human or rat cyclin D1 promoter/enhancer regions"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   822   C0033413:Promoter Regions [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   710 E C0205276:Regional [Spatial Concept]
   710 E C1947913:Regional [Spatial Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(G. H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0560020:g h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "C. A.-S.,"

Phrase: "unpublished"

Phrase: ")."
Processing 00000000.tx.1: Msx1 inhibits mammary epithelial differentiation and upregulates cyclin D1 in transgenic mice

Phrase: "Msx1"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "mammary epithelial differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C1707934:Epithelial Differentiation [Finding]
   827   C0007589:Differentiation [Cell Function]
   827   C1511938:Differentiation [Clinical Attribute]
   827   C2945687:Differentiation [Functional Concept]
   755 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "upregulates"

Phrase: "cyclin D1 in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1150565:cyclin [Molecular Function]
   760   C1416886:D1 [Gene or Genome]
Processing 00000000.tx.1: To extend our findings, we developed a transgenic mouse system to examine the consequences of Msx1 misexpression for differentiation and cyclin D1 expression in vivo. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "our findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "we"

Phrase: "developed"

Phrase: "a transgenic mouse system to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "examine"

Phrase: "the consequences of Msx1 misexpression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "for differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "cyclin D1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.2: We chose to investigate the mammary gland because of the known expression and functional significance of Msx and cyclin D1 genes in this tissue. 

Phrase: "We"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the mammary gland because of the known expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0929301:Mammary gland [Body Part, Organ, or Organ Component]
           Mammary
   770   C1521747:GLAND, MAMMARY [Tissue]
   744   C0006141:Mammary [Body Part, Organ, or Organ Component]
   744   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "functional significance of Msx"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "and"

Phrase: "cyclin D1 genes in this tissue."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0525036:Genes, Cyclin D1 [Gene or Genome]
   816 E C1413172:Cyclin D1 Gene [Gene or Genome]
   767   C1333183:Cyclin Gene [Gene or Genome]
   753   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.3: In particular, both Msx1 and Msx2 are expressed in the mammary epithelium during embryogenesis and pregnancy, and loss of Msx gene function results in profound defects in mammary gland morphogenesis during development (Friedmann and Daniel, 1996; Phippard et al., 1996; Satokata et al., 2000). 

Phrase: "In particular,"

Phrase: "both Msx1"

Phrase: "and"

Phrase: "Msx2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417388:MSX2 [Gene or Genome]

Phrase: "are"

Phrase: "expressed in the mammary epithelium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0596882:Mammary Epithelium [Body Part, Organ, or Organ Component]
   760   C0006141:Mammary [Body Part, Organ, or Organ Component]
   760   C0014609:Epithelium [Tissue]
   760   C0929301:Mammary [Body Part, Organ, or Organ Component]

Phrase: "during embryogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013936:Embryogenesis [Organ or Tissue Function]

Phrase: "and"

Phrase: "pregnancy,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "and"

Phrase: "loss of Msx gene function results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "in profound defects"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0243067:defects [Functional Concept]
   827 E C1457869:Defect [Functional Concept]
   827 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in mammary gland morphogenesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2610594:mammary gland morphogenesis [Organism Function]
   901   C1818644:gland morphogenesis [Organism Function]
   827   C0026559:Morphogenesis [Organism Function]
   734   C0929301:Mammary gland [Body Part, Organ, or Organ Component]
   734   C1521747:GLAND, MAMMARY [Tissue]

Phrase: "during development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "(Friedmann"

Phrase: "and"

Phrase: "Daniel,"

Phrase: "1996"

Phrase: "; Phippard et al.,"

Phrase: "1996"

Phrase: "; Satokata et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.4: Moreover, cyclin D1 is essential for mammary gland differentiation and function during pregnancy (Fantl et al., 1999; Fantl et al., 1995; Sicinski et al., 1995).

Phrase: "Moreover,"

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "is"

Phrase: "essential for mammary gland differentiation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205224:Essential [Qualitative Concept]

Phrase: "and"

Phrase: "function during pregnancy"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   858   C0032961:Pregnancy, function [Organism Function]
   790   C0031843:function [Physiologic Function]
   790   C0542341:Function [Functional Concept]
   790   C0700205:FUNCTION [Classification]
   790   C1705273:Function [Intellectual Product]
   718 E C0205245:Functional [Functional Concept]
   718 E C2700217:Functional [Conceptual Entity]

Phrase: "(Fantl et al.,"

Phrase: "1999"

Phrase: "; Fantl et al.,"

Phrase: "1995"

Phrase: "; Sicinski et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.1: Initially, we asked whether Msx1 also inhibited differentiation of mammary epithelial cells in culture, analogous to its effects on mesenchymal cell types (Fig. 6A). 

Phrase: "Initially,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "we"

Phrase: "asked"

Phrase: "whether"

Phrase: "Msx1 also"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "differentiation of mammary epithelial cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1326057:epithelial cell differentiation [Cell Function]
   797   C0007589:cells differentiation [Cell Function]
           Differentiation
   797   C1707934:Epithelial Differentiation [Finding]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "in culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "analogous to its effects"

Phrase: "on mesenchymal cell types"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0449475:Cell types [Intellectual Product]
   901   C1257975:Mesenchymal cell [Cell]
   867 E C0007634:Cell Type [Cell]
           Cell
   827   C0332307:Types [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1547052:*Type [Quantitative Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.2: For this purpose, we used HC11 cells, which undergo terminal differentiation and produce milk proteins, including -casein, after treatment with lactogenic hormones (Hynes et al., 1990). 

Phrase: "For this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "HC11 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "undergo"

Phrase: "terminal differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C2752630:terminal differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "produce"

Phrase: "milk proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026138:Milk Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "casein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007332:Casein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "after"

Phrase: "treatment with lactogenic hormones"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   802   C0279025:hormone treatment [Therapeutic or Preventive Procedure]
   802   C2966671:Hormone treatment [Clinical Attribute]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "(Hynes et al.,"

Phrase: "1990"

Phrase: ")."
Processing 00000000.tx.3: We found that differentiation of HC11 cells was inhibited by misexpression of Msx1, but not by Msx1A, as determined by the nearly complete absence of -casein (Csnb  Mouse Genome Informatics) expression, and that this inhibition correlated with upregulation of cyclin D1 expression (Fig. 6A).

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that differentiation of HC11 cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0007589:cells differentiation [Cell Function]
           Differentiation
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "was"

Phrase: "inhibited by misexpression of Msx1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0311403:Inhibited [Qualitative Concept]

Phrase: "but"

Phrase: "not by Msx1A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1518422:Not [Functional Concept]

Phrase: "as"

Phrase: "determined by the nearly"

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "absence of -casein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007332:Casein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Csnb  Mouse Genome Informatics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1709079:Mouse Genome Informatics [Intellectual Product]
   812   C0599807:Informatics [Occupation or Discipline]
   812   C1552237:Informatics [Professional or Occupational Group]

Phrase: ")"

Phrase: "expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "that"

Phrase: "this inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "correlated with upregulation of cyclin D1 expression"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0041904:Up-Regulation [Cell Function,Molecular Function]
   748   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0162493:Up-Regulation [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C1150565:cyclin [Molecular Function]
   748   C1416886:D1 [Gene or Genome]
   748   C1707520:Correlated [Qualitative Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.1: View larger version (43K):

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"
Processing 00000000.tx.1: [in this window]

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"
Processing 00000000.tx.1: [in a new window] &nbsp;

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "] &nbsp"

Phrase: ";"
Processing 00000000.tx.1: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.2: 6. 

Phrase: "6."
Processing 00000000.tx.3: Msx1 inhibits mammary epithelial differentiation and upregulates cyclin D1 in cell culture and in vivo. 

Phrase: "Msx1"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "mammary epithelial differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C1707934:Epithelial Differentiation [Finding]
   827   C0007589:Differentiation [Cell Function]
   827   C1511938:Differentiation [Clinical Attribute]
   827   C2945687:Differentiation [Functional Concept]
   755 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "upregulates"

Phrase: "cyclin D1 in cell culture"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0007585:Cell Culture [Laboratory Procedure]
   804   C0010453:Culture [Idea or Concept]
   804   C0220814:culture [Functional Concept]
   804   C0430400:Culture [Laboratory Procedure]
   804   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.4: (A) Ribonuclease protection analyses were performed using total RNA obtained from HC11 mammary epithelial cells infected with a control retrovirus (Vector) or with those expressing Msx1 or Msx1A. 

Phrase: "(A) Ribonuclease protection analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "obtained from HC11 mammary epithelial cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   790   C0014597:Epithelial Cells [Cell]
   790   C1273342:Epithelial Cells [Laboratory Procedure]
   753   C0006141:Mammary [Body Part, Organ, or Organ Component]
   753   C0007634:Cells [Cell]
   753   C0221908:Epithelial [Qualitative Concept]
   753   C0929301:Mammary [Body Part, Organ, or Organ Component]
   753   C1301820:Obtained [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1706701:Obtain [Activity]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "infected with a control retrovirus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0035366:Retrovirus [Virus]
   760   C0243148:control [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or with those expressing Msx1"

Phrase: "or"

Phrase: "Msx1A."
Processing 00000000.tx.5: Infected cells were grown under normal growth conditions (undifferentiated) or in conditions that promote differentiation (differentiated). 

Phrase: "Infected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown under normal growth conditions"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0018270:normal growth [Organism Function]
           'growth' NOS
   806   C0578019:Normal growth [Finding]
   781   C0231162:Normal condition [Finding]
   760   C0205307:Normal [Qualitative Concept]
   760   C0220844:growth [Physiologic Function]
   760   C0439166:% normal [Quantitative Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2347086:% Normal [Quantitative Concept]
   760   C2911660:Growth [Activity]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "(undifferentiated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205618:Undifferentiated [Qualitative Concept]
  1000   C1524083:Undifferentiated [Organism Attribute]
  1000   C1704620:Undifferentiated [Organism Attribute]

Phrase: ")"

Phrase: "or in conditions"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   756   C0012634:condition [Disease or Syndrome]
   756   C0348080:Condition [Qualitative Concept]
   756   C1705253:Condition [Conceptual Entity]
   706 E C0009647:Conditioned [Mental Process]
   706 E C1701901:Conditional [Qualitative Concept]
   706 E C1963686:Conditional [Functional Concept]

Phrase: "that"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(differentiated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0007589:Differentiated [Cell Function]
  1000   C0205615:Differentiated [Qualitative Concept]
   928 E C1511938:Differentiation [Clinical Attribute]
   928 E C2945687:Differentiation [Functional Concept]

Phrase: ")."
Processing 00000000.tx.6: (B) Ribonuclease protection analyses of total RNA prepared from the mammary fat pads of wild type (WT) and transgenic (TG) mice from virgin or pregnant females at the indicated stages. 

Phrase: "(B) Ribonuclease protection analyses of total RNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "prepared from the mammary fat pads of wild type (WT)"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   773   C1512979:Mammary Fat Pad [Tissue]
   764   C0154270:fat pads [Finding]
   764   C0935625:Fat pads [Tissue]
   764   C1883559:Wild Type [Organism Attribute]
   742   C0006141:Mammary [Body Part, Organ, or Organ Component]
   742   C0182158:Pads [Medical Device]
   742   C0332307:Type [Qualitative Concept]
   742   C0332568:Pad [Neoplastic Process]
   742   C0424612:FAT [Organism Attribute]
   742   C0445392:Wild [Intellectual Product]
   742   C0929301:Mammary [Body Part, Organ, or Organ Component]
   742   C1547052:*Type [Quantitative Concept]
   742   C1706529:Pads [Biomedical or Dental Material]
   742   C3540603:PAD [Gene or Genome]
   708   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "transgenic (TG) mice from virgin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "or"

Phrase: "pregnant females at the indicated stages."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C0033011:pregnant female [Population Group]
   753   C0015780:Females [Finding]
   753   C0086287:Females [Population Group]
   719 E C0043210:female [Population Group]
   719 E C1705497:Female [Qualitative Concept]
   719 E C1705498:Female [Qualitative Concept]
Processing 00000000.tx.7: (A,B) Ribonuclease protection assays were performed using the indicated riboprobes; 

Phrase: "(A,B) Ribonuclease protection assays"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1545588:Protection [Finding]
   771   C0005507:Assay [Laboratory Procedure]
   771   C0243073:assay [Qualitative Concept]
   771   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the indicated riboprobes"

Phrase: ";"
Processing 00000000.tx.8: each lane contains 10 g of total RNA, except for -casein in which 1.5 g of RNA was used. 

Phrase: "each lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "10 g of total RNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "except for -casein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007332:Casein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in which 1.5 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439267:g% [Quantitative Concept]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "of RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.9: RPL32 is a control for RNA loading.

Phrase: "RPL32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419659:RPL32 [Gene or Genome]

Phrase: "is"

Phrase: "a control for RNA loading."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Next, we generated transgenic mice in which the MMTV LTR was used to direct Msx1 transgene expression to the mammary epithelium (Stewart et al., 1984). 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "transgenic mice in which"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "the MMTV LTR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023978:LTR [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "Msx1 transgene expression to the mammary epithelium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0282641:Transgene [Gene or Genome]

Phrase: "(Stewart et al.,"

Phrase: "1984"

Phrase: ")."
Processing 00000000.tx.2: In virgin female mice, the mammary gland consists of a simple branched ductal epithelium that is embedded in a stromal fat pad. 

Phrase: "In virgin female mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "the mammary gland"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0929301:Mammary gland [Body Part, Organ, or Organ Component]
           Mammary
  1000   C1521747:GLAND, MAMMARY [Tissue]
   861   C0006141:Mammary [Body Part, Organ, or Organ Component]
   861   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "consists of a simple branched ductal epithelium"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C1512086:Ductal Epithelium [Tissue]
   774   C0682574:Simple epithelium [Tissue]
   757   C1253959:Branch of [Body Part, Organ, or Organ Component]
           branched
   748   C0014609:Epithelium [Tissue]
   748   C0205352:Simple [Qualitative Concept]
   748   C0332529:CONSIST [Qualitative Concept]
   748   C1512083:Ductal [Qualitative Concept]
   748   C2700384:Branched [Spatial Concept]
   714 E C1881507:Branch [Chemical Viewed Structurally]
   714 E C2700383:Branch [Plant]
   714 E C2826234:BRANCH [Intellectual Product]

Phrase: "that"

Phrase: "is"

Phrase: "embedded in a stromal fat pad."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0154270:fat pad [Finding]
   790   C0935625:Fat pad [Tissue]
   753   C0182158:pad [Medical Device]
   753   C0332568:Pad [Neoplastic Process]
   753   C0424612:FAT [Organism Attribute]
   753   C1707903:Embedded [Laboratory Procedure]
   753   C3540603:PAD [Gene or Genome]
Processing 00000000.tx.3: No significant phenotypic differences were observed in MMTV-Msx1 transgenic virgin females relative to wild type (n=6; Fig. 7A). 

Phrase: "No significant phenotypic differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1705241:*Difference [Quantitative Concept]
   793   C1705242:Difference [Qualitative Concept]
   743 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "observed in MMTV-Msx1 transgenic virgin females"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0003069:Transgenic [Animal]
   748   C0015780:Females [Finding]
   748   C0024662:MMTV [Virus]
   748   C0086287:Females [Population Group]
   748   C0555061:Virgin [Finding]
   748   C1441672:Observed [Functional Concept]
   714 E C0043210:female [Population Group]
   714 E C1705497:Female [Qualitative Concept]
   714 E C1705498:Female [Qualitative Concept]

Phrase: "relative to wild type"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "(n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.4: In contrast, we observed significant differences during pregnancy, when the epithelial ducts normally undergo extensive branching and differentiation to form complex lobuloalveolar structures that produce milk during lactation. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "significant differences during pregnancy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "when"

Phrase: "the epithelial ducts normally"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C0687028:Ducts [Body Part, Organ, or Organ Component]
   793 E C1267211:Duct [Body Part, Organ, or Organ Component]
   793 E C1550227:duct [Body Part, Organ, or Organ Component]
   793 E C1705650:Duct [Medical Device]
   743 E C1512083:Ductal [Qualitative Concept]

Phrase: "undergo"

Phrase: "extensive branching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205384:Branching [Spatial Concept]

Phrase: "and"

Phrase: "differentiation to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "complex lobuloalveolar structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "that"

Phrase: "produce"

Phrase: "milk during lactation."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0026131:Milk [Body Substance]
   790   C0349374:Milk [Food]
   790   C0444318:Milk [Substance]
   790   C2825079:Milk [Food]
   734 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   734 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   718 E C0443260:Milky [Finding]
Processing 00000000.tx.5: In two independent transgenic lines that express Msx1 at high levels (see below), we observed a significant inhibition of lobuloalveolar development with relatively normal side branching during pregnancy (n=18; Fig. 7A). 

Phrase: "In two independent transgenic lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0003069:Transgenic [Animal]
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "that"

Phrase: "express"

Phrase: "Msx1 at high levels"

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a significant inhibition of lobuloalveolar development"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "with relatively normal side branching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205384:Branching [Spatial Concept]

Phrase: "during pregnancy"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "(n=18"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.6: This defect was most apparent during the proliferative phase of lobuloalveolar development from 9.5 to 14.5 days post coitum (dpc), corresponding to the stages when endogenous Msx expression is downregulated in wild-type mice (Friedmann and Daniel, 1996; Phippard et al., 1996). 

Phrase: "This defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1457869:Defect [Functional Concept]
  1000   C1861101:DEFECT [Disease or Syndrome]

Phrase: "was"

Phrase: "most apparent during the proliferative phase of lobuloalveolar development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0750489:apparent [Idea or Concept]

Phrase: "from 9.5"

Phrase: "to 14.5 days post coitum (dpc),"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0439228:days [Temporal Concept]
   771 E C0332173:/day [Temporal Concept]
   771 E C0439505:/day [Temporal Concept]

Phrase: "corresponding to the stages"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C1306673:Stages [Qualitative Concept]
   737 E C0205390:Stage [Temporal Concept]
   737 E C1300072:Stage [Clinical Attribute]

Phrase: "when"

Phrase: "endogenous Msx expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "downregulated in wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   828   C1520150:Wild Type Mouse [Mammal]
   806   C1883559:Wild Type [Organism Attribute]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "(Friedmann"

Phrase: "and"

Phrase: "Daniel,"

Phrase: "1996"

Phrase: "; Phippard et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.7: During lactation, the lobuloalveolar structures of MMTV-Msx1 transgenic mammary glands appeared less complex than those of their wild-type littermates (n=4; Fig. 7A). 

Phrase: "During lactation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006147:Lactation [Organism Function]
  1000   C0022925:Lactation [Organ or Tissue Function]

Phrase: "the lobuloalveolar structures of MMTV-Msx1 transgenic mammary glands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0678594:structures [Spatial Concept]
   728   C1285092:Gland structure [Body Part, Organ, or Organ Component]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "less complex than those of their wild-type littermates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0439855:Complex [Qualitative Concept]
   742   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.8: These phenotypic changes appear to correspond to delayed maturation of the mammary epithelium; 

Phrase: "These phenotypic changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correspond to delayed maturation of the mammary epithelium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0596882:Mammary Epithelium [Body Part, Organ, or Organ Component]
   744   C0006141:Mammary [Body Part, Organ, or Organ Component]
   744   C0014609:Epithelium [Tissue]
   744   C0205421:Delayed [Temporal Concept]
   744   C0678723:Maturation [Organism Function]
   744   C0870861:maturation [Phenomenon or Process]
   744   C0929301:Mammary [Body Part, Organ, or Organ Component]
   744   C1254042:Maturation [Physiologic Function]
   744   C3272602:Delayed [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.9: however, the transgenic females were able to lactate and nurse their progeny, and after weaning would undergo normal mammary gland involution (data not shown).

Phrase: "however,"

Phrase: "the transgenic females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0015780:Females [Finding]
   861   C0086287:Females [Population Group]
   827 E C0043210:female [Population Group]
   827 E C1705497:Female [Qualitative Concept]
   827 E C1705498:Female [Qualitative Concept]

Phrase: "were"

Phrase: "able to lactate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0085732:Able [Organism Attribute]
   790   C1299581:Able [Finding]

Phrase: "and"

Phrase: "nurse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "their progeny,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680063:Progeny [Family Group]

Phrase: "and after weaning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0043084:Weaning [Organism Function]
   790   C1515981:And [Idea or Concept]

Phrase: "would"

Phrase: "undergo"

Phrase: "normal mammary gland involution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C2262789:mammary gland involution [Physiologic Function]
   812   C0333953:Involution [Organism Function]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.1: View larger version (61K):

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(61K"

Phrase: ")"

Phrase: ":"
Processing 00000000.tx.1: [in this window]

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"
Processing 00000000.tx.1: [in a new window] &nbsp;

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "] &nbsp"

Phrase: ";"
Processing 00000000.tx.1: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.2: 7. 

Phrase: "7."
Processing 00000000.tx.3: Impaired mammary epithelial differentiation and increased cyclin D1 expression in MMTV-Msx1 transgenic mice. 

Phrase: "Impaired mammary epithelial differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C1707934:Epithelial Differentiation [Finding]
   812   C0007589:Differentiation [Cell Function]
   812   C1511938:Differentiation [Clinical Attribute]
   812   C2945687:Differentiation [Functional Concept]
   741 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "increased cyclin D1 expression in MMTV-Msx1 transgenic mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.4: (A) Whole-mount Hematoxylin staining of mammary fat pads from female virgin, pregnant (14.5 dpc), or lactating MMTV-Msx1 transgenic mice and wild-type littermate controls, shown in low-power and high-power views. 

Phrase: "(A) Whole-mount Hematoxylin staining of mammary fat pads"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0487602:Staining [Laboratory Procedure]
   742   C1704680:Staining [Finding]

Phrase: "from female virgin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0555061:Virgin [Finding]

Phrase: "pregnant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0549206:Pregnant [Finding]
  1000   C0553641:Pregnant [Functional Concept]
  1000   C0600457:PREGNANT [Finding]

Phrase: "(14.5 dpc"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "lactating MMTV-Msx1 transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "wild-type littermate controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0243148:control [Qualitative Concept]
   779   C1550141:Control [Substance]
   779   C1882979:Control [Conceptual Entity]
   779   C2587213:Control [Functional Concept]
   779   C3274648:Control [Qualitative Concept]

Phrase: "shown in low-power"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0032863:Power [Human-caused Phenomenon or Process]
   770   C0205251:low [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "high-power views."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449911:Views [Spatial Concept]
Processing 00000000.tx.5: Although terminal end bud formation appears normal in the virgin transgenic and wild-type mice (arrows), retarded lobuloalveolar formation is observed in pregnant transgenics at 14.5 dpc (arrows). 

Phrase: "Although"

Phrase: "terminal end bud formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "normal in the virgin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "retarded"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0521111:Retarded [Qualitative Concept]
   928 E C0311403:Inhibited [Qualitative Concept]
   928 E C3463820:Inhibiting [Activity]
   907 E C0018790:arrested [Disease or Syndrome]
   907 E C0237477:Arrest [Temporal Concept]
   907 E C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "lobuloalveolar formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "observed in pregnant transgenics"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003069:Transgenics [Animal]
   770   C0549206:Pregnant [Finding]
   770   C0553641:Pregnant [Functional Concept]
   770   C0600457:PREGNANT [Finding]
   770   C1441672:Observed [Functional Concept]

Phrase: "at 14.5 dpc (arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.6: At this stage, and in lactating mice, there is reduced complexity of lobuloalveolar structures (arrows). 

Phrase: "At this stage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "and in lactating mice,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1515981:And [Idea or Concept]
   770   C2828358:Lactating [Finding]
   737 E C0022924:lactate [Organic Chemical]
   737 E C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "there"

Phrase: "is"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "complexity of lobuloalveolar structures"

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.7: (B) Immunohistochemical detection of cyclin D1 and Msx1 protein in sections from mammary glands of wild type and MMTV-Msx1 transgenic pregnant mice at 14.5 dpc. 

Phrase: "(B) Immunohistochemical detection of cyclin D1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Msx1 protein in sections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from mammary glands"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0929301:Mammary Glands [Body Part, Organ, or Organ Component]
           Mammary
   966 E C1521747:GLAND, MAMMARY [Tissue]
   861   C0006141:Mammary [Body Part, Organ, or Organ Component]
   861   C1285092:Glands [Body Part, Organ, or Organ Component]

Phrase: "of wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "MMTV-Msx1 transgenic pregnant mice at 14.5 dpc."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0025936:Mice, Transgenic [Mammal]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
Processing 00000000.tx.8: Note the elevated expression of Msx1 and cyclin D1 in nuclei of lumenal epithelial cells (arrows) in the mammary glands of the transgenic mice compared with their wild-type littermate controls. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the elevated expression of Msx1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cyclin D1 in nuclei of lumenal epithelial cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C1440380:Cells.cyclin D1 [Cell]
   770   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1150565:cyclin [Molecular Function]
   744   C1416886:D1 [Gene or Genome]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "in the mammary glands"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0929301:Mammary Glands [Body Part, Organ, or Organ Component]
           Mammary
   966 E C1521747:GLAND, MAMMARY [Tissue]
   861   C0006141:Mammary [Body Part, Organ, or Organ Component]
   861   C1285092:Glands [Body Part, Organ, or Organ Component]

Phrase: "of the transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "compared with their wild-type littermate controls."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C1883559:Wild Type [Organism Attribute]
   757   C1707504:Control Type [Research Activity]
   757   C1879930:Control Type [Intellectual Product]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1547052:*Type [Quantitative Concept]
   748   C1707455:Compared [Activity]
   714   C0243148:control [Qualitative Concept]
   714   C1550141:Control [Substance]
   714   C1882979:Control [Conceptual Entity]
   714   C2587213:Control [Functional Concept]
   714   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.9: Scale bars: 0.5 mm in A; 

Phrase: "Scale bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ":"

Phrase: "0.5 mm in A"

Phrase: ";"
Processing 00000000.tx.10: 0.05 mm in B.

Phrase: "0.05 mm in B."
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Notably, the phenotypic defects in mammary gland differentiation in Msx1 transgenic mice were paralleled by increased levels of cyclin D1 and were inversely correlated with reduced -casein expression (Figs 6B, 7B). 

Phrase: "Notably,"

Phrase: "the phenotypic defects in mammary gland differentiation"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0243067:defects [Functional Concept]
   714 E C1457869:Defect [Functional Concept]
   714 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in Msx1 transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "paralleled by increased levels of cyclin D1"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   778   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205217:Increased [Quantitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1150565:cyclin [Molecular Function]
   748   C1416886:D1 [Gene or Genome]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714   C2348042:Parallel [Qualitative Concept]
   714   C2826345:PARALLEL [Research Activity]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "were"

Phrase: "inversely"

Phrase: "correlated with reduced -casein expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0007332:Casein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0392756:Reduced [Qualitative Concept]
   760   C1707520:Correlated [Qualitative Concept]

Phrase: "(Figs 6B,"

Phrase: "7B"

Phrase: ")."
Processing 00000000.tx.2: By immunohistochemical staining, cyclin D1 protein was detected at high levels in nuclei of the transgenic mammary epithelium, correlating with the elevated levels of nuclear Msx1 protein (n=5; Fig. 7B). 

Phrase: "By immunohistochemical staining,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1441616:Immunohistochemical [Laboratory Procedure]
   861   C1704680:Staining [Finding]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "cyclin D1 protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1150565:cyclin [Molecular Function]
   827   C1416886:D1 [Gene or Genome]

Phrase: "was"

Phrase: "detected at high levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0205250:High [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C0442726:Detected [Finding]
   770   C1299351:High [Qualitative Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C2700149:HIGH [Intellectual Product]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "of the transgenic mammary epithelium,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0596882:Mammary Epithelium [Body Part, Organ, or Organ Component]
   827   C0014609:Epithelium [Tissue]
   755 E C0221908:Epithelial [Qualitative Concept]

Phrase: "correlating with the elevated levels of nuclear Msx1 protein"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   762   C0028589:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0748024:elevated protein [Finding]
   762   C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745   C0428479:Protein level [Laboratory or Test Result]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205250:Elevated [Qualitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   742   C0521447:Nuclear [Spatial Concept]
   742   C3163633:Elevated [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "(n=5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; Fig. 7B"

Phrase: ")."
Processing 00000000.tx.3: Furthermore, increased expression of cyclin D1 mRNA was found in transgenic mammary glands during mid- to late-pregnancy (fivefold at 14.5 dpc; n=6), consistent with their observed morphological defects (compare Fig. 6B with 7A). 

Phrase: "Furthermore,"

Phrase: "increased expression of cyclin D1 mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1515670:mRNA Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "found in transgenic mammary glands"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0929301:Mammary Glands [Body Part, Organ, or Organ Component]
           Mammary
   773 E C1521747:GLAND, MAMMARY [Tissue]
   760   C0003069:Transgenic [Animal]
   760   C0006141:Mammary [Body Part, Organ, or Organ Component]
   760   C0150312:Found [Quantitative Concept]
   760   C1285092:Glands [Body Part, Organ, or Organ Component]
   726 E C0243095:Find [Finding]

Phrase: "during mid- to late-pregnancy"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0878751:Late pregnancy [Pathologic Function]
   812   C0032961:Pregnancy [Organism Function]
   812   C3484365:Pregnancy [Clinical Attribute]
   741 E C0549206:Pregnant [Finding]
   741 E C0553641:Pregnant [Functional Concept]
   741 E C0600457:PREGNANT [Finding]
   729 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "(fivefold at 14.5 dpc"

Phrase: "; n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "consistent with their observed morphological defects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "Fig. 6B with 7A"

Phrase: ")."
Processing 00000000.tx.4: Interestingly, this upregulation of cyclin D1 in the Msx1 transgenic mice occurred during stages in which cyclin D1 is normally expressed in wild-type mice, whereas cyclin D1 is downregulated during lactation and involution in both wild-type and transgenic mice, despite the persistence of Msx1 transgene expression during these stages. 

Phrase: "Interestingly,"

Phrase: "this upregulation of cyclin D1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041904:Up-Regulation [Cell Function,Molecular Function]
   760   C0162493:Up-Regulation [Genetic Function]

Phrase: "in the Msx1 transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "occurred during stages"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1306673:Stages [Qualitative Concept]
   790   C1709305:Occurred [Activity]
   756 E C0205390:Stage [Temporal Concept]
   756 E C1300072:Stage [Clinical Attribute]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "in which cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "is"

Phrase: "normally"

Phrase: "expressed in wild-type mice,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   828   C1520150:Wild Type Mouse [Mammal]
   806   C1883559:Wild Type [Organism Attribute]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "whereas"

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "is"

Phrase: "downregulated during lactation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006147:Lactation [Organism Function]
   790   C0022925:Lactation [Organ or Tissue Function]

Phrase: "and"

Phrase: "involution in both wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333953:Involution [Organism Function]

Phrase: "and"

Phrase: "transgenic mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "despite the persistence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0546816:Persistence [Mental Process]
   928 E C0205322:Persistent [Temporal Concept]

Phrase: "of Msx1 transgene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   827   C0282641:Transgene [Gene or Genome]

Phrase: "during these stages."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1306673:Stages [Qualitative Concept]
   966 E C0205390:Stage [Temporal Concept]
   966 E C1300072:Stage [Clinical Attribute]
Processing 00000000.tx.5: In summary, these findings support the biological significance of Msx1 as an inhibitor of differentiation through its ability to upregulate cyclin D1 in the mammary gland.

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the biological significance of Msx1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237881:Significance [Quantitative Concept]
   760   C0750502:Significance [Idea or Concept]

Phrase: "as an inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]

Phrase: "of differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "through its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "upregulate"

Phrase: "cyclin D1 in the mammary gland."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1150565:cyclin [Molecular Function]
   753   C1416886:D1 [Gene or Genome]
Processing 00000000.tx.1: &nbsp;&nbsp; 

Phrase: "&nbsp"

Phrase: ";&nbsp"

Phrase: ";"
Processing 00000000.tx.2: DISCUSSION

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.1: TOP

Phrase: "TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.1: SUMMARY

Phrase: "SUMMARY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.1: INTRODUCTION

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]
Processing 00000000.tx.1: MATERIALS AND METHODS

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.1: RESULTS

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.1: DISCUSSION

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.1: REFERENCES

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: We have investigated the molecular mechanisms by which Msx homeobox genes control cellular processes of differentiation and proliferation during development. 

Phrase: "We"

Phrase: "have"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the molecular mechanisms by which Msx homeobox genes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0441712:Mechanisms [Functional Concept]
   711 E C1706376:Mechanism [Manufactured Object]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "cellular processes of differentiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C0007613:Cellular Process [Cell Function]
   816   C1325880:cellular process [Cell Function]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "proliferation during development."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0334094:Proliferation [Pathologic Function]
   790   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.2: We have found that Msx genes function as general inhibitors of differentiation of mesenchymal and epithelial progenitor cells in culture and in vivo, and that this inhibition is correlated with upregulation of cyclin D1 and Cdk4 activity. 

Phrase: "We"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that Msx genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "function as general inhibitors of differentiation of mesenchymal"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   767   C1334700:Mesenchymal Differentiation [Finding]
   750   C1511940:Differentiation Inhibitor [Pharmacologic Substance]
   744   C0007589:Differentiation [Cell Function]
   744   C0031843:function [Physiologic Function]
   744   C0205246:General [Spatial Concept]
   744   C0243077:inhibitors [Chemical Viewed Functionally]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1511938:Differentiation [Clinical Attribute]
   744   C1513143:Mesenchymal [Qualitative Concept]
   744   C1553889:General [Idea or Concept]
   744   C1705273:Function [Intellectual Product]
   744   C2945687:Differentiation [Functional Concept]
   711 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "epithelial progenitor cells in culture"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0038250:Progenitor Cells [Cell]
   797   C0007585:cells culture [Laboratory Procedure]
   797   C0014597:Epithelial Cells [Cell]
   797   C1273342:Epithelial Cells [Laboratory Procedure]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "that"

Phrase: "this inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "is"

Phrase: "correlated with upregulation of cyclin D1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0162493:Up-Regulation [Genetic Function]
   753   C1150565:cyclin [Molecular Function]
   753   C1416886:D1 [Gene or Genome]
   753   C1707520:Correlated [Qualitative Concept]

Phrase: "and"

Phrase: "Cdk4 activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.3: We propose that a primary function of Msx genes is to maintain cyclin D1 expression in progenitor populations during development, thereby preventing these cells from exiting the cell cycle and undergoing terminal differentiation (Fig. 8). 

Phrase: "We"

Phrase: "propose"

Phrase: "that"

Phrase: "a primary function of Msx genes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0314627:function genes [Genetic Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "cyclin D1 expression in progenitor populations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "during development,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "thereby"

Phrase: "preventing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "these cells from exiting"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "the cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "undergoing terminal differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C2752630:terminal differentiation [Cell Function]
   827   C0007589:Differentiation [Cell Function]
   827   C1511938:Differentiation [Clinical Attribute]
   827   C2945687:Differentiation [Functional Concept]
   755 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.4: Our findings establish a link between homeobox gene action and cell cycle control, and implicate Msx1 as a physiological mediator of cyclin D1 expression in vivo, which is of particular significance given the role of cyclin D1 in mammary differentiation and carcinogenesis.

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "a link between homeobox gene action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517892:Link [Intellectual Product]
   753   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "cell cycle control,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1155872:Cell Cycle Control [Cell Function]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]

Phrase: "and"

Phrase: "implicate"

Phrase: "Msx1 as a physiological mediator of cyclin D1 expression"

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "which"

Phrase: "is of particular significance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the role of cyclin D1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in mammary differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "carcinogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596263:Carcinogenesis [Neoplastic Process]
Processing 00000000.tx.1: View larger version (13K):

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"
Processing 00000000.tx.1: [in this window]

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"
Processing 00000000.tx.1: [in a new window] &nbsp;

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "] &nbsp"

Phrase: ";"
Processing 00000000.tx.1: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.2: 8 A model for Msx function in cell cycle regulation. 

Phrase: "8"

Phrase: "A model for Msx function in cell cycle regulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0814675:model regulation [Regulation or Law]
   742   C3161035:Model [Intellectual Product]
Processing 00000000.tx.3: Msx1 indirectly upregulates cyclin D1 expression (red arrows), resulting in block of cell cycle exit (red bar) and subsequent differentiation. 

Phrase: "Msx1 indirectly"

Phrase: "upregulates"

Phrase: "cyclin D1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(red arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "resulting in block of cell cycle exit (red bar)"
Meta Candidates (Total=23; Excluded=3; Pruned=0; Remaining=20)
   764   C0007586:Cell Cycle [Cell Function]
   764   C0332294:Resulting in [Functional Concept]
   764   C1155839:Cell Cycle [Cell Function]
   762   C0014792:Red Cell [Cell]
   762   C0037188:Exit Block [Disease or Syndrome]
   742   C0007634:Cell [Cell]
   742   C0028778:Block [Pathologic Function]
   742   C0332206:Block [Functional Concept]
   742   C0332575:Red [Finding]
   742   C0337094:Exit [Spatial Concept]
   742   C0678226:resulting [Functional Concept]
   742   C1260956:Red [Qualitative Concept]
   742   C1269647:Cell [Cell]
   742   C1511572:Cycle [Temporal Concept]
   742   C1533157:Block [Substance]
   742   C1550550:exit [Temporal Concept]
   742   C1704653:Cell [Medical Device]
   742   C1706084:Block [Geographic Area]
   742   C1948049:Cell [Spatial Concept]
   742   C2828370:Block [Quantitative Concept]
   708 E C1274040:Result [Functional Concept]
   708 E C1546471:Result [Idea or Concept]
   708 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "subsequent differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.4: Although cyclin D1 can promote cellular proliferation (green arrow), Msx1 does not, presumably through its effects on other cell cycle components (broken red arrow). 

Phrase: "Although"

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "can"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cellular proliferation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020507:Cellular proliferation [Pathologic Function]
  1000   C0596290:Cellular Proliferation [Cell Function]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "(green arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "Msx1"

Phrase: "does"

Phrase: "not,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "presumably through its effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on other cell cycle components"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   913   C0243092:Cell Components [Cell Component]
   896 E C1178969:Cell Component [Cell Component]
   827   C0449432:Components [Manufactured Object]
   793 E C1705248:Component [Conceptual Entity]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]

Phrase: "(broken red arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.5: Thus, overexpression of Msx1 would block cell cycle exit without promoting proliferation, while loss of Msx1 activity might lead to premature cell cycle exit.

Phrase: "Thus,"

Phrase: "overexpression of Msx1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "would"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "cell cycle exit without promoting proliferation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0337094:Exit [Spatial Concept]
   753   C1550550:exit [Temporal Concept]

Phrase: "while"

Phrase: "loss of Msx1 activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "might"

Phrase: "lead to premature cell cycle exit."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C0007586:Cell Cycle [Cell Function]
   790   C1155839:Cell Cycle [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0205252:Premature [Temporal Concept]
   753   C0337094:Exit [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1511572:Cycle [Temporal Concept]
   753   C1522538:Lead [Functional Concept]
   753   C1550550:exit [Temporal Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Homeobox genes as regulators of cell differentiation and proliferation

Phrase: "Homeobox genes as regulators of cell differentiation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0017347:Genes, Homeo Box [Gene or Genome]
   757   C0017362:Genes, Regulator [Gene or Genome]
   757   C1861886:CELL Gene [Gene or Genome]
   748   C0017337:Genes [Gene or Genome]
   748   C0242303:Homeo Box [Gene or Genome]
   748   C0598306:Homeo Box [Spatial Concept]

Phrase: "and"

Phrase: "proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.1: The expression patterns of Msx genes are consistent with a role for members of this gene family to function as general inhibitors of differentiation. 

Phrase: "The expression patterns of Msx genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Patterns [Spatial Concept]

Phrase: "are"

Phrase: "consistent with a role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "for members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0680022:members [Population Group]
   966 E C2698041:Member [Professional or Occupational Group]

Phrase: "of this gene family to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C1517488:Gene Family [Gene or Genome]
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "function as general inhibitors of differentiation."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   767   C1511940:Differentiation Inhibitor [Pharmacologic Substance]
   753   C0007589:Differentiation [Cell Function]
   753   C0031843:function [Physiologic Function]
   753   C0205246:General [Spatial Concept]
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1511938:Differentiation [Clinical Attribute]
   753   C1553889:General [Idea or Concept]
   753   C1705273:Function [Intellectual Product]
   753   C2945687:Differentiation [Functional Concept]
   719 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.2: Thus, expression of Msx genes at all stages of embryogenesis and adulthood is associated with multipotent progenitor cells, while Msx expression has not been found in any terminally differentiated cell types (Bendall and Abate-Shen, 2000; Davidson, 1995). 

Phrase: "Thus,"

Phrase: "expression of Msx genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "at all"

Phrase: "stages of embryogenesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0013936:Embryogenesis [Organ or Tissue Function]
   790   C0205390:Stage [Temporal Concept]
   790   C1300072:Stage [Clinical Attribute]
   790   C1306673:Stage [Qualitative Concept]

Phrase: "and"

Phrase: "adulthood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700597:Adulthood [Temporal Concept]

Phrase: "is"

Phrase: "associated with multipotent progenitor cells,"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   806   C0038250:Progenitor Cells [Cell]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   781   C0699040:cell associated [Cell Component]
   781   C1136335:Multipotent cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0870134:Progenitor [Family Group]
   760   C3282337:Cells [Cell]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1706221:Associate [Professional or Occupational Group]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "while"

Phrase: "Msx expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "found in any terminally differentiated cell types"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   778   C0449475:Cell types [Intellectual Product]
   748   C0007589:Differentiated [Cell Function]
           Cell Differentiation
   748   C0007634:Cell [Cell]
       E   Cell Type
   748   C0150312:Found [Quantitative Concept]
   748   C0205615:Differentiated [Qualitative Concept]
   748   C0332307:Types [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C0243095:Find [Finding]
   714 E C1547052:*Type [Quantitative Concept]

Phrase: "(Bendall"

Phrase: "and"

Phrase: "Abate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: "Shen,"

Phrase: "2000"

Phrase: "; Davidson,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.3: For example, during early embryogenesis, Msx genes are broadly expressed in mesoderm progenitors emerging from the primitive streak. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "during early embryogenesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013936:Embryogenesis [Organ or Tissue Function]

Phrase: "Msx genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "broadly"

Phrase: "expressed in mesoderm progenitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025485:Mesoderm [Embryonic Structure]
   737   C0870134:Progenitor [Family Group]

Phrase: "emerging from the primitive streak."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0033153:Primitive Streak [Embryonic Structure]
   760   C2348542:Streak [Idea or Concept]
   760   C3645627:Primitive [Intellectual Product]
Processing 00000000.tx.4: Later in embryogenesis, Msx gene expression is associated with progenitors that are restricted to particular lineages, such as the proliferating cells in the limb bud that give rise to its skeletal elements. 

Phrase: "Later in embryogenesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0205087:Late [Temporal Concept]

Phrase: "Msx gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "associated with progenitors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756   C0870134:Progenitor [Family Group]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that"

Phrase: "are"

Phrase: "restricted to particular lineages,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0443288:Restricted [Functional Concept]
   737   C1881379:Lineage [Conceptual Entity]

Phrase: "such as the proliferating cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in the limb bud"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0282505:Limb Bud [Embryonic Structure]
   861   C0015385:Limb [Body Part, Organ, or Organ Component]
   861   C1280090:Limb [Body Part, Organ, or Organ Component]
   861   C2700462:Bud [Plant]
   861   C2945744:bud [Anatomical Structure]

Phrase: "that"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to its skeletal elements."
Processing 00000000.tx.5: Furthermore, in adults Msx expression is limited to the stem cells of tissues capable of undergoing self renewal, such as the mammary epithelium, uterine epithelium and basal epithelium of the dermis (Friedmann and Daniel, 1996; Noveen et al., 1995; Pavlova et al., 1994; Phippard et al., 1996). 

Phrase: "Furthermore,"

Phrase: "in adults Msx expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "limited to the stem cells of tissues"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   778   C0038250:Stem cells [Cell]
   748   C0007634:Cells [Cell]
   748   C0040300:Tissues [Tissue]
   748   C0242767:Stem [Plant]
   748   C0439801:Limited [Functional Concept]
   748   C1186763:Stem [Body Part, Organ, or Organ Component]
   748   C3282337:Cells [Cell]
   748   C3542948:Limited [Intellectual Product]
   714 E C1269647:Cell [Cell]
   714 E C1547928:Tissue [Intellectual Product]
   714 E C1549649:Limit [Idea or Concept]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
   714 E C2349209:Limit [Conceptual Entity]

Phrase: "capable of undergoing self renewal,"

Phrase: "such as the mammary epithelium,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0596882:Mammary Epithelium [Body Part, Organ, or Organ Component]
   861   C0014609:Epithelium [Tissue]
   789 E C0221908:Epithelial [Qualitative Concept]

Phrase: "uterine epithelium"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014609:Epithelium [Tissue]
   789 E C0221908:Epithelial [Qualitative Concept]

Phrase: "and"

Phrase: "basal epithelium of the dermis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0014609:Epithelium [Tissue]

Phrase: "(Friedmann"

Phrase: "and"

Phrase: "Daniel,"

Phrase: "1996"

Phrase: "; Noveen et al.,"

Phrase: "1995"

Phrase: "; Pavlova et al.,"

Phrase: "1994"

Phrase: "; Phippard et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.6: Interestingly, Msx gene expression is also found in various carcinoma cell lines and tumors (Suzuki et al., 1993) (K. Catron and C. A.-S., unpublished), and forced expression of Msx1 promotes cellular transformation (Song et al., 1992), raising the possibility that Msx expression contributes to the reversion of differentiation that is characteristic of carcinoma cells. 

Phrase: "Interestingly,"

Phrase: "Msx gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "also"

Phrase: "found in various carcinoma cell lines"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   790   C0007600:Cell lines [Cell]
   790   C1518174:Carcinoma Cell [Cell]
   753   C0007097:Carcinoma [Neoplastic Process]
   753   C0007634:Cell [Cell]
   753   C0150312:Found [Quantitative Concept]
   753   C0205132:lines [Spatial Concept]
   753   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C0243095:Find [Finding]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "(Suzuki et al.,"

Phrase: "1993"

Phrase: ")"

Phrase: "(K. Catron"

Phrase: "and"

Phrase: "C. A.-S.,"

Phrase: "unpublished"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "forced expression of Msx1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cellular transformation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1510411:Cellular Transformation [Pathologic Function]
           Transformation
   861   C0040682:Transformation [Cell Function]
   861   C1705163:Transformation [Research Activity]

Phrase: "(Song et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: ","

Phrase: "raising"

Phrase: "the possibility"

Phrase: "that Msx expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "contributes to the reversion of differentiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0007589:Differentiation [Cell Function]
   753   C1511938:Differentiation [Clinical Attribute]
   753   C1880177:Contribute [Activity]
   753   C2945687:Differentiation [Functional Concept]

Phrase: "that"

Phrase: "is"

Phrase: "characteristic of carcinoma cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521970:Characteristic [Qualitative Concept]
Processing 00000000.tx.7: Notably, a recent study has shown that Msx1 overexpression can lead to de-differentiation of C2C12 cells into a mesenchymal progenitor that is capable of differentiating into multiple cell lineages (Odelberg et al., 2000). 

Phrase: "Notably,"

Phrase: "a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Msx1 overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]

Phrase: "can"

Phrase: "lead"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to de-differentiation of C2C12 cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0007589:cells differentiation [Cell Function]
           Differentiation
   753   C0011198:DE [Geographic Area]
   753   C0017480:DE [Geographic Area]
   753   C1511938:Differentiation [Clinical Attribute]
   753   C2945687:Differentiation [Functional Concept]
   753   C3541240:DE [Idea or Concept]

Phrase: "into a mesenchymal progenitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0870134:Progenitor [Family Group]

Phrase: "that"

Phrase: "is"

Phrase: "capable of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   761   C2698977:Capability [Qualitative Concept]

Phrase: "differentiating into multiple cell lineages"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0282637:Lineages, Cell [Idea or Concept]
   760   C0007634:Cell [Cell]
   760   C0205615:differentiating [Qualitative Concept]
   760   C0439064:Multiple [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C1881379:Lineage [Conceptual Entity]

Phrase: "(Odelberg et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.8: If this observation is confirmed in other cell types, this finding combined with the present study implies that trans-differentiation induced by Msx1 may be mediated by modulation of cell cycle regulators.

Phrase: "If"

Phrase: "this observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "is"

Phrase: "confirmed in other cell types,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0449475:Cell types [Intellectual Product]
   773 E C0007634:Cell Type [Cell]
           Cell
   760   C0332307:Types [Qualitative Concept]
   760   C0521093:confirmed [Qualitative Concept]
   760   C0750484:Confirmed [Idea or Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1456348:Confirm [Qualitative Concept]
   726 E C1547052:*Type [Quantitative Concept]

Phrase: "this finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "combined with the present study"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0205195:Combined [Qualitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   726 E C0336789:Combine [Manufactured Object]

Phrase: "implies"

Phrase: "that trans-differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2826298:TRANS [Idea or Concept]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "induced by Msx1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205263:Induced [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "mediated by modulation of cell cycle regulators."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   829   C1539026:regulator of cell cycle [Gene or Genome]
   804   C1155872:cell cycle modulation [Cell Function]
   797   C1325288:cell cycle regulator [Cell Function]
   778   C0007586:Cell Cycle [Cell Function]
   778   C1155839:Cell Cycle [Cell Function]
   748   C0007634:Cell [Cell]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0182953:regulators [Medical Device]
   748   C0443264:Modulation [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1511572:Cycle [Temporal Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C1704734:Regulator [Medical Device]
   714 E C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.1: In addition to the Msx gene family, numerous other homeobox genes have been implicated in controlling aspects of cellular proliferation and differentiation during embryogenesis, while their aberrant expression is associated with cellular transformation. 

Phrase: "In addition to the Msx gene family,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C1517488:Gene Family [Gene or Genome]
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "numerous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439064:Numerous [Quantitative Concept]

Phrase: "other homeobox genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017347:Genes, Homeo Box [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]
   861   C0242303:Homeo Box [Gene or Genome]
   861   C0598306:Homeo Box [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in controlling aspects of cellular proliferation"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   804   C0010820:Cellular aspects of [Qualitative Concept]
           cellular aspects
   778   C0020507:Cellular proliferation [Pathologic Function]
   778   C0596290:Cellular Proliferation [Cell Function]
   748   C0007634:Cellular [Cell]
   748   C0178539:Cellular [Functional Concept]
   748   C0332298:controlling [Functional Concept]
   748   C0334094:Proliferation [Pathologic Function]
   748   C1514485:Proliferation [Functional Concept]
   748   C2587213:Controlling [Functional Concept]
   714   C1547011:Aspect [Quantitative Concept]
   714   C1879746:Aspect [Qualitative Concept]

Phrase: "and"

Phrase: "differentiation during embryogenesis,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0007589:Differentiation [Cell Function]
   790   C1511938:Differentiation [Clinical Attribute]
   790   C2945687:Differentiation [Functional Concept]
   718 E C0205615:Differentiated [Qualitative Concept]

Phrase: "while"

Phrase: "their aberrant expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "associated with cellular transformation."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1510411:Cellular Transformation [Pathologic Function]
           Transformation
   770   C0007634:Cellular [Cell]
   770   C0040682:Transformation [Cell Function]
   770   C0178539:Cellular [Functional Concept]
   770   C1705163:Transformation [Research Activity]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.2: The most well studied in this regard are the Hox genes, which are the largest family of homeobox genes (Krumlauf, 1994). 

Phrase: "The most well studied in this regard"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205170:Well [Qualitative Concept]
   748   C3146287:Well [Manufactured Object]
   714   C0557651:Study [Manufactured Object]
   714   C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "the Hox genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017347:Hox Genes [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]

Phrase: "which"

Phrase: "are"

Phrase: "the largest family of homeobox genes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   803   C0017347:Homeobox Family Gene [Gene or Genome]
   773   C0424972:Large family [Family Group]
   767   C1517488:Gene Family [Gene or Genome]
   753   C0015576:Family [Family Group]
   753   C1704727:Family [Conceptual Entity]

Phrase: "(Krumlauf,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.3: Although loss-of-function mutation of members of the Hox family produces distinct phenotypic outcomes, certain common themes also emerge. 

Phrase: "Although"

Phrase: "loss-of-function mutation of members of the Hox family"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0026882:Mutation [Genetic Function]
   739   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "produces"

Phrase: "distinct phenotypic outcomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1274040:Outcome [Functional Concept]

Phrase: "certain common themes also"

Phrase: "emerge."
Processing 00000000.tx.4: Notably, Hox mutants often display vertebral transformations that have been interpreted as changes in rates of cell proliferation and/or survival (Duboule, 1995). 

Phrase: "Notably,"

Phrase: "Hox mutants often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "vertebral transformations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0040682:Transformations [Cell Function]
   827 E C1510411:Transformation [Pathologic Function]
   827 E C1705163:Transformation [Research Activity]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "interpreted as changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C1285553:interpreted [Functional Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0871208:Rate [Activity]
   966   C1521828:Rate [Quantitative Concept]

Phrase: "of cell proliferation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0596290:Cell Proliferation [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1269647:Cell [Cell]
   861   C1514485:Proliferation [Functional Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and/or"

Phrase: "survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "(Duboule,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.5: Hox genes, as well as their essential co-factors, the Pbx genes, are aberrantly expressed in leukemias and many solid tumors, and their forced expression is associated with cellular transformation (Cillo et al., 1999; Maulbecker and Gruss, 1993). 

Phrase: "Hox genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017347:Hox Genes [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]

Phrase: "as well as"

Phrase: "their essential co-factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "the Pbx genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "aberrantly"

Phrase: "expressed in leukemias"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0023418:LEUKEMIAS, NOS [Neoplastic Process]

Phrase: "and"

Phrase: "many solid tumors,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0280100:solid tumors [Neoplastic Process]
   861   C0027651:Tumors [Neoplastic Process]
   861   C0205208:Solid [Qualitative Concept]
   861   C0302909:Solid [Substance]
   861   C1378566:Solid [Biomedical or Dental Material]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "their forced expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "associated with cellular transformation"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1510411:Cellular Transformation [Pathologic Function]
           Transformation
   770   C0007634:Cellular [Cell]
   770   C0040682:Transformation [Cell Function]
   770   C0178539:Cellular [Functional Concept]
   770   C1705163:Transformation [Research Activity]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Cillo et al.,"

Phrase: "1999"

Phrase: "; Maulbecker"

Phrase: "and"

Phrase: "Gruss,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.6: Furthermore, the Gax homeobox gene negatively regulates cardiomyocyte proliferation through upregulation of the cell cycle regulatory gene, p21WAF1/CIP (Smith et al., 1997). 

Phrase: "Furthermore,"

Phrase: "the Gax homeobox gene negatively"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0017347:Homeo Box Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0242303:Homeo Box [Gene or Genome]
   812   C0598306:Homeo Box [Spatial Concept]

Phrase: "regulates"

Phrase: "cardiomyocyte proliferation through upregulation of the cell cycle regulatory gene,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C1156237:up-regulation of cell proliferation [Cell Function]
   760   C2262772:cardiomyocyte proliferation [Cell Function]
   757   C0596290:Cell Proliferation [Cell Function]
   739   C0334094:Proliferation [Pathologic Function]
   739   C1514485:Proliferation [Functional Concept]

Phrase: "p21WAF1/CIP (Smith et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.7: Thus, the link between homeobox gene function and regulation of the cell cycle machinery is likely to emerge as a prevalent theme.

Phrase: "Thus,"

Phrase: "the link between homeobox gene function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517892:Link [Intellectual Product]
   753   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "regulation of the cell cycle machinery"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C1155872:regulation of cell cycle [Cell Function]
           Cell Cycle Regulation
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "emerge as a prevalent theme."
Processing 00000000.tx.1: cyclin D1 is a downstream effector of Msx gene function

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "is"

Phrase: "a downstream effector of Msx gene function"
Processing 00000000.tx.1: cyclin D1 inhibits differentiation of multiple lineages through its ability to block exit from the cell cycle, and thus represents an excellent candidate downstream effector for Msx1 in culture (Sherr and Roberts, 1999; Walsh and Perlman, 1997). 

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "differentiation of multiple lineages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007589:Differentiation [Cell Function]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "through its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "exit from the cell cycle,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0337094:Exit [Spatial Concept]
   760   C1550550:exit [Temporal Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an excellent candidate downstream effector for Msx1"

Phrase: "in culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "(Sherr"

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "1999"

Phrase: "; Walsh"

Phrase: "and"

Phrase: "Perlman,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.2: Indeed, cyclin D1 blocks MyoD activity in myogenic progenitors (Rao and Kohtz, 1995; Skapek et al., 1995), which is noteworthy as Msx1 inhibits MyoD expression in cell culture as well as in vivo (Bendall et al., 1999; Woloshin et al., 1995). 

Phrase: "Indeed,"

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "MyoD activity in myogenic progenitors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "(Rao"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "and"

Phrase: "Kohtz,"

Phrase: "1995"

Phrase: "; Skapek et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "noteworthy as Msx1"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "MyoD expression in cell culture"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0007585:Cell Culture [Laboratory Procedure]
   804   C0010453:Culture [Idea or Concept]
   804   C0220814:culture [Functional Concept]
   804   C0430400:Culture [Laboratory Procedure]
   804   C2242979:Culture [Laboratory Procedure]

Phrase: "as well as"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(Bendall et al.,"

Phrase: "1999"

Phrase: "; Woloshin et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.3: However, the consequences of Msx1 misexpression are not entirely analogous to those of cyclin D1, as Msx1 does not significantly promote cellular proliferation, resulting in a greater percentage of Msx1-expressing cells in the G1 phase. 

Phrase: "However,"

Phrase: "the consequences of Msx1 misexpression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "are"

Phrase: "not entirely analogous to those of cyclin D1,"

Phrase: "as"

Phrase: "Msx1"

Phrase: "does"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cellular proliferation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020507:Cellular proliferation [Pathologic Function]
  1000   C0596290:Cellular Proliferation [Cell Function]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "resulting in a greater percentage of Msx1-expressing cells"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
   764   C0332294:Resulting in [Functional Concept]
   742   C0007634:Cells [Cell]
   742   C0439165:Percentage [Quantitative Concept]
   742   C0443228:greater [Quantitative Concept]
   742   C0678226:resulting [Functional Concept]
   742   C1549488:Percentage [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]
   742   C1704243:Greater [Quantitative Concept]
   742   C3282337:Cells [Cell]
   708 E C0549177:Great [Quantitative Concept]
   708 E C1269647:Cell [Cell]
   708 E C1274040:Result [Functional Concept]
   708 E C1546471:Result [Idea or Concept]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
   708 E C2825142:Result [Finding]

Phrase: "in the G1 phase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079395:G1 Phase [Temporal Concept]
   861   C0205390:Phase [Temporal Concept]
Processing 00000000.tx.4: This distinction probably reflects the fact that Msx1 upregulates cyclin D1 but not cyclin E or the G2 cyclins.

Phrase: "This distinction probably"

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the fact"

Phrase: "that Msx1"

Phrase: "upregulates"

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "but"

Phrase: "not cyclin E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0111429:Cyclin E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1259807:Cyclin E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1332697:CYCLIN E [Gene or Genome]

Phrase: "or"

Phrase: "the G2 cyclins."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0079183:Cyclins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827 E C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827 E C1150565:cyclin [Molecular Function]
Processing 00000000.tx.1: In addition, cyclin D1 is an excellent candidate downstream effector of Msx in vivo. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "is"

Phrase: "an excellent candidate downstream effector of Msx"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.2: Indeed, we have demonstrated that overexpression of Msx1 in the mammary gland results in upregulation of cyclin D1 expression. 

Phrase: "Indeed,"

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that overexpression of Msx1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in the mammary gland"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0929301:Mammary gland [Body Part, Organ, or Organ Component]
           Mammary
  1000   C1521747:GLAND, MAMMARY [Tissue]
   861   C0006141:Mammary [Body Part, Organ, or Organ Component]
   861   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "results in upregulation of cyclin D1 expression."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0041904:Up-Regulation [Cell Function,Molecular Function]
   748   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0162493:Up-Regulation [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C1150565:cyclin [Molecular Function]
   748   C1274040:Result [Functional Concept]
   748   C1416886:D1 [Gene or Genome]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]
Processing 00000000.tx.3: Furthermore, the expression patterns of Msx1 and Msx2 overlap with that of cyclin D1 at early stages of embryogenesis in the primitive streak and lateral mesoderm and later in the limb mesenchyme, neural tube, craniofacial mesenchyme, retina and mammary gland (Wianny et al., 1998; G. H. and C. A.-S., unpublished). 

Phrase: "Furthermore,"

Phrase: "the expression patterns of Msx1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "Msx2 overlap with that of cyclin D1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0185027:overlap [Therapeutic or Preventive Procedure]
   748   C1948020:Overlap [Conceptual Entity]

Phrase: "at early stages"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C2363430:early stages [Temporal Concept]
   983 E C1517886:Early Stage [Classification]
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "of embryogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013936:Embryogenesis [Organ or Tissue Function]

Phrase: "in the primitive streak"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033153:Primitive Streak [Embryonic Structure]
   861   C2348542:Streak [Idea or Concept]
   861   C3645627:Primitive [Intellectual Product]

Phrase: "and"

Phrase: "lateral mesoderm"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1517749:Lateral Mesoderm [Embryonic Structure]
   861   C0025485:Mesoderm [Embryonic Structure]
   861   C0205093:Lateral [Spatial Concept]
   789 E C0521459:Mesodermal [Body Location or Region]

Phrase: "and"

Phrase: "later in the limb mesenchyme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0205087:Late [Temporal Concept]

Phrase: "neural tube,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0231024:Neural tube [Embryonic Structure]
   861   C0175730:Tube [Medical Device]
   861   C0599851:Neural [Functional Concept]
   861   C1547937:Tube NOS [Intellectual Product]
   861   C1561954:tube [Conceptual Entity]
   861   C1704730:TUBE [Medical Device]
   805 E C0027740:Nerve [Tissue]
   805 E C0027757:NERVE [Tissue]
   805 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   768 E C0027769:nervy [Sign or Symptom]

Phrase: "craniofacial mesenchyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162415:Mesenchyme [Embryonic Structure]
   789 E C1513143:Mesenchymal [Qualitative Concept]

Phrase: "retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "mammary gland"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0929301:Mammary gland [Body Part, Organ, or Organ Component]
           Mammary
  1000   C1521747:GLAND, MAMMARY [Tissue]
   861   C0006141:Mammary [Body Part, Organ, or Organ Component]
   861   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "(Wianny et al.,"

Phrase: "1998"

Phrase: "; G. H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0560020:g h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "C. A.-S.,"

Phrase: "unpublished"

Phrase: ")."
Processing 00000000.tx.4: Moreover, the phenotypes of Msx1, Msx2 and cyclin D1 loss-of-function mutations share similarities, but are not identical, as discussed below. 

Phrase: "Moreover,"

Phrase: "the phenotypes of Msx1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0031437:Phenotypes [Organism Attribute]
   737 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "Msx2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417388:MSX2 [Gene or Genome]

Phrase: "and"

Phrase: "cyclin D1 loss-of-function mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0026882:Mutations [Genetic Function]
   766 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "similarities,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348205:Similarity [Qualitative Concept]

Phrase: "but"

Phrase: "are"

Phrase: "not identical,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205280:Identical [Qualitative Concept]

Phrase: "as"

Phrase: "discussed below."
Processing 00000000.tx.5: Our current findings do not preclude negative regulation by Msx genes of lineage-specific genes such as MyoD or osteocalcin, which are involved in terminal differentiation (Bendall et al., 1999; Newberry et al., 1997; Woloshin et al., 1995), but instead expand the repertoire of their downstream effectors to include global cell cycle regulators.

Phrase: "Our current findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "preclude"

Phrase: "negative regulation by Msx genes of lineage-specific genes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C0017263:genes regulation [Genetic Function]
   742   C0205160:Negative [Qualitative Concept]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]
   742   C1513916:Negative [Finding]
   742   C2825415:Negative [Conceptual Entity]
   742   C2825491:Negative [Qualitative Concept]

Phrase: "such as MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "or"

Phrase: "osteocalcin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0029419:Osteocalcin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412791:OSTEOCALCIN [Gene or Genome]

Phrase: "which"

Phrase: "are"

Phrase: "involved in terminal differentiation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C2752630:terminal differentiation [Cell Function]
   770   C0007589:Differentiation [Cell Function]
   770   C0205088:Terminal [Temporal Concept]
   770   C1314939:Involved [Functional Concept]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C1705314:Terminal [Manufactured Object]
   770   C1705315:Terminal [Spatial Concept]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "(Bendall et al.,"

Phrase: "1999"

Phrase: "; Newberry et al.,"

Phrase: "1997"

Phrase: "; Woloshin et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "instead"

Phrase: "expand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:Expand [Spatial Concept]

Phrase: "the repertoire of their downstream effectors to"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "global cell cycle regulators."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   906   C1325288:cell cycle regulator [Cell Function]
   812   C0182953:regulators [Medical Device]
   779 E C1704734:Regulator [Medical Device]
   779 E C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.1: Although we have found that cyclin D1 is activated as an early response gene of Msx1, the available evidence suggests that it is likely to be an indirect target. 

Phrase: "Although"

Phrase: "we"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "is"

Phrase: "activated as an early response gene of Msx1,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   800   C0599295:early response gene [Gene or Genome]
   800   C1705964:Early Response Gene [Gene or Genome]
   767   C1417387:MSX1 gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0871261:Response [Organism Attribute]
   744   C1279919:Early [Temporal Concept]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C1879547:Activated [Activity]
   744   C2911692:Response [Mental Process]
   711 E C1515877:Activate [Functional Concept]

Phrase: "the available evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "an indirect target."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1552011:indirect target [Idea or Concept]
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.2: Indeed, Msx genes encode transcriptional repressors and have not been previously implicated as transcriptional activators (Catron et al., 1996; Catron et al., 1995). 

Phrase: "Indeed,"

Phrase: "Msx genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "transcriptional repressors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1336789:Transcriptional Repressor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Repressor

Phrase: "and"

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "previously"

Phrase: "implicated as transcriptional activators"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C1336776:Transcriptional Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0040649:Transcriptional [Genetic Function]

Phrase: "(Catron et al.,"

Phrase: "1996"

Phrase: "; Catron et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.3: Given the known significance of protein-protein interactions for mediating Msx function (Bendall et al., 1999; Zhang et al., 1997), it seems plausible that Msx1 activates cyclin D1 through interaction with other transcriptional regulators, perhaps those directly upstream of cyclin D1.

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the known significance of protein-protein interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237881:Significance [Quantitative Concept]
   748   C0750502:Significance [Idea or Concept]

Phrase: "for"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "Msx function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "(Bendall et al.,"

Phrase: "1999"

Phrase: "; Zhang et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "seems"

Phrase: "plausible"

Phrase: "that Msx1"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "cyclin D1 through interaction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1150565:cyclin [Molecular Function]
   770   C1416886:D1 [Gene or Genome]

Phrase: "with other transcriptional regulators,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0040649:Transcriptional [Genetic Function]
   861   C0182953:regulators [Medical Device]
   827 E C1704734:Regulator [Medical Device]
   827 E C1704735:Regulator [Conceptual Entity]

Phrase: "perhaps"

Phrase: "those directly upstream of cyclin D1."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0522505:Upstream [Spatial Concept]
   753   C1150565:cyclin [Molecular Function]
   753   C1416886:D1 [Gene or Genome]
   753   C1947931:Directly [Qualitative Concept]
Processing 00000000.tx.1: A model for Msx gene function

Phrase: "A model for Msx gene function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.1: Based on our findings, we propose a model for the mechanism of Msx gene function in cellular proliferation and differentiation (Fig. 8). 

Phrase: "Based on our findings,"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C0243095:Finding [Finding]
   737 E C1880279:Base [Biomedical or Dental Material]
   737 E C2825141:Finding [Finding]

Phrase: "we"

Phrase: "propose"

Phrase: "a model for the mechanism of Msx gene function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3161035:Model [Intellectual Product]

Phrase: "in cellular proliferation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020507:Cellular proliferation [Pathologic Function]
  1000   C0596290:Cellular Proliferation [Cell Function]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.2: We find that Msx genes maintain cells in a proliferative state by blocking exit from the cell cycle, while not actively promoting proliferation. 

Phrase: "We"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that Msx genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "cells in a proliferative state"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "by blocking exit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337094:Exit [Spatial Concept]
   861   C1550550:exit [Temporal Concept]

Phrase: "from the cell cycle,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "while"

Phrase: "not actively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "proliferation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.3: Moreover, this model explains the apparent activity of Msx genes in inhibiting cellular differentiation as a consequence of preventing cell cycle exit. 

Phrase: "Moreover,"

Phrase: "this model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "explains"

Phrase: "the apparent activity of Msx genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "in inhibiting cellular differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C1511938:Cellular Differentiation [Clinical Attribute]
           Differentiation
   827   C0007589:Differentiation [Cell Function]
   827   C2945687:Differentiation [Functional Concept]
   755 E C0205615:Differentiated [Qualitative Concept]

Phrase: "as a consequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "of preventing cell cycle exit."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0337094:Exit [Spatial Concept]
   812   C1550550:exit [Temporal Concept]
Processing 00000000.tx.4: Thus, the model distinguishes between a direct effect on the cell cycle and an indirect effect on differentiation.

Phrase: "Thus,"

Phrase: "the model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "distinguishes between a direct effect"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439851:Direct [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C1947931:Direct [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "an indirect effect on differentiation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.1: Our model provides a basis for reconciling the observed similarities between the phenotypes of Msx loss-of-function and gain-of-function mutations (Jabs et al., 1993; Liu et al., 1995; Satokata et al., 2000; Satokata and Maas, 1994; Wilkie et al., 2000; Winograd et al., 1997). 

Phrase: "Our model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a basis for reconciling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1527178:Basis [Functional Concept]
   770   C1874451:Basis [Pharmacologic Substance]

Phrase: "the observed similarities between the phenotypes of Msx loss-of-function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   704   C2348205:Similarity [Qualitative Concept]

Phrase: "and"

Phrase: "gain-of-function mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "Jabs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1426208:JAB [Gene or Genome]
  1000   C3273630:JAB [Gene or Genome]
  1000   C3275256:JAB [Amino Acid, Peptide, or Protein]

Phrase: "et al.,"

Phrase: "1993"

Phrase: "; Liu et al.,"

Phrase: "1995"

Phrase: "; Satokata et al.,"

Phrase: "2000"

Phrase: "; Satokata"

Phrase: "and"

Phrase: "Maas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1416953:MAA [Gene or Genome]
   966   C1979919:MAA [Indicator, Reagent, or Diagnostic Aid]

Phrase: "1994"

Phrase: "; Wilkie et al.,"

Phrase: "2000"

Phrase: "; Winograd et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.2: For example, mutant mice lacking either Msx2 or both Msx1 and Msx2 display profound defects in mammary gland development that have been interpreted as arrested differentiation (Satokata et al., 2000). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "either Msx2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417388:MSX2 [Gene or Genome]

Phrase: "or"

Phrase: "both Msx1"

Phrase: "and"

Phrase: "Msx2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417388:MSX2 [Gene or Genome]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "profound defects in mammary gland development"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0243067:defects [Functional Concept]
   731   C0000768:Developmental defect [Congenital Abnormality]
   719 E C1457869:Defect [Functional Concept]
   719 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "interpreted as arrested differentiation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0007589:Differentiation [Cell Function]
   770   C0018790:arrested [Disease or Syndrome]
   770   C0237477:Arrested [Temporal Concept]
   770   C1285553:interpreted [Functional Concept]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]
   737 E C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "(Satokata et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.3: In the context of our model, loss of Msx function is predicted to result in premature exit of progenitor cells from the cell cycle, resulting in decreased proliferation and consequently impaired morphogenesis. 

Phrase: "In the context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "of our model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "loss of Msx function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in premature exit of progenitor cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   778   C0038250:Progenitor Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C0205252:Premature [Temporal Concept]
   748   C0337094:Exit [Spatial Concept]
   748   C0870134:Progenitor [Family Group]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1550550:exit [Temporal Concept]
   748   C2825142:Result [Finding]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "from the cell cycle,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "resulting in decreased proliferation"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C0332294:Resulting in [Functional Concept]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0334094:Proliferation [Pathologic Function]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C0678226:resulting [Functional Concept]
   770   C1514485:Proliferation [Functional Concept]
   737 E C0547047:Decrease [Quantitative Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "consequently impaired morphogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026559:Morphogenesis [Organism Function]
Processing 00000000.tx.4: Conversely, in MMTV-Msx1 transgenic mice, which also display defects in mammary gland differentiation, overexpression of Msx genes is predicted to block progenitor cells from exiting the cell cycle; 

Phrase: "Conversely,"

Phrase: "in MMTV-Msx1 transgenic mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "which also"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "defects in mammary gland differentiation,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0243067:defects [Functional Concept]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "overexpression of Msx genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "is"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "progenitor cells from exiting"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0038250:Progenitor Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "the cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.5: in the absence of increased proliferation, the outcome would also be impaired morphogenesis. 

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of increased proliferation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "the outcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1274040:Outcome [Functional Concept]

Phrase: "would"

Phrase: "also"

Phrase: "be"

Phrase: "impaired morphogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026559:Morphogenesis [Organism Function]
Processing 00000000.tx.6: Comparable arguments can be made for the similar phenotypes found in loss- and gain-of-function analyses of Msx function in cranial development (Jabs et al., 1993; Liu et al., 1995; Satokata et al., 2000; Satokata and Maas, 1994; Wilkie et al., 2000; Winograd et al., 1997). 

Phrase: "Comparable arguments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680226:arguments [Social Behavior]
   827 E C1704769:Argument [Conceptual Entity]

Phrase: "can"

Phrase: "be"

Phrase: "made for the similar phenotypes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0031437:Phenotypes [Organism Attribute]
   760   C2348205:Similar [Qualitative Concept]
   726 E C1285572:Phenotype [Laboratory Procedure]
   726   C1881534:Make [Functional Concept]

Phrase: "found in loss-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0150312:Found [Quantitative Concept]
   790   C1517945:Loss [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "gain-of-function analyses of Msx function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C0558024:Functional analysis [Health Care Activity]
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "in cranial development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "("

Phrase: "Jabs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1426208:JAB [Gene or Genome]
  1000   C3273630:JAB [Gene or Genome]
  1000   C3275256:JAB [Amino Acid, Peptide, or Protein]

Phrase: "et al.,"

Phrase: "1993"

Phrase: "; Liu et al.,"

Phrase: "1995"

Phrase: "; Satokata et al.,"

Phrase: "2000"

Phrase: "; Satokata"

Phrase: "and"

Phrase: "Maas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1416953:MAA [Gene or Genome]
   966   C1979919:MAA [Indicator, Reagent, or Diagnostic Aid]

Phrase: "1994"

Phrase: "; Wilkie et al.,"

Phrase: "2000"

Phrase: "; Winograd et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.7: In addition, similar phenotypes following both loss- and gain-of-function mutations have been reported for other homeobox genes (e.g. Pollock et al., 1992).

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "similar phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "both loss-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "gain-of-function mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "reported for other homeobox genes"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0017347:Genes, Homeo Box [Gene or Genome]
   760   C0017337:Genes [Gene or Genome]
   760   C0242303:Homeo Box [Gene or Genome]
   760   C0598306:Homeo Box [Spatial Concept]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "("

Phrase: "e.g. Pollock et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.1: cyclin D1 loss-of-function mutant mice display delayed maturation of the mammary gland that has been interpreted as partial blockage of differentiation (Fantl et al., 1999; Fantl et al., 1995; Sicinski et al., 1995). 

Phrase: "cyclin D1 loss-of-function mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "delayed maturation of the mammary gland"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0678723:Maturation [Organism Function]
   753   C0870861:maturation [Phenomenon or Process]
   753   C1254042:Maturation [Physiologic Function]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "interpreted as partial blockage of differentiation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0007589:Differentiation [Cell Function]
   753   C0728938:Partial [Quantitative Concept]
   753   C1285553:interpreted [Functional Concept]
   753   C1511938:Differentiation [Clinical Attribute]
   753   C1550516:partial [Idea or Concept]
   753   C1706968:Blockage [Finding]
   753   C1879887:Blockage [Phenomenon or Process]
   753   C2945687:Differentiation [Functional Concept]

Phrase: "(Fantl et al.,"

Phrase: "1999"

Phrase: "; Fantl et al.,"

Phrase: "1995"

Phrase: "; Sicinski et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.2: In particular, these mice undergo normal early proliferation and side-branching, but greatly reduced lobuloalveolar formation (Fantl et al., 1999), resembling the phenotype of MMTV-Msx1 transgenic mice. 

Phrase: "In particular,"

Phrase: "these mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "undergo"

Phrase: "normal early proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0334094:Proliferation [Pathologic Function]
   827   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "side-branching,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205384:Branching [Spatial Concept]

Phrase: "but"

Phrase: "greatly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "lobuloalveolar formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(Fantl et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "resembling"

Phrase: "the phenotype of MMTV-Msx1 transgenic mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031437:Phenotype [Organism Attribute]
   748   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.3: In cyclin D1 loss-of-function mutants, progenitor cells would be predicted to exit the cell cycle prematurely, resulting in less proliferation and hence impaired morphogenesis; 

Phrase: "In cyclin D1 loss-of-function mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "progenitor cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0038250:Progenitor Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "would"

Phrase: "be"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337094:Exit [Spatial Concept]
  1000   C1550550:exit [Temporal Concept]

Phrase: "the cell cycle prematurely,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007586:Cell Cycle [Cell Function]
   901   C1155839:Cell Cycle [Cell Function]
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1511572:Cycle [Temporal Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "resulting in less proliferation"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0332294:Resulting in [Functional Concept]
   770   C0334094:Proliferation [Pathologic Function]
   770   C0678226:resulting [Functional Concept]
   770   C1514485:Proliferation [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "hence impaired morphogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026559:Morphogenesis [Organism Function]

Phrase: ";"
Processing 00000000.tx.4: counterintuitively, the outcome would thus be similar to that of MMTV-Msx1 transgenic mice. 

Phrase: "counterintuitively,"

Phrase: "the outcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1274040:Outcome [Functional Concept]

Phrase: "would"

Phrase: "thus"

Phrase: "be"

Phrase: "similar to that of MMTV-Msx1 transgenic mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.5: Conversely, MMTV-cyclin D1 transgenic mice display mammary epithelial hyperproliferation that ultimately leads to carcinoma (Wang et al., 1994), consistent with the well-known activity of cyclin D1 in promoting cellular proliferation, unlike Msx1.

Phrase: "Conversely,"

Phrase: "MMTV-cyclin D1 transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "mammary epithelial hyperproliferation"

Phrase: "that ultimately"

Phrase: "leads to carcinoma"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0007097:Carcinoma [Neoplastic Process]
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(Wang et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: ","

Phrase: "consistent with the well-known activity of cyclin D1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in promoting cellular proliferation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0020507:Cellular proliferation [Pathologic Function]
   901   C0596290:Cellular Proliferation [Cell Function]
   827   C0334094:Proliferation [Pathologic Function]
   827   C1514485:Proliferation [Functional Concept]

Phrase: "unlike Msx1."
Processing 00000000.tx.1: The potential for Msx genes to upregulate cyclin D1 has important implications for mammary carcinogenesis. 

Phrase: "The potential for Msx genes to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3245505:Potential [Qualitative Concept]

Phrase: "upregulate"

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "has"

Phrase: "important implications for mammary carcinogenesis."
Processing 00000000.tx.2: Upregulation of cyclin D1 protein expression is one of the most prevalent alterations in breast carcinoma, occurring in approximately 40% of cases (Hall and Peters, 1996). 

Phrase: "Upregulation of cyclin D1 protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "is"

Phrase: "one of the most prevalent alterations in breast carcinoma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205447:One [Quantitative Concept]

Phrase: "occurring in approximately 40% of cases"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0332232:Approximately [Qualitative Concept]
   753   C0439509:/40 [Temporal Concept]
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]
   719   C1709305:Occur [Activity]
   719   C2745955:OCCUR [Temporal Concept]

Phrase: "(Hall"

Phrase: "and"

Phrase: "Peters,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.3: However, cyclin D1 gene amplification occurs in only a fraction of these cases, indicating that other factors are responsible for upregulating cyclin D1. 

Phrase: "However,"

Phrase: "cyclin D1 gene amplification"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1511413:Cyclin D1 Gene Amplification [Cell or Molecular Dysfunction]
   923   C0525036:Gene, Cyclin D1 [Gene or Genome]
   923   C1413172:Cyclin D1 Gene [Gene or Genome]
   875   C1333183:Cyclin Gene [Gene or Genome]
   861   C0017256:Gene Amplification [Genetic Function]
   861   C1705759:Gene Amplification [Cell or Molecular Dysfunction]
           Amplification
   812   C0017337:Gene [Gene or Genome]
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]

Phrase: "occurs in only"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205171:Only [Quantitative Concept]
   790   C1709305:Occur [Activity]
   790   C1720467:Only [Intellectual Product]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "a fraction of these cases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   760   C1554103:Fraction [Idea or Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "other factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "responsible for upregulating cyclin D1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]
Processing 00000000.tx.4: Thus, our findings suggest that a potential role for Msx genes in breast carcinogenesis deserves further study.

Phrase: "Thus,"

Phrase: "our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a potential role for Msx genes in breast carcinogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "deserves"

Phrase: "further study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.1: &nbsp;&nbsp; 

Phrase: "&nbsp"

Phrase: ";&nbsp"

Phrase: ";"
Processing 00000000.tx.2: ACKNOWLEDGMENTS

Phrase: "ACKNOWLEDGMENTS"
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: We acknowledge the expert technical assistance of Nishita Desai for immunohistochemistry. 

Phrase: "We"

Phrase: "acknowledge"

Phrase: "the expert technical assistance of Nishita Desai"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0018896:Assistance [Social Behavior]
   748   C0449851:Technical [Functional Concept]

Phrase: "for immunohistochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]
Processing 00000000.tx.2: We thank Dr Emma Lees for much valuable input and Drs Lee, Fang Liu and Isao Matsuura for advice on Cdk kinase assays. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr Emma Lees for much valuable input"

Phrase: "and"

Phrase: "Drs Lee,"

Phrase: "Fang Liu"

Phrase: "and"

Phrase: "Isao Matsuura for advice"

Phrase: "on Cdk kinase assays."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.3: We acknowledge Dr Danny Reinberg for RNA PolII antisera, Dr Charles J. 

Phrase: "We"

Phrase: "acknowledge"

Phrase: "Dr Danny Reinberg for RNA PolII antisera,"

Phrase: "Dr Charles J."
Processing 00000000.tx.4: Sherr for the murine cyclin D1, cyclin D2, cyclin D3, cyclin E and p16/ink4a cDNAs, Dr Ed Harlow for the murine retinoblastoma cDNA, Dr Bert Vogelstein for the murine p21WAF1/CIP1 cDNA, Dr Joan Massague for the murine p27kip and p57kip2 cDNAs, and Dr Edward B Ziff for the cyclin D1 promoter plasmids. 

Phrase: "Sherr for the murine cyclin D1,"

Phrase: "cyclin D2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0214570:Cyclin-D2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413173:CYCLIN D2 [Gene or Genome]
  1000   C2718191:Cyclin D2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "cyclin D3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0173532:cyclin D3 [Amino Acid, Peptide, or Protein]
  1000   C1413175:CYCLIN D3 [Gene or Genome]

Phrase: "cyclin E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0111429:Cyclin E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1259807:Cyclin E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332697:CYCLIN E [Gene or Genome]

Phrase: "and"

Phrase: "p16/ink4a cDNAs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0249880:p16-INK4a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Dr Ed Harlow for the murine retinoblastoma cDNA,"

Phrase: "Dr Bert Vogelstein for the murine p21WAF1/CIP1 cDNA,"

Phrase: "Dr Joan Massague for the murine p27kip"

Phrase: "and"

Phrase: "p57kip2 cDNAs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "Dr Edward B Ziff for the cyclin D1 promoter plasmids."
Processing 00000000.tx.5: We thank Dr Andrew Bendall and members of the Abate-Shen laboratory for stimulating discussion and advice throughout the course of this work. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr Andrew Bendall"

Phrase: "and"

Phrase: "members of the"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0680022:members [Population Group]
   756 E C2698041:Member [Professional or Occupational Group]

Phrase: "Abate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: "Shen laboratory for stimulating discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C3244292:laboratory [Functional Concept]

Phrase: "and"

Phrase: "advice throughout the course of this work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0150600:Advice [Health Care Activity]
Processing 00000000.tx.6: We also thank Drs Tom Curran, Celine Gelinas, Emma Lees, Fang Liu, Arnold Rabson and Nancy Walworth for comments on the manuscript. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs Tom Curran,"

Phrase: "Celine Gelinas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1199058:gelinas [Eukaryote]

Phrase: "Emma Lees,"

Phrase: "Fang Liu,"

Phrase: "Arnold Rabson"

Phrase: "and"

Phrase: "Nancy Walworth for comments"

Phrase: "on the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.7: This work is supported by NIH grants to C. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "is"

Phrase: "supported by NIH grants"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0018173:Grants [Quantitative Concept]
   770   C0027468:NIH [Health Care Related Organization]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]
   737 E C1548284:Grant [Idea or Concept]

Phrase: "to C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.8: A.-S. 

Phrase: "A.-S."
Processing 00000000.tx.9: (HD29446) and to M. 

Phrase: "(HD29446"

Phrase: ")"

Phrase: "and to M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.10: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.11: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.12: (HL60212 and HD38766), and a pre-doctoral fellowship from the American Heart Association (NJ97SA04) to G. 

Phrase: "(HL60212"

Phrase: "and"

Phrase: "HD38766"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a pre-doctoral fellowship from the American Heart Association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0015770:Fellowship [Educational Activity]

Phrase: "(NJ97SA04"

Phrase: ")"

Phrase: "to G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.13: H.

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.1: &nbsp;&nbsp; 

Phrase: "&nbsp"

Phrase: ";&nbsp"

Phrase: ";"
Processing 00000000.tx.2: REFERENCES

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]
Processing 00000000.tx.1: TOP

Phrase: "TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.1: SUMMARY

Phrase: "SUMMARY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.1: INTRODUCTION

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]
Processing 00000000.tx.1: MATERIALS AND METHODS

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.1: RESULTS

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.1: DISCUSSION

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.1: REFERENCES

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Ahrens, P. 

Phrase: "Ahrens,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.2: B., Solursh, M. and Reiter, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Solursh,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Reiter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.3: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.4: (1977). 

Phrase: "(1977"

Phrase: ")."
Processing 00000000.tx.5: Stage-related capacity for limb chondrogenesis in cell culture. 

Phrase: "Stage-related capacity for limb chondrogenesis in cell culture."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1516240:Capacity [Quantitative Concept]
Processing 00000000.tx.6: Dev. 

Phrase: "Dev."
Processing 00000000.tx.7: Biol. 

Phrase: "Biol."
Processing 00000000.tx.8: 60, 69-82.[Medline]

Phrase: "60,"

Phrase: "69-82."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450388:69 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Bendall, A. 

Phrase: "Bendall,"

Phrase: "A."
Processing 00000000.tx.2: J. and Abate-Shen, C. 

Phrase: "J."

Phrase: "and"

Phrase: "Abate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: "Shen,"

Phrase: "C."
Processing 00000000.tx.3: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.4: Roles for Msx and Dlx homeoproteins in vertebrate development. 

Phrase: "Roles for Msx"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0035820:Roles [Social Behavior]
   756 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "Dlx homeoproteins in vertebrate development."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242617:Homeoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.5: Gene 247, 17-31.[Medline]

Phrase: "Gene 247,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "17-31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Bendall, A. 

Phrase: "Bendall,"

Phrase: "A."
Processing 00000000.tx.2: J., Ding, J., Hu, G., Shen, M. 

Phrase: "J.,"

Phrase: "Ding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419419:DING [Gene or Genome]

Phrase: "J.,"

Phrase: "Hu,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Shen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: M. and Abate-Shen, C. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Abate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: "Shen,"

Phrase: "C."
Processing 00000000.tx.4: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.5: Msx1 antagonizes the myogenic activity of Pax3 in migrating limb muscle precursors. 

Phrase: "Msx1"

Phrase: "antagonizes"

Phrase: "the myogenic activity of Pax3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "in migrating limb muscle precursors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.6: Development 126, 4965-4976.[Abstract/Free Full&nbsp;Text]

Phrase: "Development 126,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "4965-4976."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Catron, K. 

Phrase: "Catron,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.2: M., Zhang, H., Marshall, S. 

Phrase: "M."

Phrase: ","

Phrase: "Zhang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.3: C., Inostroza, J. 

Phrase: "C., Inostroza,"

Phrase: "J."
Processing 00000000.tx.4: A., Wilson, J. 

Phrase: "A.,"

Phrase: "Wilson,"

Phrase: "J."
Processing 00000000.tx.5: M. and Abate, C. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Abate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: ","

Phrase: "C."
Processing 00000000.tx.6: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.7: Transcriptional repression by Msx-1 does not require homeodomain DNA-binding sites. 

Phrase: "Transcriptional repression by Msx-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0920533:Transcriptional Repression [Genetic Function]
   760   C0035143:Repression [Mental Process]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "homeodomain DNA-binding sites."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0005456:Binding Sites [Receptor]
   827 E C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.8: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.9: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.10: Biol. 

Phrase: "Biol."
Processing 00000000.tx.11: 15, 861-871.[Abstract]

Phrase: "15,"

Phrase: "861-871."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Catron, K. 

Phrase: "Catron,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.2: M., Wang, H., Hu, G., Shen, M. 

Phrase: "M."

Phrase: ","

Phrase: "Wang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hu,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Shen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: M. and Abate-Shen, C. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Abate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: "Shen,"

Phrase: "C."
Processing 00000000.tx.4: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.5: Comparison of MSX-1 and MSX-2 suggests a molecular basis for functional redundancy. 

Phrase: "Comparison of MSX-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "MSX-2"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a molecular basis for functional redundancy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1853126:MOLECULAR BASIS [Idea or Concept]
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]
Processing 00000000.tx.6: Mech. 

Phrase: "Mech."
Processing 00000000.tx.7: Dev. 

Phrase: "Dev."
Processing 00000000.tx.8: 55, 185-199.[Medline]

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "185-199."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Cillo, C., Faiella, A., Cantile, M. and Boncinelli, E. 

Phrase: "Cillo,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Faiella,"

Phrase: "A.,"

Phrase: "Cantile,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Boncinelli,"

Phrase: "E."
Processing 00000000.tx.2: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.3: Homeobox genes and cancer. 

Phrase: "Homeobox genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017347:Genes, Homeo Box [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]
   861   C0242303:Homeo Box [Gene or Genome]
   861   C0598306:Homeo Box [Spatial Concept]

Phrase: "and"

Phrase: "cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]
Processing 00000000.tx.4: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.5: Cell Res. 

Phrase: "Cell Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.6: 248, 1-9.[Medline]

Phrase: "248,"

Phrase: "1-9."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Davidson, D. 

Phrase: "Davidson,"

Phrase: "D."
Processing 00000000.tx.2: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.3: The function and evolution of Msx genes: pointers and paradoxes. 

Phrase: "The function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "evolution of Msx genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015219:Evolution [Genetic Function]

Phrase: ":"

Phrase: "pointers"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0324413:pointers [Mammal]
   966 E C1704635:Pointer [Manufactured Object]
   966 E C1704636:Pointer [Intellectual Product]

Phrase: "and"

Phrase: "paradoxes."
Processing 00000000.tx.4: Trends Genet. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.5: 11, 405-411.[Medline]

Phrase: "11,"

Phrase: "405-411."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Diehl, J. 

Phrase: "Diehl,"

Phrase: "J."
Processing 00000000.tx.2: A. and Sherr, C. 

Phrase: "A."

Phrase: "and"

Phrase: "Sherr,"

Phrase: "C."
Processing 00000000.tx.3: J. 

Phrase: "J."
Processing 00000000.tx.4: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.5: A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. 

Phrase: "A dominant-negative cyclin D1 mutant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   911   C1512032:Dominant-Negative Mutant [Cell or Molecular Dysfunction]
   804   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "nuclear import of cyclin-dependent kinase 4 (CDK4)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0887839:Nuclear Import [Cell Function]
   748   C0699788:Import [Occupational Activity]

Phrase: "and"

Phrase: "its phosphorylation by CDK-activating kinase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.6: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.7: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.8: Biol. 

Phrase: "Biol."
Processing 00000000.tx.9: 17, 7362-7374.[Abstract]

Phrase: "17,"

Phrase: "7362-7374."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Dodig, M., Tadic, T., Kronenberg, M. 

Phrase: "Dodig,"

Phrase: "M."

Phrase: ","

Phrase: "Tadic,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kronenberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: S., Dacic, S., Liu, Y. 

Phrase: "S."

Phrase: ","

Phrase: "Dacic,"

Phrase: "S."

Phrase: ","

Phrase: "Liu,"

Phrase: "Y."
Processing 00000000.tx.3: H., Maxson, R., Rowe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Maxson,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rowe,"

Phrase: "D."
Processing 00000000.tx.4: W. and Lichtler, A. 

Phrase: "W."

Phrase: "and"

Phrase: "Lichtler,"

Phrase: "A."
Processing 00000000.tx.5: C. 

Phrase: "C."
Processing 00000000.tx.6: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.7: Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation. 

Phrase: "Ectopic Msx2 overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514559:Overexpression [Genetic Function]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "and"

Phrase: "Msx2 antisense"

Phrase: "stimulates"

Phrase: "calvarial osteoblast differentiation."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C1159974:osteoblast differentiation [Cell Function]
   827   C0007589:Differentiation [Cell Function]
   827   C1511938:Differentiation [Clinical Attribute]
   827   C2945687:Differentiation [Functional Concept]
   755 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.8: Dev. 

Phrase: "Dev."
Processing 00000000.tx.9: Biol. 

Phrase: "Biol."
Processing 00000000.tx.10: 209, 298-307.[Medline]

Phrase: "209,"

Phrase: "298-307."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Duboule, D. 

Phrase: "Duboule,"

Phrase: "D."
Processing 00000000.tx.2: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.3: Vertebrate Hox genes and proliferation: an alternative pathway to homeosis? 

Phrase: "Vertebrate Hox genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0017347:Hox Genes [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: ":"

Phrase: "an alternative pathway to homeosis?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.4: Curr. 

Phrase: "Curr."
Processing 00000000.tx.5: Biol. 

Phrase: "Biol."
Processing 00000000.tx.6: 5, 525-528.

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "525-528."
Processing 00000000.tx.1: Fantl, V., Stamp, G., Andrews, A., Rosewell, I. and Dickson, C. 

Phrase: "Fantl,"

Phrase: "V.,"

Phrase: "Stamp,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1823540:STAMP [Gene or Genome]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Andrews,"

Phrase: "A.,"

Phrase: "Rosewell,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Dickson,"

Phrase: "C."
Processing 00000000.tx.2: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.3: Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "are"

Phrase: "small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "and"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "defects in eye"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0243067:defects [Functional Concept]
   756 E C1457869:Defect [Functional Concept]
   756 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "mammary gland development."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1326631:mammary gland development [Organ or Tissue Function]
   901   C1656975:gland development [Organ or Tissue Function]
   827   C0243107:development [Physiologic Function]
   827   C0678723:Development [Organism Function]
   827   C1527148:Development [Functional Concept]
   755 E C0458003:Developmental [Qualitative Concept]
   734   C0929301:Mammary gland [Body Part, Organ, or Organ Component]
   734   C1521747:GLAND, MAMMARY [Tissue]
Processing 00000000.tx.4: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.5: 9, 2364-2372.[Abstract]

Phrase: "9,"

Phrase: "2364-2372."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Fantl, V., Edwards, P. 

Phrase: "Fantl,"

Phrase: "V.,"

Phrase: "Edwards,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.2: A. 

Phrase: "A."
Processing 00000000.tx.3: W., Steel, J. 

Phrase: "W., Steel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038239:Steel [Biomedical or Dental Material,Inorganic Chemical]

Phrase: "J."
Processing 00000000.tx.4: H., Vonderhaar, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Vonderhaar,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.5: K. and Dickson, C. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Dickson,"

Phrase: "C."
Processing 00000000.tx.6: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.7: Impaired mammary gland development in Cyl-/- mice during pregnancy and lactation is epithelial cell autonomous. 

Phrase: "Impaired mammary gland development in Cyl-/- mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C1326631:mammary gland development [Organ or Tissue Function]
   778   C1656975:gland development [Organ or Tissue Function]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]

Phrase: "during pregnancy"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "and"

Phrase: "lactation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006147:Lactation [Organism Function]
  1000   C0022925:Lactation [Organ or Tissue Function]

Phrase: "is"

Phrase: "epithelial cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0014597:Epithelial cell [Cell]
   861   C0007634:Cell [Cell]
   861   C0221908:Epithelial [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "autonomous."
Processing 00000000.tx.8: Dev. 

Phrase: "Dev."
Processing 00000000.tx.9: Biol. 

Phrase: "Biol."
Processing 00000000.tx.10: 212, 1-11.[Medline]

Phrase: "212,"

Phrase: "1-11."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Friedmann, Y. and Daniel, C. 

Phrase: "Friedmann,"

Phrase: "Y."

Phrase: "and"

Phrase: "Daniel,"

Phrase: "C."
Processing 00000000.tx.2: W. 

Phrase: "W."
Processing 00000000.tx.3: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.4: Regulated expression of homeobox genes Msx-1 and Msx-2 in mouse mammary gland development suggests a role in hormone action and epithelial- stromal interactions. 

Phrase: "Regulated expression of homeobox genes Msx-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0017262:Gene Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Msx-2 in mouse mammary gland development"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C1326631:mammary gland development [Organ or Tissue Function]
   814   C1512980:Mouse Mammary Gland [Tissue]
   778   C0929301:Mammary gland [Body Part, Organ, or Organ Component]
           Mammary
   778   C1521747:GLAND, MAMMARY [Tissue]
   778   C1656975:gland development [Organ or Tissue Function]
   748   C0006141:Mammary [Body Part, Organ, or Organ Component]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1285092:Gland [Body Part, Organ, or Organ Component]
   748   C1527148:Development [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role in hormone action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "epithelial- stromal interactions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   988   C1516929:Epithelial-Stromal Interaction [Organ or Tissue Function]
   793   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.5: Dev. 

Phrase: "Dev."
Processing 00000000.tx.6: Biol. 

Phrase: "Biol."
Processing 00000000.tx.7: 177, 347-355.[Medline]

Phrase: "177,"

Phrase: "347-355."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Gerstenfeld, L. 

Phrase: "Gerstenfeld,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.2: C., Chipman, S. 

Phrase: "C., Chipman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.3: D., Glowacki, J. and Lian, J. 

Phrase: "D."

Phrase: ","

Phrase: "Glowacki,"

Phrase: "J."

Phrase: "and"

Phrase: "Lian,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330941:lian [Plant]

Phrase: "J."
Processing 00000000.tx.4: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.5: (1987). 

Phrase: "(1987"

Phrase: ")."
Processing 00000000.tx.6: Expression of differentiated function by mineralizing cultures of chicken osteoblasts. 

Phrase: "Expression of differentiated function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by mineralizing cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "of chicken osteoblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029418:Osteoblasts [Cell]
Processing 00000000.tx.7: Dev. 

Phrase: "Dev."
Processing 00000000.tx.8: Biol. 

Phrase: "Biol."
Processing 00000000.tx.9: 122, 49-60.[Medline]

Phrase: "122,"

Phrase: "49-60."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Ghosh-Choudhury, N., Windle, J. 

Phrase: "Ghosh-Choudhury,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Windle,"

Phrase: "J."
Processing 00000000.tx.2: J., Koop, B. 

Phrase: "J.,"

Phrase: "Koop,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.3: A., Harris, M. 

Phrase: "A.,"

Phrase: "Harris,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: A., Guerrero, D. 

Phrase: "A.,"

Phrase: "Guerrero,"

Phrase: "D."
Processing 00000000.tx.5: L., Wozney, J. 

Phrase: "L., Wozney,"

Phrase: "J."
Processing 00000000.tx.6: M., Mundy, G. 

Phrase: "M."

Phrase: ","

Phrase: "Mundy,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.7: R. and Harris, S. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Harris,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.8: E. 

Phrase: "E."
Processing 00000000.tx.9: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.10: Immortalized murine osteoblasts derived from BMP 2-T-antigen expressing transgenic mice. 

Phrase: "Immortalized murine osteoblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0029418:Osteoblasts [Cell]

Phrase: "derived from BMP 2-T-antigen"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0003343:T-Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0527443:BMP-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003320:Antigen [Immunologic Factor]
   753   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0279266:BMP [Therapeutic or Preventive Procedure]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "expressing"

Phrase: "transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.11: Endocrinology 137, 331-339.[Abstract]

Phrase: "Endocrinology 137,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "331-339."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Hall, M. and Peters, G. 

Phrase: "Hall,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Peters,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.2: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.3: Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. 

Phrase: "Genetic alterations of cyclins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C0026882:Genetic Alteration [Genetic Function]
   816   C1704257:Genetic Alteration [Finding]
   816   C1705285:Genetic Alteration [Cell or Molecular Dysfunction]
   737   C1515926:Alteration [Idea or Concept]

Phrase: "cyclin-dependent kinases,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0243045:Cyclin-Dependent Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0851827:Dependent [Qualitative Concept]
   827   C1150565:cyclin [Molecular Function]
   827   C1701901:Dependent [Qualitative Concept]
   827   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "Cdk inhibitors in human cancer."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   773   C1152568:CDK inhibitor [Molecular Function]
   773   C1511576:CDK Inhibitor [Pharmacologic Substance]
   760   C0243045:CDK [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   760   C1150557:CDK [Molecular Function]
   726 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.4: Adv. 

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.5: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.6: 68, 67-108.[Medline]

Phrase: "68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "67-108."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Hamburger, V. and Hamilton, H. 

Phrase: "Hamburger,"

Phrase: "V."

Phrase: "and"

Phrase: "Hamilton,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.2: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.3: (1951). 

Phrase: "(1951"

Phrase: ")."
Processing 00000000.tx.4: A series of normal stages in the development of the chick embryo. 

Phrase: "A series of normal stages"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205549:Series [Quantitative Concept]
   760   C2348044:Series [Intellectual Product]

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of the chick embryo."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008046:Chick Embryo [Embryonic Structure]
   861   C0013935:Embryo [Embryonic Structure]
   861   C1305370:Embryo [Embryonic Structure]
Processing 00000000.tx.5: J. 

Phrase: "J."
Processing 00000000.tx.6: Morphol. 

Phrase: "Morphol."
Processing 00000000.tx.7: 88, 49-92.

Phrase: "88,"

Phrase: "49-92."
Processing 00000000.tx.1: Hu, G., Vastardis, H., Bendall, A. 

Phrase: "Hu,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vastardis,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bendall,"

Phrase: "A."
Processing 00000000.tx.2: J., Wang, Z., Logan, M., Zhang, H., Nelson, C., Stein, S., Greenfield, N., Seidman, C. 

Phrase: "J.,"

Phrase: "Wang,"

Phrase: "Z.,"

Phrase: "Logan,"

Phrase: "M."

Phrase: ","

Phrase: "Zhang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nelson,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Stein,"

Phrase: "S."

Phrase: ","

Phrase: "Greenfield,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Seidman,"

Phrase: "C."
Processing 00000000.tx.3: E. et al. 

Phrase: "E. et al."
Processing 00000000.tx.4: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.5: Haploinsufficiency of MSX1: a mechanism for selective tooth agenesis. 

Phrase: "Haploinsufficiency of MSX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2936267:Haploinsufficiency [Cell or Molecular Dysfunction]

Phrase: ":"

Phrase: "a mechanism for selective tooth agenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.6: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.7: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.8: Biol. 

Phrase: "Biol."
Processing 00000000.tx.9: 18, 6044-6051.[Abstract/Free Full&nbsp;Text]

Phrase: "18,"

Phrase: "6044-6051."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Hughes, S. 

Phrase: "Hughes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551730:Hughes [Population Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.2: H., Greenhouse, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Greenhouse,"

Phrase: "J."
Processing 00000000.tx.3: J., Petropoulos, C. 

Phrase: "J.,"

Phrase: "Petropoulos,"

Phrase: "C."
Processing 00000000.tx.4: J. and Sutrave, P. 

Phrase: "J."

Phrase: "and"

Phrase: "Sutrave,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.5: (1987). 

Phrase: "(1987"

Phrase: ")."
Processing 00000000.tx.6: Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. 

Phrase: "Adaptor plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "simplify"

Phrase: "the insertion of foreign DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021107:Insertion [Therapeutic or Preventive Procedure]
   760   C0441587:Insertion [Health Care Activity]
   760   C1512796:Insertion [Genetic Function]
   760   C1883719:Insertion [Functional Concept]

Phrase: "into helper-independent retroviral vectors."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C1514926:retroviral vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035366:Retroviral [Virus]
   812   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vectors [Spatial Concept]
   779 E C1705099:Vector [Idea or Concept]
Processing 00000000.tx.7: J. 

Phrase: "J."
Processing 00000000.tx.8: Virol. 

Phrase: "Virol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0965991:virol [Lipid]
Processing 00000000.tx.9: 61, 3004-3012.[Medline]

Phrase: "61,"

Phrase: "3004-3012."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Hynes, N. 

Phrase: "Hynes,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.2: E., Taverna, D., Harwerth, I. 

Phrase: "E.,"

Phrase: "Taverna,"

Phrase: "D."

Phrase: ","

Phrase: "Harwerth,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.3: M., Ciardiello, F., Salomon, D. 

Phrase: "M."

Phrase: ","

Phrase: "Ciardiello,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Salomon,"

Phrase: "D."
Processing 00000000.tx.4: S., Yamamoto, T. and Groner, B. 

Phrase: "S."

Phrase: ","

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Groner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.5: (1990). 

Phrase: "(1990"

Phrase: ")."
Processing 00000000.tx.6: Epidermal growth factor receptor, but not c-erb-2 activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells. 

Phrase: "Epidermal growth factor receptor,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0034802:Epidermal Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]
   923   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   923   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   923   C1323367:epidermal growth factor [Molecular Function]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0014520:Epidermal [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0221920:Epidermal [Spatial Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "but"

Phrase: "not c-erb-2 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1879547:Activation [Activity]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "lactogenic hormone induction of the beta-casein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0920532:gene induction [Genetic Function]
   744   C0205263:Induction [Functional Concept]
   744   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in mouse mammary epithelial cells."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   861   C0014597:Epithelial Cells [Cell]
   861   C1273342:Epithelial Cells [Laboratory Procedure]
   812   C0006141:Mammary [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]
   812   C0221908:Epithelial [Qualitative Concept]
   812   C0929301:Mammary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.7: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.8: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.9: Biol. 

Phrase: "Biol."
Processing 00000000.tx.10: 10, 4027-4034.[Medline]

Phrase: "10,"

Phrase: "4027-4034."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Jabs, E. 

Phrase: "Jabs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1426208:JAB [Gene or Genome]
  1000   C3273630:JAB [Gene or Genome]
  1000   C3275256:JAB [Amino Acid, Peptide, or Protein]

Phrase: ","

Phrase: "E."
Processing 00000000.tx.2: W., Mller, U., Li, X., Ma, L., Luo, W., Haworth, I. 

Phrase: "W., Mller,"

Phrase: "U.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "X.,"

Phrase: "Ma,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "W.,"

Phrase: "Haworth,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.3: S., Klisak, I., Sparkes, R., Warman, M. 

Phrase: "S."

Phrase: ","

Phrase: "Klisak,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sparkes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Warman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: L., Mulliken, J. 

Phrase: "L., Mulliken,"

Phrase: "J."
Processing 00000000.tx.5: B. et al. 

Phrase: "B. et al."
Processing 00000000.tx.6: (1993). 

Phrase: "(1993"

Phrase: ")."
Processing 00000000.tx.7: A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. 

Phrase: "A mutation in the homeodomain of the human MSX2 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0596611:Gene Mutation [Genetic Function]
   739   C0026882:Mutation [Genetic Function]
   739   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in a family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "affected with autosomal dominant craniosynostosis."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0443147:Autosomal dominant [Intellectual Product]
   760   C0010278:Craniosynostosis [Congenital Abnormality,Disease or Syndrome]
   760   C0392760:Affected [Functional Concept]
   760   C0596142:autosomal [Cell Component]
   760   C1314939:Affected [Functional Concept]
   760   C1442871:craniosynostosis [Gene or Genome]
   760   C1527180:Dominant [Functional Concept]
   726 E C0001721:Affect [Mental Process]
Processing 00000000.tx.8: Cell 75, 443-450.[Medline]

Phrase: "Cell 75,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "443-450."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Kinsella, T. 

Phrase: "Kinsella,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.2: M. and Nolan, G. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Nolan,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.3: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.4: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.5: Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. 

Phrase: "Episomal vectors rapidly"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vectors [Spatial Concept]
   793 E C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "stably"

Phrase: "produce"

Phrase: "high-titer recombinant retrovirus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035366:Retrovirus [Virus]
Processing 00000000.tx.6: Hum. 

Phrase: "Hum."
Processing 00000000.tx.7: Gene Ther. 

Phrase: "Gene Ther."
Processing 00000000.tx.8: 7, 1405-1413.[Medline]

Phrase: "7,"

Phrase: "1405-1413."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Krumlauf, R. 

Phrase: "Krumlauf,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.2: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.3: Hox genes in vertebrate development. 

Phrase: "Hox genes in vertebrate development."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0017347:Hox Genes [Gene or Genome]
   762   C0017340:Genes, Developmental [Gene or Genome]
   760   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.4: Cell 78, 191-201.[Medline]

Phrase: "Cell 78,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "191-201."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Littlewood, T. 

Phrase: "Littlewood,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.2: D., Hancock, D. 

Phrase: "D."

Phrase: ","

Phrase: "Hancock,"

Phrase: "D."
Processing 00000000.tx.3: C., Danielian, P. 

Phrase: "C., Danielian,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.4: S., Parker, M. 

Phrase: "S."

Phrase: ","

Phrase: "Parker,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.5: G. and Evan, G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Evan,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.6: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.7: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.8: A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. 

Phrase: "A modified oestrogen receptor ligand-binding domain as an improved switch"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   775   C0597358:receptor ligand binding [Molecular Function]
           Receptor Binding
   775   C0682969:Ligand Binding Domain [Amino Acid Sequence]
   772   C1149369:estrogen receptor binding [Molecular Function]
   772   C1516971:Estrogen Binding Domain [Amino Acid Sequence]
   756   C1517880:Ligand Binding [Molecular Function]
   756   C1621296:receptor ligand [Molecular Function]
   738   C0023688:Ligand [Chemical]
   738   C0243122:binding [Functional Concept]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1880389:Domain [Functional Concept]
   738   C1883221:Domain [Conceptual Entity]
   738   C3541951:Domain [Intellectual Product]

Phrase: "for the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of heterologous proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.9: Nucleic Acids Res. 

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.10: 23, 1686-1690.[Abstract]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "1686-1690."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Liu, Y. 

Phrase: "Liu,"

Phrase: "Y."
Processing 00000000.tx.2: H., Kundu, R., Wu, L., Luo, W., Ignelzi Jr, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kundu,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "W.,"

Phrase: "Ignelzi Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: A., Snead, M. 

Phrase: "A.,"

Phrase: "Snead,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: L. and Maxson Jr, R. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Maxson Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.5: E. 

Phrase: "E."
Processing 00000000.tx.6: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.7: Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull. 

Phrase: "Premature suture closure"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0332877:Closure, premature [Congenital Abnormality]
   901   C0009068:suture closure [Therapeutic or Preventive Procedure]
   827   C0185003:Closure [Therapeutic or Preventive Procedure]
   827   C1521802:Closure [Research Activity]
   771 E C0447303:Occlusal [Body Location or Region]
   771 E C0591895:occlusal [Organic Chemical,Pharmacologic Substance]
   771 E C1947917:Occlusal [Functional Concept]

Phrase: "and"

Phrase: "ectopic cranial bone in mice"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0037303:Bone, Cranial [Body Part, Organ, or Organ Component]
           Cranial
   806   C0447962:Cranial bone [Body Part, Organ, or Organ Component]
   781   C1511240:Mouse Bone [Tissue]
   760   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   760   C0391978:Bone [Tissue]
   760   C1266908:Bone [Body Part, Organ, or Organ Component]
   760   C1266909:Bone [Body System]
   760   C3163632:Cranial [Spatial Concept]
   745   C1522418:Mouse Cranium [Tissue]

Phrase: "expressing"

Phrase: "Msx2 transgenes in the developing skull."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0282641:Transgenes [Gene or Genome]
Processing 00000000.tx.8: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.9: Natl. 

Phrase: "Natl."
Processing 00000000.tx.10: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.11: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.12: USA 92, 6137-6141.[Abstract/Free Full&nbsp;Text]

Phrase: "USA 92,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "6137-6141."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Maulbecker, C. 

Phrase: "Maulbecker,"

Phrase: "C."
Processing 00000000.tx.2: C. and Gruss, P. 

Phrase: "C."

Phrase: "and"

Phrase: "Gruss,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.3: (1993). 

Phrase: "(1993"

Phrase: ")."
Processing 00000000.tx.4: The oncogenic potential of deregulated homeobox genes. 

Phrase: "The oncogenic potential of deregulated homeobox genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.5: Cell Growth &amp; 

Phrase: "Cell Growth &amp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0007595:Cell Growth [Cell Function]

Phrase: ";"
Processing 00000000.tx.6: Diff. 

Phrase: "Diff."
Processing 00000000.tx.7: 4, 431-441.[Abstract]

Phrase: "4,"

Phrase: "431-441."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Mina, M., Gluhak, J. and Rodgers, B. 

Phrase: "Mina,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426245:MINA [Gene or Genome]

Phrase: "M."

Phrase: ","

Phrase: "Gluhak,"

Phrase: "J."

Phrase: "and"

Phrase: "Rodgers,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.2: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.3: Downregulation of Msx-2 expression results in chondrogenesis in the medial region of the avian mandible. 

Phrase: "Downregulation of Msx-2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "results in chondrogenesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0598067:Chondrogenesis [Organ or Tissue Function]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "in the medial region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of the avian mandible."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0024687:Mandible [Body Part, Organ, or Organ Component]
   861   C1279059:Mandible [Body Part, Organ, or Organ Component]
Processing 00000000.tx.4: Conn. 

Phrase: "Conn."
Processing 00000000.tx.5: Tissue Res. 

Phrase: "Tissue Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.6: 35, 79-84.[Medline]

Phrase: "35,"

Phrase: "79-84."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Newberry, E. 

Phrase: "Newberry,"

Phrase: "E."
Processing 00000000.tx.2: P., Boudreaux, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Boudreaux,"

Phrase: "J."
Processing 00000000.tx.3: M. and Towler, D. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Towler,"

Phrase: "D."
Processing 00000000.tx.4: A. 

Phrase: "A."
Processing 00000000.tx.5: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.6: Stimulus-selective inhibition of rat osteocalcin promoter induction and protein-protein interactions by the homeodomain repressor Msx2. 

Phrase: "Stimulus-selective inhibition of rat osteocalcin promoter induction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "protein-protein interactions by the homeodomain repressor Msx2."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0242617:Homeodomain Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0248606:MSX2 protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0872079:Protein-Protein Interaction [Molecular Function]
           interactions protein
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   711   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.7: J. 

Phrase: "J."
Processing 00000000.tx.8: Biol. 

Phrase: "Biol."
Processing 00000000.tx.9: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.10: 272, 29607-29613.[Abstract/Free Full&nbsp;Text]

Phrase: "272,"

Phrase: "29607-29613."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Noveen, A., Jiang, T. 

Phrase: "Noveen,"

Phrase: "A.,"

Phrase: "Jiang,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.2: X., Ting-Berreth, S. 

Phrase: "X.,"

Phrase: "Ting-Berreth,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.3: A. and Chuong, C. 

Phrase: "A."

Phrase: "and"

Phrase: "Chuong,"

Phrase: "C."
Processing 00000000.tx.4: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.5: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.6: Homeobox genes Msx-1 and Msx-2 are associated with induction and growth of skin appendages. 

Phrase: "Homeobox genes Msx-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0017347:Genes, Homeo Box [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]
   812   C0242303:Homeo Box [Gene or Genome]
   812   C0598306:Homeo Box [Spatial Concept]

Phrase: "and"

Phrase: "Msx-2"

Phrase: "are"

Phrase: "associated with induction"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0205263:Induction [Functional Concept]
   790   C0857127:induction [Therapeutic or Preventive Procedure]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "growth of skin appendages."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0423785:Skin growth [Organ or Tissue Function]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]
Processing 00000000.tx.7: J. 

Phrase: "J."
Processing 00000000.tx.8: Invest. 

Phrase: "Invest."
Processing 00000000.tx.9: Dermatol. 

Phrase: "Dermatol."
Processing 00000000.tx.10: 104, 711-719.[Abstract]

Phrase: "104,"

Phrase: "711-719."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Odelberg, S. 

Phrase: "Odelberg,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.2: J., Kollhoff, A. and Keating, M. 

Phrase: "J.,"

Phrase: "Kollhoff,"

Phrase: "A."

Phrase: "and"

Phrase: "Keating,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.4: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.5: Dedifferentiation of mammalian myotubes induced by msx1. 

Phrase: "Dedifferentiation of mammalian myotubes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0002793:Dedifferentiation [Neoplastic Process]
   770   C2248595:dedifferentiation [Cell Function]

Phrase: "induced by msx1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205263:Induced [Functional Concept]
Processing 00000000.tx.6: Cell 103, 1099-1109.[Medline]

Phrase: "Cell 103,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1099-1109."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Parry, D., Mahony, D., Wills, K. and Lees, E. 

Phrase: "Parry,"

Phrase: "D."

Phrase: ","

Phrase: "Mahony,"

Phrase: "D."

Phrase: ","

Phrase: "Wills,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042950:wills [Mental Process]
  1000   C0043177:Wills [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Lees,"

Phrase: "E."
Processing 00000000.tx.2: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.3: Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. 

Phrase: "Cyclin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1150565:cyclin [Molecular Function]

Phrase: "D-"

Phrase: "CDK subunit arrangement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449830:Arrangement [Spatial Concept]

Phrase: "is"

Phrase: "dependent on the availability of competing INK4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "p21 class inhibitors."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.4: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.5: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.6: Biol. 

Phrase: "Biol."
Processing 00000000.tx.7: 19, 1775-1783.[Abstract/Free Full&nbsp;Text]

Phrase: "19,"

Phrase: "1775-1783."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Pavlova, A., Boutin, E., Cunha, G. and Sassoon, D. 

Phrase: "Pavlova,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0996292:Pavlova [Eukaryote]

Phrase: "A.,"

Phrase: "Boutin,"

Phrase: "E.,"

Phrase: "Cunha,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Sassoon,"

Phrase: "D."
Processing 00000000.tx.2: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.3: Msx1 (Hox-7.1) in the adult mouse uterus: cellular interactions underlying regulation of expression. 

Phrase: "Msx1"

Phrase: "(Hox-7.1"

Phrase: ")"

Phrase: "in the adult mouse uterus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1519876:Mouse Uterus [Tissue]
   827   C0042149:Uterus [Body Part, Organ, or Organ Component]
   827   C1269032:Uterus [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "cellular interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "underlying"

Phrase: "regulation of expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0851285:Regulation [Governmental or Regulatory Activity]
   790   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.4: Development 120, 335-346.[Abstract/Free Full&nbsp;Text]

Phrase: "Development 120,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "335-346."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Phippard, D. 

Phrase: "Phippard,"

Phrase: "D."
Processing 00000000.tx.2: J., Weber-Hall, S. 

Phrase: "J.,"

Phrase: "Weber-Hall,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.3: J., Sharpe, P. 

Phrase: "J.,"

Phrase: "Sharpe,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.4: T., Naylor, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Naylor,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.5: S., Jayatalake, H., Maas, R., Woo, I., Roberts-Clark, D., Francis-West, P. 

Phrase: "S."

Phrase: ","

Phrase: "Jayatalake,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Maas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1416953:MAA [Gene or Genome]
   966   C1979919:MAA [Indicator, Reagent, or Diagnostic Aid]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Woo,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Roberts-Clark,"

Phrase: "D."

Phrase: ","

Phrase: "Francis-West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705493:West [Spatial Concept]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.6: H., Liu, Y.-H. et al. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Liu,"

Phrase: "Y.-H. et al."
Processing 00000000.tx.7: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.8: Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development. 

Phrase: "Regulation of Msx-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "Msx-2,"

Phrase: "Bmp-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0527443:BMP-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0279266:BMP [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Bmp-4 during foetal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0530979:BMP-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0015965:Fetal [Embryonic Structure]
   770   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0279266:BMP [Therapeutic or Preventive Procedure]
   770   C0521457:Fetal [Functional Concept]

Phrase: "and"

Phrase: "postnatal mammary gland development."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C1326631:mammary gland development [Organ or Tissue Function]
   902   C1135598:postnatal development [Organism Function]
   861   C1656975:gland development [Organ or Tissue Function]
   812   C0243107:development [Physiologic Function]
   812   C0678723:Development [Organism Function]
   812   C1527148:Development [Functional Concept]
   741 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.9: Development 122, 2729-2737.[Abstract/Free Full&nbsp;Text]

Phrase: "Development 122,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "2729-2737."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Pollock, R. 

Phrase: "Pollock,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0328442:Pollock [Fish]
  1000   C0453004:Pollack [Food]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.2: A., Jay, G. and Bieberich, C. 

Phrase: "A.,"

Phrase: "Jay,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326402:Jay [Bird]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Bieberich,"

Phrase: "C."
Processing 00000000.tx.3: J. 

Phrase: "J."
Processing 00000000.tx.4: (1992). 

Phrase: "(1992"

Phrase: ")."
Processing 00000000.tx.5: Altering the boundaries of Hox3.1 expression: evidence for antipodal gene regulation. 

Phrase: "Altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "the boundaries of Hox3.1 expression"

Phrase: ":"

Phrase: "evidence for antipodal gene regulation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.6: Cell 71, 911-923.[Medline]

Phrase: "Cell 71,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007634:Cell [Cell]
   861   C0450389:71 [Intellectual Product]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "911-923."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Rao, S. 

Phrase: "Rao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.2: S. and Kohtz, D. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Kohtz,"

Phrase: "D."
Processing 00000000.tx.3: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.4: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.5: Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. 

Phrase: "Positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "negative regulation of"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0205160:Negative [Qualitative Concept]
   790   C0851285:Regulation [Governmental or Regulatory Activity]
   790   C1327622:Regulation [Biologic Function]
   790   C1513916:Negative [Finding]
   790   C2825415:Negative [Conceptual Entity]
   790   C2825491:Negative [Qualitative Concept]

Phrase: "D-"

Phrase: "type cyclin expression in skeletal myoblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by basic fibroblast growth factor"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0380603:Fibroblast Growth Factor, Basic [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0919506:FIBROBLAST GROWTH FACTOR, BASIC [Gene or Genome]
  1000   C1522505:Basic Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0016026:Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0016030:Fibroblast [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1527178:Basic [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   741 E C0920750:basicity [Quantitative Concept]

Phrase: "and"

Phrase: "transforming growth factor beta."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
  1000   C0040690:Transforming Growth Factor beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2004068:Beta [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
Processing 00000000.tx.6: A role for cyclin D1 in control of myoblast differentiation. 

Phrase: "A role for cyclin D1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of myoblast differentiation."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1159966:myoblast differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.7: J. 

Phrase: "J."
Processing 00000000.tx.8: Biol. 

Phrase: "Biol."
Processing 00000000.tx.9: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.10: 270, 4093-4100.[Abstract/Free Full&nbsp;Text]

Phrase: "270,"

Phrase: "4093-4100."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Reznikoff, C. 

Phrase: "Reznikoff,"

Phrase: "C."
Processing 00000000.tx.2: A., Brankow, D. 

Phrase: "A.,"

Phrase: "Brankow,"

Phrase: "D."
Processing 00000000.tx.3: W. and Heidelberger, C. 

Phrase: "W."

Phrase: "and"

Phrase: "Heidelberger,"

Phrase: "C."
Processing 00000000.tx.4: (1973). 

Phrase: "(1973"

Phrase: ")."
Processing 00000000.tx.5: Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. 

Phrase: "Establishment"

Phrase: "and"

Phrase: "characterization of a cloned line of C3H mouse embryo cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1880022:Characterization [Activity]

Phrase: "sensitive to postconfluence inhibition of division."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332324:Sensitive to [Functional Concept]
           Sensitive
   753   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.6: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.7: 33, 3231-3238.[Medline]

Phrase: "33,"

Phrase: "3231-3238."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Satokata, I., Ma, L., Ohshima, H., Bei, M., Woo, I., Nishizawa, K., Maeda, T., Takano, Y., Uchiyama, M., Heaney, S. et al. 

Phrase: "Satokata,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ma,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ohshima,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bei,"

Phrase: "M."

Phrase: ","

Phrase: "Woo,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Nishizawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Maeda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takano,"

Phrase: "Y.,"

Phrase: "Uchiyama,"

Phrase: "M."

Phrase: ","

Phrase: "Heaney,"

Phrase: "S. et al."
Processing 00000000.tx.2: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.3: Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. 

Phrase: "Msx2 deficiency in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011155:Deficiency [Functional Concept]
   770   C0162429:Deficiency [Disease or Syndrome]
   770   C1623416:deficiency [Qualitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "pleiotropic defects in bone growth"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0243067:defects [Functional Concept]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "ectodermal organ formation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1658435:organ formation [Organ or Tissue Function]
   877   C1160068:ectoderm formation [Organ or Tissue Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
Processing 00000000.tx.4: Nat. 

Phrase: "Nat."
Processing 00000000.tx.5: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.6: 24, 391-395.[Medline]

Phrase: "24,"

Phrase: "391-395."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Satokata, I. and Maas, R. 

Phrase: "Satokata,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Maas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1416953:MAA [Gene or Genome]
   966   C1979919:MAA [Indicator, Reagent, or Diagnostic Aid]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.2: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.3: Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. 

Phrase: "Msx1 deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "cleft palate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0008925:Cleft Palate [Congenital Abnormality]
  1000   C1837218:CLEFT PALATE [Finding]
  1000   C2981150:Cleft palate [Congenital Abnormality]
   861   C0205242:Cleft [Spatial Concept]
   861   C0700374:Palate [Body Part, Organ, or Organ Component]
   861   C1278914:Palate [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "abnormalities of craniofacial"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   858   C0376634:Craniofacial Abnormalities [Congenital Abnormality]
   790   C0000768:Abnormalities [Congenital Abnormality]
   790   C0000769:abnormalities [Functional Concept]
   756 E C1704258:Abnormality [Finding]
   706 E C0205161:Abnormal [Qualitative Concept]
   706 E C2347472:% Abnormal [Quantitative Concept]
   706 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "and"

Phrase: "tooth development."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0028877:tooth development [Organ or Tissue Function]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.4: Nat. 

Phrase: "Nat."
Processing 00000000.tx.5: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.6: 6, 348-355.[Medline]

Phrase: "6,"

Phrase: "348-355."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Shen, M. 

Phrase: "Shen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: M. and Leder, P. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Leder,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.3: (1992). 

Phrase: "(1992"

Phrase: ")."
Processing 00000000.tx.4: Leukemia inhibitory factor is expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro. 

Phrase: "Leukemia inhibitory factor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0125606:leukemia inhibitory factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1366463:LEUKEMIA-INHIBITORY FACTOR [Gene or Genome]
  1000   C1453955:Leukemia-Inhibitory Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1761537:leukemia inhibitory factor [Molecular Function]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   827   C3463820:Inhibitory [Activity]

Phrase: "is"

Phrase: "expressed by the preimplantation uterus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0042149:Uterus [Body Part, Organ, or Organ Component]
   760   C1269032:Uterus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "selectively"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "primitive ectoderm formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1160068:ectoderm formation [Organ or Tissue Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.5: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.6: Natl. 

Phrase: "Natl."
Processing 00000000.tx.7: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.8: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.9: USA 89, 8240-8244.[Abstract]

Phrase: "USA 89,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "8240-8244."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Sherr, C. 

Phrase: "Sherr,"

Phrase: "C."
Processing 00000000.tx.2: J. and Roberts, J. 

Phrase: "J."

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.3: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.5: CDK inhibitors: positive and negative regulators of G1-phase progression. 

Phrase: "CDK inhibitors"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   966   C1152568:CDK inhibitor [Molecular Function]
   966   C1511576:CDK Inhibitor [Pharmacologic Substance]
   861   C0243045:CDK [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1150557:CDK [Molecular Function]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: ":"

Phrase: "positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "negative regulators of G1-phase progression."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0182953:regulators [Medical Device]
   753   C0205160:Negative [Qualitative Concept]
   753   C1513916:Negative [Finding]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]
   719 E C1704734:Regulator [Medical Device]
   719 E C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.6: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.7: 13, 1501-1512.[Free Full&nbsp;Text]

Phrase: "13,"

Phrase: "1501-1512."

Phrase: "[Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Sicinski, P., Donaher, J. 

Phrase: "Sicinski,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Donaher,"

Phrase: "J."
Processing 00000000.tx.2: L., Parker, S. 

Phrase: "L., Parker,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.3: B., Li, T., Fazeli, A., Gardner, H., Haslam, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Fazeli,"

Phrase: "A.,"

Phrase: "Gardner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Haslam,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.4: Z., Bronson, R. 

Phrase: "Z.,"

Phrase: "Bronson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.5: T., Elledge, S. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Elledge,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.6: J. and Weinberg, R. 

Phrase: "J."

Phrase: "and"

Phrase: "Weinberg,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.7: A. 

Phrase: "A."
Processing 00000000.tx.8: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.9: Cyclin D1 provides a link between development and oncogenesis in the retina and breast. 

Phrase: "Cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a link between development"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1517892:Link [Intellectual Product]
   770   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "oncogenesis in the retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007621:Oncogenesis [Neoplastic Process]
   770   C0596263:Oncogenesis [Neoplastic Process]

Phrase: "and"

Phrase: "breast."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0006141:Breast [Body Part, Organ, or Organ Component]
  1000   C1268990:Breast [Body Part, Organ, or Organ Component]
   944 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   944 E C1521735:Pectoral [Qualitative Concept]
   916 E C0817096:Chest [Body Location or Region]
   916 E C1527391:Chest [Body Location or Region]
Processing 00000000.tx.10: Cell 82, 621-630.[Medline]

Phrase: "Cell 82,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "621-630."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Skapek, S. 

Phrase: "Skapek,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.2: X., Rhee, J., Spicer, D. 

Phrase: "X.,"

Phrase: "Rhee,"

Phrase: "J.,"

Phrase: "Spicer,"

Phrase: "D."
Processing 00000000.tx.3: B. and Lassar, A. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Lassar,"

Phrase: "A."
Processing 00000000.tx.4: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.5: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.6: Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. 

Phrase: "Inhibition of myogenic differentiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "in proliferating myoblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596995:Myoblasts [Cell]

Phrase: "by cyclin D1-dependent kinase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.7: Science 267, 1022-1024.[Medline]

Phrase: "Science 267,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1022-1024."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Smith, R. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.2: C., Branellec, D., Gorski, D. 

Phrase: "C., Branellec,"

Phrase: "D."

Phrase: ","

Phrase: "Gorski,"

Phrase: "D."
Processing 00000000.tx.3: H., Guo, K., Perlman, H., Dedieu, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guo,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Perlman,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dedieu,"

Phrase: "J."
Processing 00000000.tx.4: F., Pastore, C., Mahfoudi, A., Denefle, P., Isner, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Pastore,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mahfoudi,"

Phrase: "A.,"

Phrase: "Denefle,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Isner,"

Phrase: "J."
Processing 00000000.tx.5: M. et al. 

Phrase: "M. et al."
Processing 00000000.tx.6: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.7: p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. 

Phrase: "p21CIP1-mediated inhibition of cell proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C1156236:Inhibition of Cell Proliferation [Cell Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "by overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "of the gax homeodomain gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0017347:Homeodomain Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.8: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.9: 11, 1674-1689.[Abstract]

Phrase: "11,"

Phrase: "1674-1689."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Song, K., Wang, Y. and Sassoon, D. 

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wang,"

Phrase: "Y."

Phrase: "and"

Phrase: "Sassoon,"

Phrase: "D."
Processing 00000000.tx.2: (1992). 

Phrase: "(1992"

Phrase: ")."
Processing 00000000.tx.3: Expression of Hox-7.1 in myoblasts inhibits terminal differentiation and induces cell transformation. 

Phrase: "Expression of Hox-7.1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in myoblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596995:Myoblasts [Cell]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "terminal differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C2752630:terminal differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cell transformation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0040682:cell transformation [Cell Function]
           Transformation
  1000   C1510411:Cell Transformation [Pathologic Function]
           Transformation
   861   C1705163:Transformation [Research Activity]
Processing 00000000.tx.4: Nature 360, 477-481.[Medline]

Phrase: "Nature 360,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "477-481."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Stewart, T. 

Phrase: "Stewart,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551641:Stewart [Population Group]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.2: A., Pattengale, P. 

Phrase: "A.,"

Phrase: "Pattengale,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.3: K. and Leder, P. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Leder,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.4: (1984). 

Phrase: "(1984"

Phrase: ")."
Processing 00000000.tx.5: Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. 

Phrase: "Spontaneous mammary adenocarcinomas in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0858252:Mammary adenocarcinoma [Neoplastic Process]
   753   C0001418:Adenocarcinomas [Neoplastic Process]
   753   C0006141:Mammary [Body Part, Organ, or Organ Component]
   753   C0929301:Mammary [Body Part, Organ, or Organ Component]
   750   C1522299:Mouse Adenocarcinoma [Neoplastic Process]

Phrase: "that"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "and"

Phrase: "express"

Phrase: "MTV/myc fusion genes."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   875   C0026902:Genes, myc [Gene or Genome]
   858 E C0079068:myc gene [Gene or Genome]
   858 E C0086661:MYC gene [Gene or Genome]
   844   C1533585:Fusion Gene [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.6: Cell 38, 627-637.[Medline]

Phrase: "Cell 38,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "627-637."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Suzuki, M., Tanaka, M., Iwase, T., Naito, Y., Sugimura, H. and Kino, I. 

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "M."

Phrase: ","

Phrase: "Tanaka,"

Phrase: "M."

Phrase: ","

Phrase: "Iwase,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Naito,"

Phrase: "Y.,"

Phrase: "Sugimura,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kino,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1011810:kino [Plant]
  1000   C1969618:KINO [Gene or Genome]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.2: (1993). 

Phrase: "(1993"

Phrase: ")."
Processing 00000000.tx.3: Over-expression of HOX-8, the human homolog of the mouse Hox-8 homeobox gene, in human tumors. 

Phrase: "Over-expression of HOX-8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205136:Over [Spatial Concept]

Phrase: "the human homolog of the mouse Hox-8 homeobox gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1334043:Gene Homolog [Gene or Genome]
           Homolog

Phrase: "in human tumors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]
Processing 00000000.tx.4: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.5: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.6: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.7: Commun. 

Phrase: "Commun."
Processing 00000000.tx.8: 194, 187-193.[Medline]

Phrase: "194,"

Phrase: "187-193."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Walsh, K. and Perlman, H. 

Phrase: "Walsh,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Perlman,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.2: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.3: Cell cycle exit upon myogenic differentiation. 

Phrase: "Cell cycle exit upon myogenic differentiation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0337094:Exit [Spatial Concept]
   753   C1550550:exit [Temporal Concept]
Processing 00000000.tx.4: Curr. 

Phrase: "Curr."
Processing 00000000.tx.5: Opin. 

Phrase: "Opin."
Processing 00000000.tx.6: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.7: Dev. 

Phrase: "Dev."
Processing 00000000.tx.8: 7, 597-602.[Medline]

Phrase: "7,"

Phrase: "597-602."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Wang, T. 

Phrase: "Wang,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.2: C., Cardiff, R. 

Phrase: "C., Cardiff,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.3: D., Zukerberg, L., Lees, E., Arnold, A. and Schmidt, E. 

Phrase: "D."

Phrase: ","

Phrase: "Zukerberg,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lees,"

Phrase: "E.,"

Phrase: "Arnold,"

Phrase: "A."

Phrase: "and"

Phrase: "Schmidt,"

Phrase: "E."
Processing 00000000.tx.4: V. 

Phrase: "V."
Processing 00000000.tx.5: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.6: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. 

Phrase: "Mammary hyperplasia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020507:Hyperplasia [Pathologic Function]

Phrase: "and"

Phrase: "carcinoma in MMTV-cyclin D1 transgenic mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1522070:Mouse Carcinoma [Neoplastic Process]
   748   C0007097:Carcinoma [Neoplastic Process]
Processing 00000000.tx.7: Nature 369, 669-671.[Medline]

Phrase: "Nature 369,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "669-671."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Wianny, F., Real, F. 

Phrase: "Wianny,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Real,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237400:Real [Qualitative Concept]
  1000   C3272377:REAL [Intellectual Product]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.2: X., Mummery, C. 

Phrase: "X.,"

Phrase: "Mummery,"

Phrase: "C."
Processing 00000000.tx.3: L., Rooijen, M. 

Phrase: "L., Rooijen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: V., Lahti, J., Samarut, J. and Savatier, P. 

Phrase: "V., Lahti,"

Phrase: "J.,"

Phrase: "Samarut,"

Phrase: "J."

Phrase: "and"

Phrase: "Savatier,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.5: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.6: G1 phase regulators, Cyclin D1, Cyclin D2 and Cyclin D3: up-regulation at gastrulation and dynamic expression during neurulation. 

Phrase: "G1 phase regulators,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0182953:regulators [Medical Device]
   793 E C1704734:Regulator [Medical Device]
   793 E C1704735:Regulator [Conceptual Entity]
   734   C0079395:G1 Phase [Temporal Concept]

Phrase: "Cyclin D1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "Cyclin D2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0214570:Cyclin-D2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413173:CYCLIN D2 [Gene or Genome]
  1000   C2718191:Cyclin D2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "and"

Phrase: "Cyclin D3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0173532:cyclin D3 [Amino Acid, Peptide, or Protein]
  1000   C1413175:CYCLIN D3 [Gene or Genome]

Phrase: ":"

Phrase: "up-regulation at gastrulation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0041904:Up-Regulation [Cell Function,Molecular Function]
   833   C0162493:Up-Regulation [Genetic Function]
   770   C0547043:Up [Spatial Concept]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1282911:Up [Spatial Concept]
   770   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "dynamic expression during neurulation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.7: Dev. 

Phrase: "Dev."
Processing 00000000.tx.8: Dyn. 

Phrase: "Dyn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600130:dyn [Quantitative Concept]
Processing 00000000.tx.9: 212, 49-62.[Medline]

Phrase: "212,"

Phrase: "49-62."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Wilkie, A. 

Phrase: "Wilkie,"

Phrase: "A."
Processing 00000000.tx.2: O. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.3: M., Tang, Z., Elanko, N., Walsh, S., Twigg, S. 

Phrase: "M."

Phrase: ","

Phrase: "Tang,"

Phrase: "Z.,"

Phrase: "Elanko,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Walsh,"

Phrase: "S."

Phrase: ","

Phrase: "Twigg,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.4: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.5: F., Hurst, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hurst,"

Phrase: "J."
Processing 00000000.tx.6: A., Wall, S. 

Phrase: "A.,"

Phrase: "Wall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0677535:Wall [Manufactured Object]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.7: A., Chrzanowska, K. 

Phrase: "A.,"

Phrase: "Chrzanowska,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.8: H. and Maxson, R. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Maxson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.9: E. 

Phrase: "E."
Processing 00000000.tx.10: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.11: Funtional haploinsufficiency of the human homeobox gene MSX2 causes defects in skull ossification. 

Phrase: "Funtional haploinsufficiency of the human homeobox gene MSX2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2936267:Haploinsufficiency [Cell or Molecular Dysfunction]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "defects in skull ossification."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   819   C1969678:Ossification defects [Finding]
   770   C0243067:defects [Functional Concept]
   737 E C1457869:Defect [Functional Concept]
   737 E C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.12: Nat. 

Phrase: "Nat."
Processing 00000000.tx.13: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.14: 24, 387-390.[Medline]

Phrase: "24,"

Phrase: "387-390."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Winograd, J., Reilly, M. 

Phrase: "Winograd,"

Phrase: "J.,"

Phrase: "Reilly,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: P., Roe, R., Lutz, J., Laughner, E., Xu, X., Hu, L., Asakura, T., vander Kolk, C., Strandberg, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Roe,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lutz,"

Phrase: "J.,"

Phrase: "Laughner,"

Phrase: "E.,"

Phrase: "Xu,"

Phrase: "X.,"

Phrase: "Hu,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Asakura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "vander Kolk,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Strandberg,"

Phrase: "J."
Processing 00000000.tx.3: D. et al. 

Phrase: "D. et al."
Processing 00000000.tx.4: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.5: Perinatal lethality and multiple craniofacial malformations in MSX2 transgenic mice. 

Phrase: "Perinatal lethality"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C3277740:Perinatal lethality [Finding]
   964 E C1833770:Perinatal lethal [Finding]
   789   C3151529:Lethal [Finding]

Phrase: "and"

Phrase: "multiple craniofacial malformations in MSX2 transgenic mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0000768:malformations [Congenital Abnormality]
   748   C0243070:malformations [Functional Concept]
Processing 00000000.tx.6: Hum. 

Phrase: "Hum."
Processing 00000000.tx.7: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.8: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.9: 6, 369-379.[Abstract/Free Full&nbsp;Text]

Phrase: "6,"

Phrase: "369-379."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Woloshin, P., Song, K., Degnin, C., Killary, A. 

Phrase: "Woloshin,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Degnin,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Killary,"

Phrase: "A."
Processing 00000000.tx.2: M., Goldhamer, D. 

Phrase: "M."

Phrase: ","

Phrase: "Goldhamer,"

Phrase: "D."
Processing 00000000.tx.3: J., Sassoon, D. and Thayer, M. 

Phrase: "J.,"

Phrase: "Sassoon,"

Phrase: "D."

Phrase: "and"

Phrase: "Thayer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: J. 

Phrase: "J."
Processing 00000000.tx.5: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.6: MSX1 inhibits MyoD expression in fibroblast x 10T1/2 cell hybrids. 

Phrase: "MSX1"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "MyoD expression in fibroblast x 10T1/2 cell hybrids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.7: Cell 82, 611-620.[Medline]

Phrase: "Cell 82,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "611-620."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Xu, C., Ji, X., Harris, M. 

Phrase: "Xu,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ji,"

Phrase: "X.,"

Phrase: "Harris,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: A., Mundy, G. 

Phrase: "A.,"

Phrase: "Mundy,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.3: R. and Harris, S. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Harris,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.4: E. 

Phrase: "E."
Processing 00000000.tx.5: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.6: A clonal chondrocytic cell line derived from BMP-2/T antigen-expressing transgenic mouse. 

Phrase: "A clonal chondrocytic cell line"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0007600:Cell Line [Cell]
   839   C0009013:Clone Cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "derived from BMP-2/T antigen-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0003343:T-Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0527443:BMP-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003320:Antigen [Immunologic Factor]
   753   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0279266:BMP [Therapeutic or Preventive Procedure]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "expressing"

Phrase: "transgenic mouse."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mouse, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]
Processing 00000000.tx.7: In Vitro Cell Dev. 

Phrase: "In Vitro Cell Dev."
Processing 00000000.tx.8: Biol. 

Phrase: "Biol."
Processing 00000000.tx.9: Anim. 

Phrase: "Anim."
Processing 00000000.tx.10: 34, 359-363.[Medline]

Phrase: "34,"

Phrase: "359-363."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Yaffe, D. and Saxel, O. 

Phrase: "Yaffe,"

Phrase: "D."

Phrase: "and"

Phrase: "Saxel,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.2: (1977). 

Phrase: "(1977"

Phrase: ")."
Processing 00000000.tx.3: Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. 

Phrase: "Serial passaging"

Phrase: "and"

Phrase: "differentiation of myogenic cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0007589:cells differentiation [Cell Function]
           Differentiation
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "isolated from dystrophic mouse muscle."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C1513763:Mouse Muscle [Tissue]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0026845:Muscle [Tissue]
   760   C0205409:Isolated [Functional Concept]
   760   C0333607:Dystrophic [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.4: Nature 270, 725-727.[Medline]

Phrase: "Nature 270,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "725-727."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Zhang, H., Catron, K. 

Phrase: "Zhang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Catron,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.2: M. and Abate-Shen, C. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Abate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: "Shen,"

Phrase: "C."
Processing 00000000.tx.3: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.4: A role for the Msx-1 homeodomain in transcriptional regulation: residues in the N-terminal arm mediate TATA binding protein interaction and transcriptional repression. 

Phrase: "A role for the Msx-1 homeodomain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in transcriptional regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1158770:Transcriptional Regulation [Genetic Function]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]

Phrase: ":"

Phrase: "residues in the N-terminal arm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "TATA binding protein interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0872079:protein interaction [Molecular Function]
   812   C1704675:Interaction [Functional Concept]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "transcriptional repression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0920533:Transcriptional Repression [Genetic Function]
   861   C0035143:Repression [Mental Process]
Processing 00000000.tx.5: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.6: Natl. 

Phrase: "Natl."
Processing 00000000.tx.7: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.8: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.9: USA 93, 1764-1769.[Abstract/Free Full&nbsp;Text]

Phrase: "USA 93,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "1764-1769."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Zhang, H., Hu, G., Wang, H., Sciavolino, P., Iler, N., Shen, M. 

Phrase: "Zhang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hu,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Wang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sciavolino,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Iler,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Shen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: M. and Abate-Shen, C. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Abate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878195:Abate [Activity]

Phrase: "Shen,"

Phrase: "C."
Processing 00000000.tx.3: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.4: Heterodimerization of Msx and Dlx homeoproteins results in functional antagonism. 

Phrase: "Heterodimerization of Msx"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1512424:Heterodimerization [Molecular Function]

Phrase: "and"

Phrase: "Dlx homeoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242617:Homeoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "results in functional antagonism."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205245:Functional [Functional Concept]
   770   C0542341:Functional [Functional Concept]
   770   C0680242:antagonism [Social Behavior]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2700217:Functional [Conceptual Entity]
   770   C2825142:Result [Finding]
Processing 00000000.tx.5: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.6: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.7: Biol. 

Phrase: "Biol."
Processing 00000000.tx.8: 17, 2920-2932.[Abstract]

Phrase: "17,"

Phrase: "2920-2932."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

